0001493152-17-009199.txt : 20170814 0001493152-17-009199.hdr.sgml : 20170814 20170814154729 ACCESSION NUMBER: 0001493152-17-009199 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 85 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170814 DATE AS OF CHANGE: 20170814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KIWA BIO-TECH PRODUCTS GROUP CORP CENTRAL INDEX KEY: 0001159275 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 870448400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-33167 FILM NUMBER: 171029869 BUSINESS ADDRESS: STREET 1: 3200 GUASTI ROAD, STREET 2: SUITE 100 CITY: ONTARIO STATE: CA ZIP: 91761 BUSINESS PHONE: 626-715-5855 MAIL ADDRESS: STREET 1: 3200 GUASTI ROAD, STREET 2: SUITE 100 CITY: ONTARIO STATE: CA ZIP: 91761 FORMER COMPANY: FORMER CONFORMED NAME: TINTIC GOLD MINING CO DATE OF NAME CHANGE: 20010918 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2017

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ____________ to ____________

Commission File Number: 000-33167

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

(Exact name of registrant as specified in its charter)

Nevada		77-0632186
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

3200 Guasti Road, Suite #100, Ontario, California		91761
(Address of principal executive offices)		(Zip Code)

(909) 456-8828

(Registrant’s telephone number, including area code)

310 N. Indian Hill Blvd., #702

Claremont, California 91711

(Former address)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [ ]

Non-accelerated filer [ ]	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

As of August 14, 2017, the Company had 10,459,217 shares of common stock, $0.001 par value, issued and outstanding.

Table of contents

PART I. FINANCIAL INFORMATION

Item 1. CONDENSED UNAUDITED CONSOLIDATED Financial Statements	3

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	23

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	28

Item 4. Controls and Procedures	28

PART II. OTHER INFORMATION

Item 1. Legal Proceedings	29

ITEM 1A. RISK FACTORS	29

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	29

Item 3. Defaults Upon Senior Securities	29

Item 4. Mine safety disclosures	29

Item 5. Other Information	29

Item 6. Exhibits	30

SIGNATURES	31

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

KIWA BIO-TECH PRODUCTS GROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2017		December 31, 2016
	(Unaudited)
ASSETS
Current assets
Cash and cash equivalents	$	71,554	$	13,469
Accounts receivable, net		9,425,359		1,122,754
Prepaid expenses		66,769		92,504
Other receivable		1,471,291		1,561,331
Rent Deposit-current		39,301		-
Advance to suppliers		1,255,218		1,805,044
Total current assets		12,329,492		4,595,102
OTHER ASSETS
Property, plant and equipment, net		43,312		59,778
Rent Deposit-non current		33,907		34,519
Deposit for Long-Term Investment		147,423		-
Goodwill and Intangible Assets		35,114		34,112
Total non-current assets		259,756		128,409
Total assets	$	12,589,248	$	4,723,511

LIABILITIES AND STOCKHOLDERS’ EQUITY(DEFICIENCY)
Current liabilities
Accounts payable	$	4,697,764	$	1,318,802
Accrued expenses		17,183		35,715
Advances from customers		-		12,883
Construction costs payable		-		255,539
Due to related parties - trade		-		1,122,754
R&D expense payable		233,598		160,461
Due to related parties - non-trade		83,798		100,798
Convertible notes payable		1,106,205		150,250
Notes payable		360,000		360,000
Unsecured loans payable		-		1,655,343
Salary payable		1,225,869		1,688,353
Taxes payable		616,908		919,255
Penalty payable		523,140		482,327
Interest payable		1,124,638		1,042,661
Other payables		865,793		1,019,583
Total current liabilities		10,854,896		10,324,724

SHAREHOLDER’S EQUITY(DEFICIENCY)
Preferred stock - $0.001 par value, Authorized 20,000,000 shares. Issued and outstanding 500,000 and 500,000 shares at June 30, 2017 and December 31, 2016, respectively.		500		500
Common stock - $0.001 per value. Authorized 100,000,000 shares. Issued and outstanding $10,028,219 and 8,728,981 shares at June 30, 2017 and December 31, 2016, respectively		10,028		8,729
Additional paid-in capital		15,741,427		13,789,990
Statutory Reserve		307,350		127,884
Accumulated deficit		(14,343,604)		(19,489,400)
Accumulated other comprehensive gain (loss)		18,651		(38,916)
Total stockholders’ equity (deficiency)		1,734,352		(5,601,213)
Total liabilities and shareholder’s equity	$	12,589,248	$	4,723,511

The accompanying notes are an integral part of these condensed consolidated financial statements.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2017			2016			2017			2016

Revenue	$	5,682,108		$	-		$	8,827,897		$	-

Cost of goods sold		(3,970,915	)		-			(6,034,924	)		-

Gross Profit		1,711,193			-			2,792,973			-

Operating expenses
Selling expense		54,232			-			90,485			-
Research and development		36,433			74,776			72,724			151,769
General and administrative		664,019			138,786			1,095,396			225,670
Total operating expenses		754,685			213,562			1,258,606			377,439

Operating income (loss)		956,508			(213,562	)		1,534,367			(377,439	)

Other Income
License revenue		-			443,085			-			710,095

Other expense
Penalty expense		(20,575	)		(19,223	)		(40,814	)		(38,108	)
Interest expense		(52,346	)		(28,325	)		(83,430	)		(56,443	)
Total other expense		(72,921	)		(47,548	)		(124,244	)		(94,551	)

Income from continuing operations before income taxes		883,587			181,975			1,410,123			238,105
Income taxes		(379,973	)		-			(599,022	)		-
Income from continuing operations		503,614			181,975			811,101			238,105

Discontinued operations
Gain from discontinued operations, net of taxes		4,513,363			-			4,514,161			-

Net Income		5,016,977			181,975			5,325,262			238,105

Other comprehensive income
Foreign currency translation adjustment		89,910			129,199			57,567			94,105
Total comprehensive income	$	5,106,887		$	311,174		$	5,382,830		$	332,210

Earnings per share – Basis:
Income from continuing operations		0.05			0.07			0.09			0.06
Discontinued operations		0.46			-			0.47			-
Net Income		0.51			0.07			0.56			0.06

Earnings per share – Diluted:
Income from continuing operations		0.05			0.05			0.08			0.04
Discontinued operations		0.40			-			0.41			-
Net Income		0.45			0.05			0.49			0.04

Weighted average number of common shares outstanding - basic		9,865,031			2,617,584			9,564,506			3,766,705
Weighted average number of common shares outstanding - diluted		11,360,700			3,550,696			11,033,303			5,623,035

The accompanying notes are an integral part of these condensed consolidated financial statements.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Six Months Ended June, 30
	2017			2016
Cash flows from operating activities:
Net income	$	5,325,262		$	238,105
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation		17,787			3,073
Amortization		58			-
Provision for penalty payable		40,813			38,108
Accrued interest on convertible notes		83,430			56,443
Employee benefits		102,743			-
Consulting fee		372,465			-
Changes in operating assets and liabilities:
Accounts receivable		(8,164,649	)		(54,940	)
Other receivables		126,080			(1,210,111	)
Advance to supplier		585,523			-
Rent & Utility Deposit		(37,412	)		-
Prepaid expenses		26,626			-
Accounts payable		3,302,256			49,999
Advance from customers		(13,018	)		-
Accrued expenses		(19,089	)		-
Salary payable		(468,631	)		78,080
Taxes payable		(320,211	)		29,982
Due to related parties - trade		(1,061,367	)		153,033
Other payable		(166,874	)		469,297
Loan payable		(1,672,666	)		-
Construction cost payable		(258,213	)		-
Net cash used in operating activities		(2,199,087	)		(148,931	)

Cash flows from investing activities:
Purchase of intangible assets		(1,047	)
Investment in subsidiary		(145,449	)		-
Purchase of property plant and equipment		(1,286	)		(78,775	)
Net cash used by investing activities		(147,782	)		(78,775	)

Cash flows from financing activities:
Proceeds from related parties, net of payments to related parties		17,000			40,500
Proceeds from sales of common stock		1,481,508			176,000
Proceeds from convertible note		955,955			-
Net cash provided by financing activities		2,454,463			216,500

Effect of exchange rate change		(49,509	)		22,852

Cash and cash equivalents:
Net increase		58,085			11,646
Balance at beginning of period		13,469			721
Balance at end of period	$	71,554		$	12,367

Non-cash financing activities:
Issuance of common stock for debts settlement	$	-		$	3,141,000
Issuance of common stock for consulting service	$	179,897		$	-
Supplemental Disclosures of Cash flow Information:
Cash paid for interest	$	-		$	-
Cash paid for income taxes	$	411,846		$	-

The accompanying notes are an integral part of these condensed consolidated financial statements.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. Description of Business and Organization

Organization

Kiwa Bio-Tech Products Group Corporation (“the Company”) is the result of a share exchange transaction accomplished on March 12, 2004 between the shareholders of Kiwa Bio-Tech Products Group Ltd. (“Kiwa BVI”), a company originally organized under the laws of the British Virgin Islands on June 5, 2002 and Tintic Gold Mining Company (“Tintic”), a corporation originally incorporated in the state of Utah on June 14, 1933 to perform mining operations in Utah. The share exchange resulted in a change of control of Tintic, with former Kiwa BVI stockholders owning approximately 89% of Tintic on a fully diluted basis and Kiwa BVI surviving as a wholly-owned subsidiary of Tintic. Subsequent to the share exchange transaction, Tintic changed its name to Kiwa Bio-Tech Products Group Corporation. On July 21, 2004, the Company completed its reincorporation in the State of Delaware. On March 8, 2017, we completed our reincorporation in the State of Nevada.

The Company operates through a series of subsidiaries in the Peoples Republic of China as detailed in the following Organizational Chart. The Company had previously operated its business through its subsidiaries Kiwa Bio-Tech Products (Shandong) Co., Ltd. (“Kiwa Shandong”) and Tianjin Kiwa Feed Co., Ltd. (“Kiwa Tianjin “). Kiwa Tianjin has been dissolved since July 11, 2012. On February 11, 2017, the Company entered an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) to transfer all of shareholders’ right, title and interest in Kiwa Shandong to the Transferee for USD $1.00. On April 12, 2017, the government processing of transfer has been completed.

Business

The Company’s business plan is to develop and market innovative, manufacture, distribute cost-effective and environmentally safe bio-technological products for agriculture markets primarily in China. The Company has acquired technologies to produce and market bio-fertilizer.

2. Summaries of Significant Accounting Policies

Principle of Consolidation

These consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries, Kiwa BVI, Hong Kong Baina Group Holding Company, Kiwa Baiao Bio-Tech (Beijing) Co., Ltd, Kiwa Baiao Bio-Tech (Shandong) Co., Ltd (“Kiwa Shandong”), Kiwa Bio-Tech Products (Shenzhen) Co., Ltd and Kiwa Bio-Tech Products (Hebei) Co., Ltd. All significant inter-company balances or transactions are eliminated on consolidation.

Reverse Split

On January 14, 2016, the Company filed a Certificate of Amendment of its Certificate of Incorporation with the State of Delaware with reference to a 1-for-200 reverse stock split with respect to its Common Stock with effective date of January 28, 2016. In connection with the reverse split, the Company’s authorized capital was amended to be 120,000,000 shares, comprising 100,000,000 shares of Common Stock par value $0.001 and 20,000,000 shares of Preferred Stock par value $0.001. All relevant information relating to numbers of shares, options and per share information have been retrospectively adjusted to reflect the reverse stock split for all periods presented.

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant accounting estimates include the valuation of securities issued, deferred tax assets and related valuation allowance.

Certain of our estimates, including evaluating the collectability of accounts receivable and the fair market value of long-lived assets, could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. We re-evaluate all of our accounting estimates annually based on these conditions and record adjustments when necessary.

Cash and Cash Equivalents

Cash and cash equivalents consist of all cash balances and highly liquid investments with an original maturity of three months or less. Because of the short maturity of these investments, the carring amounts approximate their fair value. Restricted cash is excluded from cash and cash equivalents.

Accounts Receivables

Accounts receivables represent customer accounts receivables. The allowance for doubtful accounts is based on a combination of current sales, historical charge offs and specific accounts identified as high risk. Uncollectible accounts receivable are charged against the allowance for doubtful accounts when all reasonable efforts to collect the amounts due have been exhausted. Such allowances, if any, would be recorded in the period the impairment is identified.

Allowance for doubtful accounts

The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. There was no allowance for doubtful accounts at June 30, 2017 and December 31, 2016.

Property, plant and equipment

Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Gains or losses on disposals are reflected as gain or loss in the year of disposal. The cost of improvements that extend the life of property, plant and equipment are capitalized. These capitalized costs may include structural improvements, equipment and fixtures. All ordinary repair and maintenance costs are expensed as incurred. Depreciation for financial reporting purposes is provided using the straight-line method over the estimated useful lives of the assets as follows:

	Useful Life
	(In years)
Buildings		30 - 35
Machinery and equipment		5 - 10
Automobiles		8
Office equipment		2 - 5
Computer software		3

Impairment of Long-Lived Assets

The Company’s long-lived assets consist of property, equipment and intangible assets. The Company evaluates its investment in long-lived assets, including property and equipment, for recoverability whenever events or changes in circumstances indicate the net carrying amount may not be recoverable. Judgments regarding potential impairment are based on legal factors, market conditions and operational performance indicators, among others. In assessing the impairment of property and equipment, the Company makes assumptions regarding the estimated future cash flows and other factors to determine the fair value of the respective assets.

Goodwill and Other Intangibles

In accordance with Accounting Standards Update (ASU) No. 2014-02, management evaluates goodwill on an annual basis in the fourth quarter of more frequently if management believes indicators of impairment exist. Such indicators could, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. If management concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, management conducts a two-step quantitative goodwill impairment test. The first step of the impairment test involves comparing the fair value of the applicable reporting unit with its carrying value. The Company estimates the fair value of its reporting units using a combination of the income, or discounted cash flows, approach and the market approach, with utilizes comparable companies’ data. If the carrying amount of a reporting unit exceeds the reporting unit’s fair value, management performs the second step of the goodwill impairment test. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit’s goodwill with the carrying value of that goodwill. The amount, by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss. The Company’s evaluation of goodwill completed during the three and six months ended June 30, 2017 resulted in no impairment losses.

Fair Value of Financial Instruments

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820- 10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value with U.S. GAAP, and expands disclosures about fair value measurements.

To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

	●	Level 1: quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

	●	Level 2: pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

	●	Level 3: Pricing inputs that are generally observable inputs and not corroborated by market data.

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The carrying amount of the Company’s financial assets and liabilities, such as cash and cash equivalent, prepaid expenses, accounts payable and accrued expenses, approximate their fair value because of the short maturity of those instruments.

Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.

It is not however practical to determine the fair value of advances from stockholders, if any, due to their related party nature.

Revenue Recognition

The Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.

The Company derives its revenues from sales contracts with its customers with revenues being recognized upon delivery of products. Persuasive evidence of an arrangement is demonstrated via invoice; and the sales price to the customer is fixed upon acceptance of the purchase order and there is no separate sales rebate, discount, or volume incentive.

Advertising Costs

The Company charges all advertising costs to expense as incurred. The total amounts of advertising costs charged to selling, general and administrative expense were $58,419 and nil for the six months ended June 30, 2017 and 2016, and were $935 and nil for the three months ended June 30, 2017 and 2016, respectively.

Research and Development Costs

Research and development costs are charged to expense as incurred. During the six months ended June 30, 2017 and 2016, research and development costs were $72,724 and $151,769, respectively. During the three months ended June 30, 2017 and 2016, research and development costs were $36,433 and $74,776, respectively.

Shipping and Handling Costs

Substantially all costs of shipping and handling of products to customers are included in selling expense. Shipping and handling costs for the three and six months ended June 30, 2017 and 2016 were nil, respectively.

Income Taxes

The Company accounts for income taxes under the provisions of FASB ASC Topic 740, “Income Tax,” which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the difference between the tax bases of assets and liabilities and their reported amounts in the financial statements. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company establishes a valuation when it is more likely than not that the assets will not be recovered.

ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. We have no material uncertain tax positions for any of the reporting periods presented.

Stock Based Compensation

The Company accounts for share-based compensation awards to employees in accordance with FASB ASC Topic 718, “Compensation – Stock Compensation”, which requires that share-based payment transactions with employees be measured based on the grant-date fair value of the equity instrument issued and recognized as compensation expense over the requisite service period.

The Company accounts for share-based compensation awards to non-employees in accordance with FASB ASC Topic 718 and FASB ASC Subtopic 505-50, “Equity-Based Payments to Non-employees”. Under FASB ASC Topic 718 and FASB ASC Subtopic 505-50, stock compensation granted to non-employees has been determined as the fair value of the consideration received or the fair value of equity instrument issued, whichever is more reliably measured and is recognized as an expense as the goods or services are received.

Foreign Currency Translation and Other Comprehensive Income

The Company uses United States dollars (“US Dollar” or “US$” or “$”) for financial reporting purposes. However, the Company maintains the books and records in its functional currency, Chinese Renminbi (“RMB”), being the functional currency of the economic environment in which its operations are conducted. In general, the Company translates its assets and liabilities into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statement of comprehensive loss and the statement of cash flow are translated at average exchange rates during the reporting period. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the Company’s financial statements are recorded as accumulated other comprehensive income.

Other comprehensive income for the six months ended June 30, 2017 and 2016 represented foreign currency translation adjustments and were included in the consolidated statements of comprehensive loss.

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the consolidated financial statements were as follows:

		As of June 30, 2017				As of December 31, 2016
Balance sheet items, except for equity accounts			6.7832				6.9472

	Six months ended June 30
	2017		2016
Items in the statements of comprehensive loss		6.8753		6.5345

Earnings Per Common Share

Net income per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the period.

Diluted net income per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly Influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the consolidated financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Commitments and Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Cash Flows Reporting

The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.

Subsequent Events

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), Revenue from Contracts with Customers. ASU 2014-09 will eliminate transaction- and industry-specific revenue recognition guidance under current GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. ASU 2014-09 also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. Based on the FASB’s Exposure Draft Update issued on April 29, 2015, and approved in July 2015, Revenue from Contracts With Customers (Topic 606): Deferral of the Effective Date, ASU 2014-09 is now effective for reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The adoption of ASU 2014-09 is not expected to have any impact on the Company’s financial statement presentation or disclosures.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term. ASU 2016-02 requires classification of all cash payments within operating activities in the statement of cash flows. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. ASU 2016-02 is effective for fiscal years beginning after December IS, 2018, including interim periods within those fiscal years. Early application is permitted. The Company has not yet evaluated the impact of the adoption of ASU 2016-02 on the Company’s financial statement presentation or disclosures.

In January 2017, the FASB issued ASU 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” The amendments in this guidance are clarifying the definition of a business to assist entities when determining whether an integrated set of assets and activities meets the definition of a business. The update provides that when substantially all the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The adoption of this new guidance is not expected to have a material impact on our consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04—Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The amendments in this guidance to eliminate the requirement to calculate the implied fair value of goodwill to measure goodwill impairment charge (Step 2). As a result, an impairment charge will equal the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the amount of goodwill allocated to the reporting unit. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The amendment should be applied on a prospective basis. The guidance is effective for goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for goodwill impairment tests performed after January 1, 2017. The impact of this guidance for the Company will depend on the outcomes of future goodwill impairment tests.

In May 2017, the FASB issued Accounting Standards Update No. 2017-09 (ASU 2017-09), Compensation — Stock Compensation (Topic 718) Scope of Modification Accounting. The amendments in ASU 2017-09 provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The adoption of ASU 2017-09 which will become effective for annual periods beginning after December 15, 2017 and for interim periods within those annual periods, is not expected to have any impact on the Company’s financial statement presentation or disclosures.

Management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

3. Accounts Receivable, net

Accounts receivable consisted of the following:

	June 30, 2017		December 31, 2016
Accounts receivable	$	9,425,359	$	1,122,754
Less: Allowance for doubtful debts		-		-
Accounts receivable, net	$	9,425,359	$	1,122,754

As of June 30, 2017 and December 31, 2016, the management has determined that no allowance for doubtful debts was necessary.

4. Prepaid Expense

Prepaid expenses consisted of the following:

	June 30, 2017		December 31, 2016
Prepaid office rent	$	28,021	$	12,504
Prepaid government filing expense		33,588		5,000
Prepaid packaging expense		-		75,000
Prepayment for purchasing furniture		5,160		-
	$	66,769	$	92,504

5. Other Receivable

Other receivable consisted of the following:

	June 30, 2017		December 31, 2016
Due from customer-Kangtan Gerui (Beijing) Bio-Tech Co., Ltd.		1,338,111		1,522,435
Advance to employees		105,171		31,700
Others		28,009		7,196
Less: Allowance for doubtful debts		-		-
Other receivable, net	$	1,471,291	$	1,561,331

Due from customer-Kangtan Gerui (Beijing) Bio-Tech Co.,Ltd. represents the remaining balance of advancement for production of fertilizers during the first through the third quarter of 2016. In September 2016, the Company obtained a fertilizer sales permit from Chinese government and began to sell the products by their own and gradually decrease the business cooperation with Gerui.

For the six months ended June 30, 2017, the Company has collected $184,324 advancement from Gerui and management has determined that no allowance for doubtful debts was necessary.

6. Advance to suppliers

Since currently the Company does not have manufacturing facility, it has contracted with several third parties to produce fertilizer products. Pursuant to the agreements entered by the Company and those third party companies, the Company was required to make partially prepayments in advance of purchase or completion of productions. As of June 30, 2017 and December 31, 2016, such advance to suppliers was $ 1,255,218 and $1,805,044, respectively.

7. Property, Plant and Equipment

Property, plant and equipment, net consisted of the following:

	June 30, 2017			December 31, 2016
Office equipment	$	942		$	942
Furniture		10,260			8,276
Leasehold improvement		72,174			70,871
Total Property, plant and equipment	$	83,376		$	80,089
Less: accumulated depreciation		(40,064	)		(20,311	)
Less: impairment of long-lived assets		-			-
Property, plant and equipment - net	$	43,312		$	59,778

Depreciation expense was $17,787 and $ 3,073 for the six months ended June 30, 2017 and 2016, and $8,318 and $3,073 for the three months ended June 30, 2017 and 2016, respectively.

Impairment of long-lived assets was nil for the three and six months ended June 30, 2017 and 2016, respectively.

All of our property, plant and equipment have been held as collateral to secure the 6% Notes (see Note 14).

8. Deposit for long-term investment

On June 8, 2017, the Company entered an equity purchase agreement with Yantai Peng Hao New Materials Technology Co. Ltd., which relates to the acquisition of a new factory for purchase price of about $2.2 million (approximately RMB 15 million). The factory to be acquired by the Company will be completed in accordance with the Company’s construction plan to facilitate the production design of combining of microbial fermentation and terminal fertilizer products.

Pursuant to the payment terms of purchase agreement, the Company made the first payment of $147,423 (approximately RMB 1,000,000) to Yantai Peng Hao New Materials Technology Co. Ltd. on June 30, 2017.

9. Goodwill and other intangibles

On November 30, 2015, Kiwa Bio-tech Products Group Ltd in BVI (“Kiwa BVI”) entered an acquisition agreement with shareholders of Caber Holdings Ltd. (“Acquiree”) in Hong Kong to acquire 100 percent entity interest of the acquiree, including a wholly owned subsidiary, Oriental Baina Co., Ltd. in Beijing for US$30,000. The acquisition was completed in January, 2016. On the acquisition date, there was no any asset or liability acquired, and thus no fair value was allocated to asset and liability. Including legal fee and government fees, the total payment of approximately $34,112 ($30,000 plus legal fee and government fees totaled $4,112) was recorded as goodwill. The fair value of the goodwill is tested prior to June 30, 2017 and management determined there is no impairment to the goodwill as of June 30, 2017.

The Company purchased the computer software in May, 2017, which cost was $ 1,061. Amortization expense for the three and six months ended June 30, 2017 was $59 and nil.

10. Construction Costs Payable

Construction costs payable mainly represents the payables which had been carried on Kiwa Shandong’s book for a length of years. As of December 31, 2016, construction costs payable was $255,539.

On February 11, 2017, the Company entered an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) to transfer all of shareholders’ right, title and interest, as well as all the obligations in Kiwa Shandong to the Transferee for USD $1.00. On April 12, 2017, the transaction was completed and the balance was removed.

11. Related Party Transactions

(1). Amounts due to related parties

Amounts due to related parties consisted of the following as of June 30, 2017 and December 31, 2016:

Item

Nature

Notes

June 30, 2017

December 31, 2016

Kiwa-CAU R&D Center

Trade

(b)

1,122,754

CAAS IARRP and IAED Institutes

Trade

(c)

160,461

Total

1,283,215

(a) Yvonne Wang

Ms. Wang is a board member and Acting President, Acting Chief Executive Officer and Acting Chief Financial Officer. From time to time, Ms. Wang paid various expenses on behalf of the Company. As of June 30, 2017 and December 31, 2016, the amount due to Ms. Wang was $83,798 and $100,798, respectively.

(b) In November 2006, Kiwa and China Agricultural University (the “CAU”) agreed to jointly establish a new research and development center, named Kiwa-CAU R&D Center. Pursuant to the agreement, Kiwa committed to fund RMB 1 million (approximately $160,000) annually to the research center. Prof. Qi Wang, a director of the Company was also the director of Kiwa-CAU R&D Center. Although the agreement was expired on June 30, 2016, the payable balance remains on Kiwa Shandong’s book until April 12, 2017 when the transaction of transfer Kiwa Shandone’s all assets and liabilities to Dian ShiCheng Jing (Beijing) was completed.

The Company recorded nil and $36,363 research and development expenses related to this Kiwa-CAU R&D Center for the six months ended June 30, 2017 and 2016, respectively.

(c) On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). The term of the Agreement was three years ends on November 4, 2017.

Pursuant to the agreement, Kiwa agree to invest RMB 1 million (approximately $160,000) each year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. Prof. Yong Chang Wu, the authorized representative of IARRP, CAAS, was also one of the Company's directors until he resigned on March 13, 2017. Since Prof. Yong Chang Wu is no longer a board member, the balance of $233,598 at June 30, 2017 has been reclassified from part due to related party – trade to R&D expenses payable.

The Company recorded $36,291and $38,764 research and development expenses related to the institutes, for the six months ended June 30, 2017 and 2016, respectively.

(2). Convertible Note Payables

(a). Geng Liu

Geng Liu became a shareholder of the Company and has held 500,000 shares of common stock since September, 2016

On January 17, 2017, the Company entered into a Convertible Loan Agreement with Geng Liu wherein the lender agreed to advance of approximately US $442,269 (RMB3,000,000) under a Convertible Promissory Note with a term of 12 months bearing interest at a rate of Fifteen Percent (15%) per annum. The Loan is convertible into Common Stock at any time at the option of the Lender at a conversion price of $ 0.90 per share within the term.

As of June 30, 2017, the Company received proceeds about $147,423 (RMB 1,000,000) from Geng Liu and recorded interest expense related to this note $5,442 and $8,472 for the three and six months ended June 30, 2017, respectively.

(b). Junwei Zheng

Junwei Zheng became a shareholder of the Company and has held 920,000 shares of common stock since March, 2017

On May 9, 2017, Company entered into a Convertible Loan Agreement with Junwei Zheng wherein the lender agreed to advance of approximately US$ 4.5 million (RMB 30,000,000) under a Convertible Promissory Note with a term of 24 months bearing interest at a rate of Fifteen Percent (15%) per annum. The Loan is convertible into Common Stock at any time at the option of the Lender at a conversion price of $3.50 per share within the term

As of June 30, 2017, the Company has received proceeds of about $810,827 (RMB 5,500,000) from Junwei Zheng and the interest expense related to this note was $17,328 for the three and six months ended June 30, 2017.

12. Unsecured Loans Payable

Unsecured loan payable mainly represents the payables of the subsidiary company - Kiwa Shandong, which hadn’t achieved active operation for a lengh of years. As of December 31, 2016, construction costs payable was $1,655,343.

13. Convertible Notes Payable

Convertible notes payable consists $ 150,250 of 6% secured convertible notes issued to FirsTrust Group Inc. on June 29, 2006 , $145,127 of 15% convertible note issued to Mr. Geng Liu on January 17, 2017 and $810,827 of 15% convertible note issued to Mr. Junwei Zheng on May 9, 2017.

6% secured convertible notes

In 2006, we completed a $2.45 million 6% Secured Convertible Note (“6% Convertible Note”) transaction with six institutional investors, including Nite Capital LP, which purchased a total of $300,000 of the Note in three tranches ($105,000, $90,000, $105,000 respectively). The 6% Convertible Note allows the note holder to convert into shares of our common stock. We filed a registration statement under the Securities Act covering the resale of the shares issued upon conversion of the 6% Notes in 2006 and the registration statement was declared effective on October 13, 2006.

On March 18, 2008, FirsTrust Group, Inc. purchased three remaining 6% Convertible Notes, totaling $168,000 ($59,100, $50,400 and $59,100 respectively), from Nite Capital for a cash payment of $100,000. As of June 30, 2017, there is no other outstanding 6% Note than those owned by FirsTrust Group. The total outstanding Convertible Note payable to FirsTrust is $150,250, and the total accumulated interest and penalty is $194,537 and $523,141, respectively.

15% convertible notes- Geng Liu

On January 17, 2017, the Company entered a Convertible Note Agreement with an individual person with principal of RMB 3 million or approximately $435,380. The note bears interest at 15% per annum and will mature on January 16, 2018. Before the maturity date, the Note holder has an option to convert partial or all of the outstanding principal and accrued interest to the Company’s common shares with a conversion price of $0.90 per share. As of June 30, 2017, the Company has received partial principal totaled $145,127 (RMB 1 million). The Company accrued $5,442 and $8,472 interest expense on this convertible notes for the three and six months ended June 30, 2017, respectively.

15% convertible notes- Junwei Zheng

On May 9, 2017, the Company entered a Convertible Note Agreement with an individual person with principal of RMB 30 million or approximately $4.5 million. The note bears interest at 15% per annum and will mature on May 8, 2019. Before the maturity date, the Note holder has an option to convert partial or all of the outstanding principal and accrued interest to the Company’s common shares with a conversion price of $3.5 per share. As of June 30, 2017, the Company has received partial principal totaled $810,827 (RMB 5.5 million). The Company accrued $17,328 interest expense on this convertible notes for both of the six months and three months ended June 30, 2017.

14. Note Payable

On May 29, 2007, the Company issued a $360,000 promissory note (the “Promissory Note”) to an unrelated individual (the “Original Note holder”). This note bears interest at 18% per annum and was due on July 27, 2007. This note is currently in default and bears interest of 25% per annum (the “Default rate”) until paid in full. This note is secured by a pledge of 6,178,336 (post-reverse split 30,892) shares of the Company’s common stock owned by Investlink (China) Limited (the “Pledged Shares”). The Company accrued $45,000 and $45,000 interest expense on note payable for the six months ended June 30, 2017 and 2016, and $22,500 and $22,500 interest expense on note payable for the three months ended June 30, 2017 and 2016, respectively.

As of December 31, 2016, the Original Note holder informed us that all right, title and interests in the Promissory Note has been assigned and transferred to FirsTrust Group, Inc. (“FirsTrust”). As of June 30, 2017, all of $360,000 of Promissory Note to FirsTrust is still outstanding, and total interest of the Promissory Note is $ 904,300. We have begun preliminary discussion with FirsTrust with regards to a potential settlement of the Note, but no agreement has been reached. As of June 30, 2017, with the Company’s acknowledgement, FirsTrust has taken possession of 30,892 Pledged Share from Investline (China) Limited according to the default clause of the Promissory Note.

15. Other Payable

Other payable includes the payables to two unrelated potential investors and other liabilities. As of June 30, 2017, two potential investors have made the payments approximately $471,754 to the Company and the investment agreements have not been finalized. Other payable were $865,793 and $1,019,583 at June 30, 2017 and December 31, 2017, respectively,

16. Stockholders’ Equity

In March, 2016, the Company issued 3,140,000 shares of common stock to Mr. Li and Ms. Wang for debt and salary payable settlement for an aggregate amount of $3,141,000. In addition, the Company issued 101,947 common shares to Jimmy Zhou, former CEO in August 2016, to settle payable to him for $50,974. All of issuances of common shares for settlement of debts were based the stock price on the transaction dates.

During the year ended December 31, 2016, the Company issued 1,650,000 common shares for cash at $0.8 per share for an aggregate subscribe price equivalent to $1,320,000, of which $759,659 has received while approximately $560,341 remaining subscribe receivable at December 31, 2016. The remaining subscribe receivable was totally received in August 3, 2017.

On November 15, 2016, the Company completed another private offering of common stock to an accredited investor for 125,000 shares of its common stock and warrants to purchase 300,000 shares of Company common stock at an exercise price of $3.00 per share prior to November 15, 2021. The Company may adjust the exercise price for some or all of the warrants under certain terms and conditions. We have determined the issued warrants do not meet the definition of a derivative security, and thus allocated the net proceeds of the sale of the common stock to the par value of the common stock, with the remainder to additional paid in capital.

During the year ended December 31, 2016, the Company issued 1,710,808 common shares to four consulting companies and three individuals as compensation for their consulting service received. The agreements have the service periods from 6 months to 36 months with a total of $1,688,300 that was determined as fair value at the time of execution of the agreement. The total services fee will be recognized based straight-line amortization method over the service term. The Company recorded $331,800 as consulting service expense for the six months ended June 30, 2017 and $254,250 approximately for the year ended December 31, 2016.

In February, 2017, the Company issued 1,000,000 common shares to Mr. Junwei Zheng for cash at $1.00 per share for an aggregate price to $1,000,000, all of which has been received as of June 30, 2017.

On February 15, 2017, the Company entered a consulting agreement with Mr. Yuan Wang to assist the Company in financing projects. The agreement has one year term with a total of $85,400 that was determined as fair value at the time of execution of the agreement. The total services fee will be recognized based straight-line amortization method over the service term. On March 3, 2017, the Company issued 70,000 common shares to Mr. Yuan Wang based on market price of $1.22 per share. The Company realized $32,025 as a compensation for Mr. Wang’s consulting service for the six months ended June 30, 2017.

On May 25, 2017, the Company issued 19,380 common shares to an individual to assist the Company in financing projects based on market price of $2.74 per share. The agreement has one year term with a total of $53,101 that was determined as fair value at the time of execution of the agreement. The total services fee will be recognized based straight-line amortization method over the service term. The Company recorded $5,237 as consulting service expense for the six months ended June 30, 2017.

On June 1, 2017, the Company issued 15,108 common shares to an individual to assist the Company in technical support based on market price of $2.78 per share. The agreement has one year term with a total of $41,396 that was determined as fair value at the time of execution of the agreement. The total services fee will be recognized based straight-line amortization method over the service term. The Company recorded $3,402 as consulting service expense for the six months ended June 30, 2017.

On June 13, 2017, the Company issued 96,900 common shares to Mr. Yuan Wang for cash at $3.00 per share for an aggregate price to $290,700, all of which has been received as of June 30, 2017.

On June 30, 2017, the Company issued 97,850 common shares to ten employees for cash at $1.95 per share for an aggregate price to $190,807, all of which has been received as of June 30, 2017. The Company determined the fair price per common stock was $3.0 per share, thus the difference of $1.05 per share between fair price per share ($3.00) and the employees purchase price per share ($1.95), totaled $102,273 was recognized as expense of employee benefits and accordingly, credited the same amount to APIC.

Subsequently the Company issued 98,000 shares of common stock for cash $294,000, and 88,000 shares of common stock for consulting service. Please refer to Note 22 Subsequent Events for additional information.

17. Stock-based Compensation

On March 15, 2017, the Board of Directors approved a new stock option plan with ten years’ term. As of June 30, 2017, the Company has not granted any incentive compensation under this plan.

18. Statutory Reserves

The Company is required to make appropriations to reserve funds, comprising the statutory surplus reserve, statutory public welfare fund and discretionary surplus reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (the “PRC GAAP”). Appropriation to the statutory surplus reserve should be at least 10% of the after tax net income determined in accordance with the PRC GAAP until the reserve is equal to 50% of the entities’ registered capital or members’ equity. In accordance with the Chinese Company Law, the Company allocated 10% of income after taxes to the statutory surplus reserve for the six months ended June 30, 2017 and the year ended December 31, 2016, statutory reserve activity is as follows:

Balance – January 1, 2016	$	-
Addition to statutory reserve in 2016		127,884
Balance – December 31, 2016		127,884
Addition to statutory reserve for the six months ended June 30, 2017		179,466
Balance – June 30, 2017	$	307,350

19. Income Tax

In accordance with the current tax laws in China, Kiwa Shandong is subject to a corporate income tax rate of 25% on its taxable income. However, Kiwa Shandong has not provided for any corporate income taxes since it had no taxable income for the six months ended June 30, 2017 and 2016.

Kiwa Baiao Co., Ltd., is also subject to a corporation income tax rate of 25% on its taxable income. For the six months ended June 30, 2017, it recorded income tax provision for RMB 4,112,924 or approximately $598,222. For the three months ended June 30, 2017, it recorded income tax provision for RMB 2,601,847 or approximately $379,973.

Provision for taxes $800 to the minimum California state franchise tax. In accordance with the relevant tax laws in the British Virgin Islands, Kiwa BVI, as an International Business Company, is exempt from income taxes.

A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:

	Three months ended June 30,						Six months ended June 30,
	2017			2016			2017			2016

Pre-tax income	$	5,396,950		$	181,975		$	5,924,464		$	238,105
U.S. federal corporate income tax rate		34	%		34	%		34	%		34	%
Income tax computed at U.S. federal corporation income tax rate		1,834,963			61,872			2,014,318			80,956
Reconciling items:
Rate differential for PRC earnings		(124,683	)		8,770			(202,353	)		13,668
Change of valuation allowance		195,403			80,006			305,935			146,608
Non-deductible expenses		(1,525,710	)		(150,648	)		(1,518,877	)		(241,232	)
Effective tax expenses	$	379,973		$	-		$	599,022		$	-

The Company had deferred tax assets as follows:

	June 30, 2017			December 31, 2016

Net operating losses carried forward	$	3,458,902		$	3,473,331
Less: Valuation allowance		(3,458,902	)		(3,473,331	)

Net deferred tax assets	$	-		$	-

As of June 30, 2017 and December 31, 2016, the Company had approximately $3.4 million and $3.4 million net operating loss carryforwards available to reduce future taxable income. Net operating loss of the Company could be carried forward and taken against any taxable income for a period of not more than twenty years from the year of the initial loss pursuant to Section 172 of the Internal Revenue Code of 1986, as amended. The net operating loss of Kiwa Shandong could be carried forward for a period of not more than five years from the year of the initial loss pursuant to relevant PRC tax laws and regulations. It is more likely than not that the deferred tax assets cannot be utilized in the future because there will not be significant future earnings from the entity which generated the net operating loss. Therefore, the Company recorded a full valuation allowance on its deferred tax assets.

As of June 30, 2017 and December 31, 2016, the Company has no material unrecognized tax benefits which would favorably affect the effective income tax rate in future periods and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during six months ended June 30, 2017 and December 31, 2016, and no provision for interest and penalties is deemed necessary as of June 30, 2017 and December 31, 2016.

According to the PRC Tax Administration and Collection Law, the statute of limitations is three years if the underpayment of taxes is due to computational errors made by the taxpayer or its withholding agent. The statute of limitations extends to five years under special circumstances, which are not clearly defined. In the case of a related party transaction, the statute of limitation is ten years. There is no statute of limitation in the case of tax evasion.

20. Commitments and Contingencies

The Company has the following material contractual obligations:

(1) Investment in manufacturing facilities in Penglai City, Shandong Province in China

On June 8, 2017, the Company entered an equity purchase agreement with Yantai Peng Hao New Materials Technology Co. Ltd. (“Acquirer”), which relates to the acquisition of a new factory for purchase price of about $2.2 million (approximately RMB 15 million). The factory to be acquired by the Company will be completed in accordance with the Company’s construction plan to facilitate the production design of combining of microbial fermentation and terminal fertilizer products.

Pursuant to the payment terms of purchase agreement, the Company made the first payment of $147,423 (approximately RMB 1,000,000) to the Acquirer on June, 2017 and will make the second payment of RMB 10,000,000 as long as the Company obtains the land use right certificate and will make the final payment of RMB 4,000,000 after the government processing has been completed.

(2) Strategic cooperation with the institutes in China

On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015 and will expire on November 19, 2018.

(3) Distribution agreement with Kangtan Gerui Bio-Tech in China

On December 17, 2015, Kiwa Bio-Tech Products Group Corporation (the “Company”) entered into a distribution agreement (the “Agreement”) with Kangtan Gerui (Beijing) Bio-Tech Co., Ltd. (“Gerui”) and formally awarded Gerui a right to sell and distribute the Company’s fertilizer products in 3 major agricultural regions of China— Hainan Province, Hunan Province and Xinjiang Autonomous Region. The Company’s Research and Development department has been conducting application experiments in Hainan and Hunan Provinces since August 2015, in accordance with the market requirements. The experiment data indicates that the Company’s fertilizer products have fulfilled the requirements of reduction of content of heavy metals in soil and improve crop yield. Gerui was founded in Beijing in April 2015 and relies on the sales network of China’s Supply and Marketing Cooperatives system. Currently, the Company and Gerui do not hold any interest in each other; however, a collaboration and integration may take place in the future. The term of the Agreement is for a period of three years commencing December 17, 2015. In September 2016, Kiwa Baiao Bio-Tech (Beijing) Co., Ltd obtained a fertilizer sales permit from the Chinese government and began to sale the products directly to customers in those 3 major agricultural regions.

(4) Lease payments

(1) On April 29, 2016, Kiwa Baiao Bio-Tech (Beijing) Co., Ltd. entered an office lease agreement with two-year term. Monthly lease payment and building management fee totaled RMB 77,867 or approximately USD $11,303.

(2) In June 20, 2017, Kiwa Bio-Tech (Shenzhen) Co., Ltd, a newly established subsidiary entered an office lease agreement with two-year term. Monthly lease payment is RMB 115,000 or approximately of USD $16,954. And the previous lease agreement terminated automatically since the landloard is the same one.

(3) On May 5, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with 13 months term. Monthly lease payment totaled USD $680.

(4) On July 1, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with one-year term. Monthly lease payment totaled USD $1,087.

The future lease payments at June 30, 2017 are summarized below.

	Beijing Office		Shenzhen Office		USA Office		Total
2017	$	68,876	$	101,722	$	10,605	$	181,203
2018	$	45,917		203,444	$	9,925	$	259,286
2019	$	-	$	101,722	$	-	$	101,722
Thereafter	$	-	$	-	$	-	$	-

21. Discontinued Operation

On February 11, 2017, the Company executed an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) whereby the Company transferred all of its right, title and interest in Kiwa Bio-Tech Products (Shandong) Co., Ltd. (“Shandong”) to the Transferee for the RMB equivalent of US$1.00. The government processing of the transaction has been completed on April 12, 2017. This transaction was completed and effective on April 12, 2017. The Company recorded a net gain of approximately $4,514,161 during the six months ended June 30, 2017 and approximately $4,513,363 during the three months ended June 30, 2017 based on the discharge of the excess liabilities over the assets of the Kiwa Shandong.

22. Subsequent Events

On July 1, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with two-year term. Monthly lease payment totaled USD $1,087.

On July 19, 2017, the Company entered into Common Stock Purchase Agreement with Junwei Zheng. Pursuant to the Agreement, the Company will issue total 245,000 shares of restricted common stock at $3.00 per share price for an aggregate amount of $735,000. As of August 14, 2017, the Company has not received the amount yet.

On July 19, 2017, the Company entered into Common Stock Purchase Agreement with Quanzhen Shen. Pursuant to the Agreement, the Company will issue total 98,000 shares of restricted common stock at $3.00 per share price for an aggregate amount of $294,000. The Company has received the full amount.

On July 19, 2017, the Company issued 49,000 common shares to Quanzhen Shen for her consulting service to assist the Company in financing projects. The number of shares was determined based on the fair value of the service. The agreement has one year term.

On July 18, 2017, the Company issued 39,000 common shares to Yuan Wang in assistance with the Company financing projects. The number of shares was determined based on the fair value of the service. The agreement has one year term.

On August 3, 2017, the Company fully collected $487,627 (RMB 3,360,000) of the entire subscribe receivable balance at December 31, 2016.

The Company has evaluated the existence of significant events subsequent to the balance sheet date through the date these financial statements were issued and has determined that, other than as stated above, there were no subsequent events or transactions which would require recognition or disclosure in the financial statements, other than noted herein.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

This Quarterly Report on Form 10-Q for the three and six months ended June 30, 2017 contains “forward-looking statements” within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates,” or similar expressions. These forward-looking statements include, among others, statements concerning our expectations regarding our working capital requirements, financing requirements, business, growth prospects, competition and results of operations, and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. The forward-looking statements in this Quarterly Report on Form 10-Q for the three and six months ended June 30, 2017 involve known and unknown risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those expressed in or implied by the forward-looking statements contained herein.

Overview

The Company took its present corporate form in March 2004 when shareholders of Kiwa Bio-Tech Products Group Ltd. (“Kiwa BVI”), a company originally organized under the laws of the British Virgin Islands on June 5, 2002 and Tintic Gold Mining Company (“Tintic”), a corporation originally incorporated in the state of Utah on June 14, 1933 to perform mining operations in Utah, entered into a share exchange transaction. The share exchange transaction left the shareholders of Kiwa BVI owning a majority of Tintic and Kiwa BVI a wholly-owned subsidiary of Tintic. For accounting purposes this transaction was treated as an acquisition of Tintic by Kiwa BVI in the form of a reverse triangular merger and a recapitalization of Kiwa BVI and its wholly owned subsidiary, Kiwa Bio-Tech Products (Shandong) Co., Ltd. (“Kiwa Shandong”). On July 21, 2004, we completed our reincorporation in the State of Delaware. On March 8, 2017, we completed our reincorporation in the State of Nevada.

We have established a subsidiary in China, Kiwa Shandong in 2002, a wholly-owned subsidiary, engaging in the bio-fertilizer business. Formerly, our subsidiary Tianjin Kiwa Feed Co., Ltd. (“Kiwa Tianjin”), was engaged in the bio-enhanced feed business. At the end of 2009, Kiwa Tianjin could no longer use its assets including machinery and inventory in the normal course of operations. Kiwa Tianjin has been dissolved since July 11, 2012. On February 11, 2017, the Company entered an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) to transfer all of shareholders’ right, title and interest in Kiwa Shandong to the Transferee for USD $1.00. On April 12, 2017, the government processing of transfer has been completed.

On November 30, 2015, we entered into an acquisition agreement (the “Agreement”) with the shareholders of Caber Holdings LTD, whose Chinese name is Hong Kong Baina Group Co., Ltd, located in Hong Kong (“Baina Hong Kong”), and Oriental Baina Co. Ltd. (hereinafter referred to as “Baina Beijing”), Baina Hong Kong’s wholly-owned subsidiary in Beijing, China. Kiwa will rename Baina Beijing to Kiwa Baiao Co. Ltd. Kiwa Baiao Co. Ltd will replace Kiwa’s current subsidiary in China - Kiwa Bio-Tech (Shandong) Co., Ltd (“Kiwa Shandong”) - to operate Kiwa’s bio-fertilizer market expansion and become Kiwa’s platform for future acquisitions of new agricultural-related projects in China. In accordance with the terms of the Agreement, Kiwa agreed to pay US$30,000 to the Baina Hong Kong Shareholders for the acquisition of 100% of the equity of Baina Hong Kong. The acquisition was completed on January 7, 2016. Both Baina Hong Kong and Baina Beijing had no activities before the acquisition date and had no assets and liabilities. The purpose of this acquisition was to acquire Baina Hong Kong’s corporation registration in Hong Kong and In China. The total payment of approximately $34,000 was recorded as intangible assets.

We started to generate revenues from selling Bio Organic fertilizers in the third quarter of 2016 and through June 30, 2017. Comparing with six months ended June 30, 2017 and 2016, there was no sales revenues in the six months ended June 30, 2016 while we recorded approximately $8.83 million revenue for the six months ended June 30, 2017. On the other hand, we generated no license revenue in the six months ended June 30, 2017, compared approximately $710,095 license revenues recorded in the six months ended June 30, 2016. We recognized a net income of $5,325,262 and $238,105 for the six months ended June 30, 2017 and 2016, respectively, of which includes $4,514,161 and nil gain from discontinued operations.

As of June 30, 2017, the Company had cash of $71,554. The Company expects to generate additional revenue while seeking additional equity and debt financing. Management of the Company already raised additional equity for approximately $1,481,508 and approximately $955,955 from issuance of convertible note during the six months ended June 30, 2017.

Trends and Uncertainties in Regulation and Government Policy in China

Foreign Investment Policy Change in China

On March 16, 2007, China’s parliament, the National People’s Congress, adopted the Enterprise Income Tax Law, which took effect on January 1, 2008. The new income tax law sets a unified income tax rate for domestic and foreign companies at 25% and abolishes the favorable policy for foreign invested enterprises. As a result subsidiaries established in China in the future will not enjoy the original favorable policy unless they are certified as qualified high and new technology enterprises.

Results of Operations

Results of Operations for Three Months Ended June 30, 2017 and 2016

Revenue

Revenue was $5,682,108 and nil for the three months ended June 30, 2017 and 2016, respectively. Revenue was generated from sales of products.

Cost of Revenue and Gross Profit

Cost of revenue for the three months ended June 30, 2017 was $3,970,915, reflecting an increase of 100% from the same period last year. Consequently, gross margin as a percentage of total sales is 30.12% compared with nil for the same period last year, principally due to the increase of sales of products.

Selling Expense

Selling expenses for the three months ended June 30, 2017 and 2016 were $54,232 and nil, respectively, representing a 100% increase from the same period last year. Selling expenses include salaries of sales personnel, sales commission, travel and entertainment etc.

General and Administration

General and administration expenses for the three months ended June 30, 2017 and 2016 were $664,019 and $138,786, respectively, representing a $525,233 or 378% increase. General and administrative expenses include salaries, travel and entertainment, rent, office expense, telephone expense, consulting expense and insurance costs etc.

Research and Development

Research and development expense for the three months ended June 30, 2017 reflected a decrease of $38,343 or 51.28% from $74,776 in the three months ended June 30, 2016 to $36,433 for the same period of 2017. In July 2006, the Company opened a new research center with CAU through our subsidiary, Kiwa Shandong, which goes under the name, KiwaCAU BioTech Research & Development Center. Pursuant to an agreement reached between CAU and Kiwa Shandong on November 14, 2006, Kiwa Shandong agreed to contribute RMB 1 million (approximately $160,000) each year to fund research at the R&D Center. The term of the agreement is ten years. The agreement expired on June, 2016.

The Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”) on November 5, 2015. Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015. Prof. Yong Chang Wu, the authorized representative of IARRP, CAAS, is also one of the Company’s directors since November 20, 2015 until March 13, 2017.

Penalty Expense

The Company incurred liquidated damages resulting from the default of 6% Notes. The penalty charge, which is calculated monthly at 2% of the outstanding amounts of convertible notes and unpaid interest on the notes, was $20,575 and $19,223 for three months ended June 30, 2017 and 2016, respectively. The increase of penalty expense was mainly due to accrued and unpaid interest on the notes.

Interest Expenses

Net interest expense was $52,346 for the three months ended June 30, 2017 and $28,325 for the same period of 2016. Interest expense included accrued interest on convertible note and other note payable for the three months ended June 30, 2017 and 2016.

Other Income (License revenue)

Other income was nil and $443,085 for the three months ended June 30, 2017 and 2016, respectively. Revenue was generated from licensing our trademark to Gerui. We signed the license agreement with Gerui to allow Gerui to sell fertilizer using our trademark in December 2015.

Gain from discontinued opereation

Gain from discontinued operation was 4,513,363 and nil for the three months ended June 30, 2017 and 2016, respectively. The Company entered an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) to transfer all of shareholders’ right, title and interest, as well as all the obligations in Kiwa Shandong to the Transferee for USD $1.00 on April 12, 2017, which results in 100% increase of gain from discontinued operation for the three months ended June 30, 2017 compared with the same period of 2016.

Net Income

During the three months ended June 30, 2017, net income was $5,016,977 and for the same period of 2016 net income was $181,975, representing a change of $4,835,002 or 2,656.9%. The change was due to the reasons discussed above.

Comprehensive Income

Comprehensive income for the three months ended June 30, 2017 was $5,106,888. Comparably, during the same period of 2016, comprehensive income was $311,174. The change was due to the reasons discussed above.

Results of Operations for Six Months Ended June 30, 2017 and 2016

Revenue

Revenue was $8,827,897 and nil for the six months ended June 30, 2017 and 2016, respectively. Revenue was generated from sales of products.

Cost of Revenue and Gross Profit

Cost of revenue for the six months ended June 30, 2017 was $6,034,924, reflecting an increase of 100% from the same period last year. Consequently, gross margin as a percentage of total sales is 31.64% compared with nil for the same period last year, principally due to the increase of sales of products.

Selling Expense

Selling expenses for the six months ended June 30, 2017 and 2016 were $90,485 and nil, respectively, representing a 100% increase from the same period last year. Selling expenses include salaries of sales personnel, sales commission, travel and entertainment etc.

General and Administration

General and administration expenses for six months ended June 30, 2017 and 2016 were $1,095,396 and $225,670, respectively, representing a $869,726 or 385% increase. General and administrative expenses include salaries, travel and entertainment, rent, office expense, telephone expense and insurance costs etc.

Research and Development

Research and development expense for the six months ended June 30, 2017 reflected an decrease of $79,045 or 52.08% from $151,769 in the six months ended June 30, 2016 to $72,724 for the same period of 2017. In July 2006, the Company opened a new research center with CAU through our subsidiary, Kiwa Shandong, which goes under the name, Kiwa-CAU Bio-Tech Research & Development Center. Pursuant to an agreement reached between CAU and Kiwa Shandong on November 14, 2006, Kiwa Shandong agreed to contribute RMB 1 million (approximately $160,000) each year to fund research at the R&D Center. The term of the agreement is ten years.

Penalty Expense

The Company incurred liquidated damages resulting from the default of 6% Notes. The penalty charge, which is calculated monthly at 2% of the outstanding amounts of convertible notes and unpaid interest on the notes, was $40,814 and $38,108 for the six months ended June 30, 2017 and 2016, respectively. The increase of penalty expense was mainly due to accrued and unpaid interest on the notes.

Interest Expenses

Net interest expense was $83,430 for the six months ended June 30, 2017 and $56,443 for the same period of 2016. Interest expense included accrued interest on convertible note and other note payable for the six months ended June 30, 2017 and 2016.

Other Income (License revenue)

Other income was nil and $710,095 for the six months ended June 30, 2017 and 2016, respectively. Revenue was generated from licensing our trademark to Gerui. We signed the license agreement with Gerui to allow Gerui to sell fertilizer using our trademark in December 2015.

Gain from discontinued opereation

Gain from discontinued operation was 4,514,161 and nil for the three months ended June 30, 2017 and 2016, respectively. The Company entered an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) to transfer all of shareholders’ right, title and interest, as well as all the obligations in Kiwa Shandong to the Transferee for USD $1.00 on April 12, 2017, which results in 100% increase of gain from discontinued operation for the six months ended June 30, 2017 compared with the same period of 2016.

Net Income

During the six months ended June 30, 2017, net income was $5,325,262, and for the same period of 2016 net income was $238,105, representing a change of $5,087,157 or 2136%. The change was due to the reasons discussed above.

Comprehensive Income

Comprehensive income for the six months ended June 30, 2017 was $5,382,830. Comparably, during the same period of 2016, comprehensive loss was $332,210. The change was due to the reasons discussed above.

Liquidity and Capital Resources

Since inception of our ag-biotech business in 2002, we have relied on the proceeds from the sale of our equity securities and loans from both unrelated and related parties to provide the resources necessary to fund our operations and the execution of our business plan. During the six months ended June 30, 2017, the advances from related parties, net of repayment by the Company to related parties, was $83,798. As of June 30, 2017, our current assets exceeded current liabilities by $1,474,595, representing a current ratio of 1.13. Comparably, as of December 31, 2016, our current liabilities exceeded current assets by $5,729,622, denoting a current ratio of 0.445.

As of June 30, 2017 and December 31, 2016, we had cash of $71,554 and $13,469, respectively. Changes in cash balances are outlined as follows:

During the six months ended June 30, 2017, our operations used cash of $2,199,087 as compared with $148,931 used in the same period of 2016. Cash was mainly used for working capital for public company operation.

During the six months ended June 30, 2017 and 2016, we used $147,782 and $78,775 for investing activities.

During the six months ended June 30, 2017, our financing activities incurred net cash inflow of $2,454,463, $17,000 of which are generated from advances from related parties, $1,481,508 of which are generated from sales of common stock and $955,955 of which are generated from convertible note. During the six months ended June 30, 2016, we generated $216,500 from financing activities by borrowing from related party and sales of common stock.

Commitments and Contingencies

See Note 20 to the Consolidated Financial Statements under Item 1 in Part I.

Off-Balance Sheet Arrangements

At June 30, 2017, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Securities Exchange Act Rule 13a-15(e)) as of the end of the quarterly period covered by this report, have concluded that our disclosure controls and procedures are not effective to reasonably ensure that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s Rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The principal basis for this conclusion is the lack of segregation of duties within our financial function and the lack of an operating Audit Committee.

(b) Changes in Internal Control over Financial Reporting

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) under the Exchange Act) during the current quarter ended June 30, 2017, to have materially affected the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

None.

ITEM 1A. RISK FACTORS

Smaller reporting companies are not required to provide the information required by this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following is a list of securities issued for cash or converted with debentures or as stock compensation to consultants during the period from January 1, 2017 through August 14, 2017, which were not registered under the Securities Act:

Name of Purchaser	Issue Date	Security	Shares		Consideration
Junwei Zheng	3/3/17	Common		920,000	Stock Purchase
Yuan Wang	3/3/17	Common		80,000	Stock Purchase
Yuan Wang	3/3/17	Common		70,000	Consultant Fees
Haiping Liu	6/13/17	Common		19,380	Consultant Fees
Yang Yang	6/13/17	Common		96,900	Stock Purchase
Yuan Zeng	6/30/17	Common		21,100	Stock Purchase
Baoyu Ouyang	6/30/17	Common		17,000	Stock Purchase
Honghua Zhang	6/30/17	Common		15,000	Stock Purchase
Weiqiang Xu	6/30/17	Common		10,000	Stock Purchase
Jialin Xiong	6/30/17	Common		3,750	Stock Purchase
Kun Wei	6/30/17	Common		3,000	Stock Purchase
Yanyu Guo	6/30/17	Common		2,000	Stock Purchase
Yanjiao Guo	6/30/17	Common		1,000	Stock Purchase
Mengsha Yuan	6/30/17	Common		10,000	Stock Purchase
Mo Han	6/30/17	Common		15,000	Stock Purchase
Hebe Han	6/30/17	Common		15,108	Stock Purchase
Quanzhen Shen	8/1/17	Common		98,000	Stock Purchase
Quanzhen Shen	8/1/17	Common		49,000	Consultant Fees
Yuan Wang	8/1/17	Common		39,000	Consultant Fees
Junwei Zheng	8/1/17	Common		245,000	Stock Purchase

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine safety disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit No.		Description

31.1/31.2		Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) and Rule15d-14(a) of the Securities Exchange Act of 1934, as amended

32.1/32.2		Certification of Principal Executive Officer and Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	KIWA BIO-TECH PRODUCTS GROUP CORPORATION

August 14, 2017	By:	/s/ Yvonne Wang
		Yvonne Wang, Interim Chief Executive Officer and
		Interim Chief Financial Officer

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

I, Yvonne Wang, certify that:

	1.	I have reviewed this Form 10-Q for the period ended June 30, 2017 of Kiwa Bio-Tech Products Group Corporation;

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

	4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2017

/s/ Yvonne Wang
Yvonne Wang
Principal Executive Officer

EX-31.2 3 ex31-2.htm

EXHIBIT 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

I, Yvonne Wang, certify that:

	1.	I have reviewed this Form 10-Q for the period ended June 30, 2017 of Kiwa Bio-Tech Products Group Corporation;

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

	4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2017

/s/ Yvonne Wang
Yvonne Wang
Principal Financial Officer

EX-32.1 4 ex32-1.htm

EXHIBIT 32.1

CERTIFICATIONS PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Kiwa Bio-Tech Products Group Corporation, a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The quarterly report on Form 10-Q for the period ended June 30, 2017 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 14, 2017

	/s/ Yvonne Wang
	Yvonne Wang
	Principal Executive Officer

A signed original of this written statement required by Section 906 has been provided to KIWA BIO-TECH PRODUCTS GROUP CORPORATION and will be retained by KIWA BIO-TECH PRODUCTS GROUP CORPORATION and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 ex32-2.htm

EXHIBIT 32.2

CERTIFICATIONS PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

Date: August 14, 2017

	/s/ Yvonne Wang
	Yvonne Wang
	Principal Financial and Accounting Officer

GRAPHIC 6 image_003.jpg begin 644 image_003.jpg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end EX-101.INS 7 kwbt-20170630.xml XBRL INSTANCE FILE 0001159275 2017-01-01 2017-06-30 0001159275 2016-12-31 0001159275 2017-06-30 0001159275 2016-01-01 2016-06-30 0001159275 KWBT:KiwaCauRAndDCenterMember KWBT:TradeTransactionMember 2016-12-31 0001159275 2017-08-14 0001159275 KWBT:KiwaCauRAndDCenterMember currency:CNY 2017-01-01 2017-06-30 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember 2015-11-04 2015-11-05 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember KWBT:TradeTransactionMember 2016-12-31 0001159275 KWBT:TwoInstitutesInChinaMember currency:CNY 2015-11-04 2015-11-05 0001159275 KWBT:UnrelatedIndividualMember 2007-05-29 0001159275 KWBT:UnrelatedIndividualMember 2007-05-28 2007-05-29 0001159275 KWBT:InvestlinkChinaLimitedMember 2007-05-28 2007-05-29 0001159275 2016-01-13 2016-01-14 0001159275 2016-01-14 0001159275 KWBT:NoteSixPercentageMember 2006-06-28 2006-06-29 0001159275 KWBT:NoteSixPercentageMember 2006-06-29 0001159275 KWBT:JimmyZhouMember 2016-08-01 2016-08-31 0001159275 us-gaap:BuildingMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0001159275 us-gaap:BuildingMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0001159275 us-gaap:MachineryAndEquipmentMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0001159275 us-gaap:MachineryAndEquipmentMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0001159275 us-gaap:AutomobilesMember 2017-01-01 2017-06-30 0001159275 us-gaap:OfficeEquipmentMember us-gaap:MinimumMember 2017-01-01 2017-06-30 0001159275 us-gaap:ComputerEquipmentMember 2017-01-01 2017-06-30 0001159275 us-gaap:OfficeEquipmentMember 2016-12-31 0001159275 KWBT:MrLiAndMsWangMember 2016-03-01 2016-03-31 0001159275 KWBT:BalanceSheetItemsExceptForEquityAccountsMember 2016-12-31 0001159275 KWBT:BalanceSheetItemsExceptForEquityAccountsMember 2017-06-30 0001159275 KWBT:ItemsInTheStatementsOfComprehensiveLossMember 2016-12-31 0001159275 KWBT:ItemsInTheStatementsOfComprehensiveLossMember 2017-06-30 0001159275 KWBT:KiwaBioTechBeijingCoLtdMember KWBT:OfficeLeaseAgreementMember 2016-04-28 2016-04-29 0001159275 KWBT:KiwaBioTechBeijingCoLtdMember currency:CNY KWBT:OfficeLeaseAgreementMember 2016-04-28 2016-04-29 0001159275 KWBT:FurnitureMember 2016-12-31 0001159275 KWBT:LeaseholdImprovementMember 2016-12-31 0001159275 KWBT:AcquisitionAgreementMember 2015-11-30 0001159275 KWBT:AcquisitionAgreementMember 2015-11-29 2015-11-30 0001159275 KWBT:PrivateOfferingMember KWBT:AccreditedInvestorMember 2016-11-14 2016-11-15 0001159275 KWBT:PrivateOfferingMember KWBT:AccreditedInvestorMember 2016-11-15 0001159275 2015-12-31 0001159275 KWBT:EquityTransferAgreementMember 2017-02-11 0001159275 us-gaap:OfficeEquipmentMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0001159275 KWBT:DueFromCustomerKangtanGeruiMember 2017-06-30 0001159275 KWBT:DueFromCustomerKangtanGeruiMember 2016-12-31 0001159275 KWBT:AdvanceToEmployeesMember 2017-06-30 0001159275 KWBT:AdvanceToEmployeesMember 2016-12-31 0001159275 us-gaap:OfficeEquipmentMember 2017-06-30 0001159275 KWBT:FurnitureMember 2017-06-30 0001159275 KWBT:LeaseholdImprovementMember 2017-06-30 0001159275 KWBT:YvonneWangMember 2017-06-30 0001159275 KWBT:KiwaCauRAndDCenterMember 2017-01-01 2017-06-30 0001159275 KWBT:KiwaCauRAndDCenterMember 2016-01-01 2016-06-30 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember currency:CNY 2015-11-04 2015-11-05 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember 2017-01-01 2017-06-30 0001159275 KWBT:KiwaCauRAndDCenterMember KWBT:TradeTransactionMember 2017-06-30 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember KWBT:TradeTransactionMember 2017-06-30 0001159275 KWBT:EquityTransferAgreementMember KWBT:DianShiChengJingBeijingTechnologyMember 2017-02-10 2017-02-11 0001159275 KWBT:FirsTrustGroupIncMember 2006-06-29 0001159275 KWBT:MrGengLiuMember 2017-01-17 0001159275 KWBT:FirsTrustGroupIncMember 2006-06-28 2006-06-29 0001159275 KWBT:MrGengLiuMember 2017-01-15 2017-01-17 0001159275 KWBT:TwoUnrelatedPotentialInvestorsMember 2017-01-01 2017-06-30 0001159275 2016-01-01 2016-12-31 0001159275 KWBT:MrJunweiZhengMember 2017-02-01 2017-02-28 0001159275 KWBT:MrJunweiZhengMember 2017-02-28 0001159275 KWBT:MrJunweiZhengMember 2017-01-01 2017-06-30 0001159275 KWBT:ConsultingAgreementMember 2017-02-14 2017-02-15 0001159275 KWBT:MrYuanWangMember 2017-03-02 2017-03-03 0001159275 KWBT:MrYuanWangMember 2017-03-03 0001159275 KWBT:MrYuanWangMember 2017-01-01 2017-06-30 0001159275 KWBT:BoardOfDirectorsMember 2017-03-14 2017-03-15 0001159275 KWBT:RMBMember 2017-01-01 2017-06-30 0001159275 KWBT:BeijingOfficeMember 2017-06-30 0001159275 KWBT:ShenzhenOfficeMember 2017-06-30 0001159275 2017-04-01 2017-06-30 0001159275 2016-04-01 2016-06-30 0001159275 2016-06-30 0001159275 KWBT:GeruiMember 2017-01-01 2017-06-30 0001159275 KWBT:OthersMember 2017-06-30 0001159275 KWBT:OthersMember 2016-12-31 0001159275 KWBT:YantaiPengHaoNewMaterialsTechnologyCoLtdMember KWBT:EquityPurchaseAgreementMember 2017-06-07 2017-06-08 0001159275 KWBT:YantaiPengHaoNewMaterialsTechnologyCoLtdMember KWBT:RMBMember KWBT:EquityPurchaseAgreementMember 2017-06-07 2017-06-08 0001159275 KWBT:YantaiPengHaoNewMaterialsTechnologyCoLtdMember KWBT:EquityPurchaseAgreementMember 2017-01-01 2017-06-30 0001159275 KWBT:YantaiPengHaoNewMaterialsTechnologyCoLtdMember KWBT:RMBMember KWBT:EquityPurchaseAgreementMember 2017-01-01 2017-06-30 0001159275 us-gaap:ComputerSoftwareIntangibleAssetMember 2017-05-01 2017-05-31 0001159275 us-gaap:ComputerSoftwareIntangibleAssetMember 2017-04-01 2017-06-30 0001159275 us-gaap:ComputerSoftwareIntangibleAssetMember 2017-01-01 2017-06-30 0001159275 KWBT:YvonneWangMember 2016-12-31 0001159275 KWBT:MsWangMember 2017-01-01 2017-06-30 0001159275 KWBT:MsWangMember 2016-01-01 2016-06-30 0001159275 KWBT:GengLiuMember 2017-06-30 0001159275 KWBT:GengLiuMember KWBT:ConvertibleLoanAgreementMember 2017-01-17 0001159275 KWBT:GengLiuMember KWBT:ConvertibleLoanAgreementMember KWBT:RMBMember 2017-01-17 0001159275 KWBT:GengLiuMember KWBT:ConvertibleLoanAgreementMember 2017-01-01 2017-06-30 0001159275 KWBT:GengLiuMember KWBT:ConvertibleLoanAgreementMember KWBT:RMBMember 2017-01-01 2017-06-30 0001159275 KWBT:GengLiuMember KWBT:ConvertibleLoanAgreementMember 2017-04-01 2017-06-30 0001159275 KWBT:JunweiZhengMember 2017-06-30 0001159275 KWBT:JunweiZhengMember KWBT:ConvertibleLoanAgreementMember 2017-05-09 0001159275 KWBT:JunweiZhengMember KWBT:ConvertibleLoanAgreementMember KWBT:RMBMember 2017-05-09 0001159275 KWBT:JunweiZhengMember KWBT:ConvertibleLoanAgreementMember 2017-01-01 2017-06-30 0001159275 KWBT:JunweiZhengMember KWBT:ConvertibleLoanAgreementMember KWBT:RMBMember 2017-01-01 2017-06-30 0001159275 KWBT:JunweiZhengMember KWBT:ConvertibleLoanAgreementMember 2017-04-01 2017-06-30 0001159275 KWBT:MrJunweiZhengMember 2017-05-08 2017-05-09 0001159275 KWBT:MrJunweiZhengMember 2017-05-09 0001159275 KWBT:FirsTrustMember 2017-06-30 0001159275 KWBT:FirsTrustMember 2017-01-01 2017-06-30 0001159275 KWBT:InvestlineChinaLimitedMember 2017-06-30 0001159275 KWBT:SixPercentageSecuredConvertibleNoteMember KWBT:SixInstitutionalInvestorsMember KWBT:NiteCapitalLPMember 2006-06-29 0001159275 KWBT:SixPercentageSecuredConvertibleNoteMember KWBT:SixInstitutionalInvestorsMember KWBT:NiteCapitalLPMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2006-06-28 2006-06-30 0001159275 KWBT:SixPercentageSecuredConvertibleNoteMember KWBT:SixInstitutionalInvestorsMember KWBT:NiteCapitalLPMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2006-06-28 2006-06-30 0001159275 KWBT:SixPercentageSecuredConvertibleNoteMember KWBT:SixInstitutionalInvestorsMember KWBT:NiteCapitalLPMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2006-06-28 2006-06-30 0001159275 KWBT:SixPercentageConvertibleNoteMember KWBT:FirsTrustGroupIncMember 2008-03-17 2008-03-18 0001159275 KWBT:SixPercentageSecuredConvertibleNoteMember KWBT:SixInstitutionalInvestorsMember KWBT:NiteCapitalLPMember 2006-06-28 2006-06-29 0001159275 KWBT:SixPercentageConvertibleNoteMember KWBT:FirsTrustGroupIncMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2008-03-17 2008-03-18 0001159275 KWBT:SixPercentageConvertibleNoteMember KWBT:FirsTrustGroupIncMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2008-03-17 2008-03-18 0001159275 KWBT:SixPercentageConvertibleNoteMember KWBT:FirsTrustGroupIncMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2008-03-17 2008-03-18 0001159275 KWBT:FirsTrustGroupIncMember 2017-06-30 0001159275 KWBT:FirsTrustGroupIncMember 2017-01-01 2017-06-30 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:GengLiuMember 2017-01-17 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:RMBMember KWBT:FifteenPercentConvertibleNotesMember KWBT:GengLiuMember 2017-01-17 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:GengLiuMember 2017-01-16 2017-01-17 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:GengLiuMember 2017-01-01 2017-06-30 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:GengLiuMember KWBT:RMBMember 2017-01-01 2017-06-30 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:GengLiuMember 2017-04-01 2017-06-30 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:RMBMember KWBT:FifteenPercentConvertibleNotesMember KWBT:MrJunweiZhengMember 2017-05-09 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:MrJunweiZhengMember 2017-05-09 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:MrJunweiZhengMember 2017-05-08 2017-05-09 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:MrJunweiZhengMember KWBT:RMBMember 2017-01-01 2017-06-30 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:MrJunweiZhengMember 2017-04-01 2017-06-30 0001159275 KWBT:ConvertibleNoteAgreementMember KWBT:FifteenPercentConvertibleNotesMember KWBT:MrJunweiZhengMember 2017-01-01 2017-06-30 0001159275 KWBT:FinancingProjectsMember 2017-05-24 2017-05-25 0001159275 KWBT:FinancingProjectsMember 2017-01-01 2017-06-30 0001159275 KWBT:FinancingProjectsMember 2017-05-25 0001159275 KWBT:TechnicalSupportMember 2017-05-30 2017-06-02 0001159275 KWBT:TechnicalSupportMember 2017-06-02 0001159275 KWBT:TechnicalSupportMember 2017-01-01 2017-06-30 0001159275 KWBT:MrYuanWangMember 2017-06-13 0001159275 KWBT:MrYuanWangMember 2017-06-12 2017-06-13 0001159275 KWBT:TenEmployeesMember 2017-01-01 2017-06-30 0001159275 KWBT:TenEmployeesMember 2017-06-30 0001159275 KWBT:ConsultantMember 2017-01-01 2017-06-30 0001159275 KWBT:RMBMember 2017-04-01 2017-06-30 0001159275 KWBT:CaliforniaStateFranchiseTaxMember 2017-01-01 2017-06-30 0001159275 KWBT:EquityPurchaseAgreementMember 2017-06-07 2017-06-08 0001159275 KWBT:EquityPurchaseAgreementMember KWBT:RMBMember 2017-06-07 2017-06-08 0001159275 KWBT:EquityPurchaseAgreementMember KWBT:FirstPaymentMember 2017-06-07 2017-06-08 0001159275 KWBT:EquityPurchaseAgreementMember KWBT:FirstPaymentMember KWBT:RMBMember 2017-06-07 2017-06-08 0001159275 KWBT:EquityPurchaseAgreementMember KWBT:SecondPaymentMember KWBT:RMBMember 2017-06-07 2017-06-08 0001159275 KWBT:EquityPurchaseAgreementMember KWBT:FinalPaymentMember KWBT:RMBMember 2017-06-07 2017-06-08 0001159275 KWBT:KiwaBioTechShenzhenCoLtdMember KWBT:RMBMember KWBT:ApartmentLeaseMember 2017-06-19 2017-06-20 0001159275 KWBT:KiwaBioTechShenzhenCoLtdMember KWBT:ApartmentLeaseMember 2017-06-19 2017-06-20 0001159275 KWBT:KiwaBioTechProductGroupMember KWBT:OfficeLeaseAgreementMember 2017-05-04 2017-05-05 0001159275 KWBT:KiwaBioTechProductGroupMember KWBT:OfficeLeaseAgreementMember 2017-06-29 2017-07-02 0001159275 KWBT:USAOfficeMember 2017-06-30 0001159275 2017-02-11 0001159275 us-gaap:SubsequentEventMember 2017-06-29 2017-07-02 0001159275 us-gaap:SubsequentEventMember 2017-08-03 0001159275 us-gaap:SubsequentEventMember KWBT:RMBMember 2017-08-03 0001159275 us-gaap:SubsequentEventMember KWBT:JunweiZhengMember 2017-07-17 2017-07-19 0001159275 us-gaap:SubsequentEventMember KWBT:JunweiZhengMember 2017-07-19 0001159275 us-gaap:SubsequentEventMember KWBT:QuanzhenShenMember KWBT:CommonStockPurchaseAgreementMember 2017-07-17 2017-07-19 0001159275 us-gaap:SubsequentEventMember KWBT:QuanzhenShenMember KWBT:CommonStockPurchaseAgreementMember 2017-07-19 0001159275 us-gaap:SubsequentEventMember KWBT:QuanzhenShenMember 2017-07-17 2017-07-19 0001159275 us-gaap:SubsequentEventMember KWBT:YuanWangMember 2017-07-17 2017-07-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CNY KIWA BIO-TECH PRODUCTS GROUP CORP 10-Q 2017-06-30 false --12-31 Smaller Reporting Company KWBT

13469

71554

721

12367

5325262

238105

5016977

181975

6.9472

6.7832

6.5345

6.8753

1.00

1283215

1122754

160461

1000000

160000

1000000

160000

1000000

0.18

0.06

0.15

3473331

3458902

3473331

3458902

0.001

100000000

0.001

20000000

500000

11. Related Party Transactions   (1). Amounts due to related parties   Amounts due to related parties consisted of the following as of June 30, 2017 and December 31, 2016:   <table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; line-height: 107%">Item</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: center; line-height: 107%">Nature</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: center; line-height: 107%">Notes</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: center; line-height: 107%">June 30, 2017</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: center; line-height: 107%">December 31, 2016</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; padding-bottom: 8pt; text-align: justify; line-height: 107%">Kiwa-CAU R&D Center</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 11%; padding-bottom: 8pt; text-align: center; line-height: 107%">Trade</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 11%; padding-bottom: 8pt; text-align: center; line-height: 107%">(b)</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 15%; padding-bottom: 8pt; text-align: right; line-height: 107%">-</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 15%; padding-bottom: 8pt; text-align: right; line-height: 107%">1,122,754</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 8pt; text-align: justify; line-height: 107%">CAAS IARRP and IAED Institutes</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; text-align: center; line-height: 107%">Trade</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; text-align: center; line-height: 107%">(c)</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: right; line-height: 107%">-</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: right; line-height: 107%">160,461</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 8pt; text-align: justify; line-height: 107%">Total</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; text-align: center; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; text-align: center; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 8pt; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 8pt; text-align: right; line-height: 107%">-</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 8pt; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 8pt; text-align: right; line-height: 107%">1,283,215</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td></tr> </table>   (a) Yvonne Wang   Ms. Wang is a board member and Acting President, Acting Chief Executive Officer and Acting Chief Financial Officer. From time to time, Ms. Wang paid various expenses on behalf of the Company. As of June 30, 2017 and December 31, 2016, the amount due to Ms. Wang was $83,798 and $100,798, respectively.   (b) In November 2006, Kiwa and China Agricultural University (the “CAU”) agreed to jointly establish a new research and development center, named Kiwa-CAU R&D Center. Pursuant to the agreement, Kiwa committed to fund RMB 1 million (approximately $160,000) annually to the research center. Prof. Qi Wang, a director of the Company was also the director of Kiwa-CAU R&D Center. Although the agreement was expired on June 30, 2016, the payable balance remains on Kiwa Shandong’s book until April 12, 2017 when the transaction of transfer Kiwa Shandone’s all assets and liabilities to Dian ShiCheng Jing (Beijing) was completed.   The Company recorded nil and $36,363 research and development expenses related to this Kiwa-CAU R&D Center for the six months ended June 30, 2017 and 2016, respectively.   (c) On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). The term of the Agreement was three years ends on November 4, 2017.   Pursuant to the agreement, Kiwa agree to invest RMB 1 million (approximately $160,000) each year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. Prof. Yong Chang Wu, the authorized representative of IARRP, CAAS, was also one of the Company's directors until he resigned on March 13, 2017. Since Prof. Yong Chang Wu is no longer a board member, the balance of $233,598 at June 30, 2017 has been reclassified from part due to related party – trade to R&D expenses payable.   The Company recorded $36,291and $38,764 research and development expenses related to the institutes, for the six months ended June 30, 2017 and 2016, respectively.    (2). Convertible Note Payables   (a). Geng Liu   Geng Liu became a shareholder of the Company and has held 500,000 shares of common stock since September, 2016   On January 17, 2017, the Company entered into a Convertible Loan Agreement with Geng Liu wherein the lender agreed to advance of approximately US $442,269 (RMB3,000,000) under a Convertible Promissory Note with a term of 12 months bearing interest at a rate of Fifteen Percent (15%) per annum. The Loan is convertible into Common Stock at any time at the option of the Lender at a conversion price of $ 0.90 per share within the term.   As of June 30, 2017, the Company received proceeds about $147,423 (RMB 1,000,000) from Geng Liu and recorded interest expense related to this note $5,442 and $8,472 for the three and six months ended June 30, 2017, respectively.   (b). Junwei Zheng   Junwei Zheng became a shareholder of the Company and has held 920,000 shares of common stock since March, 2017   On May 9, 2017, Company entered into a Convertible Loan Agreement with Junwei Zheng wherein the lender agreed to advance of approximately US$ 4.5 million (RMB 30,000,000) under a Convertible Promissory Note with a term of 24 months bearing interest at a rate of Fifteen Percent (15%) per annum. The Loan is convertible into Common Stock at any time at the option of the Lender at a conversion price of $3.50 per share within the term   As of June 30, 2017, the Company has received proceeds of about $810,827 (RMB 5,500,000) from Junwei Zheng and the interest expense related to this note was $17,328 for the three and six months ended June 30, 2017.

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the consolidated financial statements were as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">As of June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">As of December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Balance sheet items, except for equity accounts</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.7832</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.9472</td> <td style="line-height: 107%"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Six months ended June 30</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify; line-height: 107%">Items in the statements of comprehensive loss</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">6.8753</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">6.5345</td> <td style="width: 1%; line-height: 107%"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; line-height: 107%">Item</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: center; line-height: 107%">Nature</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: center; line-height: 107%">Notes</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: center; line-height: 107%">June 30, 2017</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: center; line-height: 107%">December 31, 2016</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; padding-bottom: 8pt; text-align: justify; line-height: 107%">Kiwa-CAU R&D Center</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 11%; padding-bottom: 8pt; text-align: center; line-height: 107%">Trade</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 11%; padding-bottom: 8pt; text-align: center; line-height: 107%">(b)</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 15%; padding-bottom: 8pt; text-align: right; line-height: 107%">-</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td> <td style="width: 15%; padding-bottom: 8pt; text-align: right; line-height: 107%">1,122,754</td> <td style="width: 1%; padding-bottom: 8pt; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 8pt; text-align: justify; line-height: 107%">CAAS IARRP and IAED Institutes</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; text-align: center; line-height: 107%">Trade</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; text-align: center; line-height: 107%">(c)</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: right; line-height: 107%">-</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; padding-bottom: 8pt; text-align: right; line-height: 107%">160,461</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 8pt; text-align: justify; line-height: 107%">Total</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; text-align: center; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; text-align: center; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 8pt; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 8pt; text-align: right; line-height: 107%">-</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="padding-bottom: 8pt; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; padding-bottom: 8pt; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; padding-bottom: 8pt; text-align: right; line-height: 107%">1,283,215</td> <td style="padding-bottom: 8pt; line-height: 107%"> </td></tr> </table>   (a) Yvonne Wang   Ms. Wang is a board member and Acting President, Acting Chief Executive Officer and Acting Chief Financial Officer. From time to time, Ms. Wang paid various expenses on behalf of the Company. As of June 30, 2017 and December 31, 2016, the amount due to Ms. Wang was $83,798 and $100,798, respectively.   (b) In November 2006, Kiwa and China Agricultural University (the “CAU”) agreed to jointly establish a new research and development center, named Kiwa-CAU R&D Center. Pursuant to the agreement, Kiwa committed to fund RMB 1 million (approximately $160,000) annually to the research center. Prof. Qi Wang, a director of the Company was also the director of Kiwa-CAU R&D Center. Although the agreement was expired on June 30, 2016, the payable balance remains on Kiwa Shandong’s book until April 12, 2017 when the transaction of transfer Kiwa Shandone’s all assets and liabilities to Dian ShiCheng Jing (Beijing) was completed.   The Company recorded nil and $36,363 research and development expenses related to this Kiwa-CAU R&D Center for the six months ended June 30, 2017 and 2016, respectively.   (c) On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). The term of the Agreement was three years ends on November 4, 2017.   Pursuant to the agreement, Kiwa agree to invest RMB 1 million (approximately $160,000) each year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. Prof. Yong Chang Wu, the authorized representative of IARRP, CAAS, was also one of the Company's directors until he resigned on March 13, 2017. Since Prof. Yong Chang Wu is no longer a board member, the balance of $233,598 at June 30, 2017 has been reclassified from part due to related party – trade to R&D expenses payable.   The Company recorded $36,291and $38,764 research and development expenses related to the institutes, for the six months ended June 30, 2017 and 2016, respectively.    (2). Convertible Note Payables   (a). Geng Liu   Geng Liu became a shareholder of the Company and has held 500,000 shares of common stock since September, 2016   On January 17, 2017, the Company entered into a Convertible Loan Agreement with Geng Liu wherein the lender agreed to advance of approximately US $442,269 (RMB3,000,000) under a Convertible Promissory Note with a term of 12 months bearing interest at a rate of Fifteen Percent (15%) per annum. The Loan is convertible into Common Stock at any time at the option of the Lender at a conversion price of $ 0.90 per share within the term.   As of June 30, 2017, the Company received proceeds about $147,423 (RMB 1,000,000) from Geng Liu and recorded interest expense related to this note $5,442 and $8,472 for the three and six months ended June 30, 2017, respectively.   (b). Junwei Zheng   Junwei Zheng became a shareholder of the Company and has held 920,000 shares of common stock since March, 2017   On May 9, 2017, Company entered into a Convertible Loan Agreement with Junwei Zheng wherein the lender agreed to advance of approximately US$ 4.5 million (RMB 30,000,000) under a Convertible Promissory Note with a term of 24 months bearing interest at a rate of Fifteen Percent (15%) per annum. The Loan is convertible into Common Stock at any time at the option of the Lender at a conversion price of $3.50 per share within the term   As of June 30, 2017, the Company has received proceeds of about $810,827 (RMB 5,500,000) from Junwei Zheng and the interest expense related to this note was $17,328 for the three and six months ended June 30, 2017.

The Company had deferred tax assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify; line-height: 107%">Net operating losses carried forward</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">3,458,902</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">3,473,331</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Less: Valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(3,458,902</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(3,473,331</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Net deferred tax assets</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>

A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Three months ended June 30,</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Six months ended June 30,</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%; line-height: 107%">Pre-tax income</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">5,396,950</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">181,975</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">5,924,464</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">238,105</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">U.S. federal corporate income tax rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34</td> <td style="line-height: 107%">%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Income tax computed at U.S. federal corporation income tax rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,834,963</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">61,872</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">2,014,318</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">80,956</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Reconciling items:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Rate differential for PRC earnings</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(124,683</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">8,770</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(202,353</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">13,668</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change of valuation allowance</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">195,403</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">80,006</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">305,935</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">146,608</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Non-deductible expenses</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,525,710</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(150,648</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,518,877</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(241,232</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Effective tax expenses</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">379,973</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">599,022</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>

0.89

The term of the Agreement is for three years beginning November 20, 2015 and will expire on November 19, 2018.

0.25

-5601213

1734352

500000

3400000

2007-07-27

2009-06-29

2018-01-16

2019-05-08

360000

6178336

101947

3140000

0.25

30892

1-for-200

120000000

8472

5442

17328

0.06 0.06 0.15 0.15 0.06

120000

435380

3000000

30000000

4500000

72724

151769

36363

233598

36433

74776

36291

38764

-202353

13668

-124683

8770

45000

22500

8472

5442

17328

904300

1286

78775

125000

179897

254250

1. Description of Business and Organization   Organization   Kiwa Bio-Tech Products Group Corporation (“the Company”) is the result of a share exchange transaction accomplished on March 12, 2004 between the shareholders of Kiwa Bio-Tech Products Group Ltd. (“Kiwa BVI”), a company originally organized under the laws of the British Virgin Islands on June 5, 2002 and Tintic Gold Mining Company (“Tintic”), a corporation originally incorporated in the state of Utah on June 14, 1933 to perform mining operations in Utah. The share exchange resulted in a change of control of Tintic, with former Kiwa BVI stockholders owning approximately 89% of Tintic on a fully diluted basis and Kiwa BVI surviving as a wholly-owned subsidiary of Tintic. Subsequent to the share exchange transaction, Tintic changed its name to Kiwa Bio-Tech Products Group Corporation. On July 21, 2004, the Company completed its reincorporation in the State of Delaware. On March 8, 2017, we completed our reincorporation in the State of Nevada.   The Company operates through a series of subsidiaries in the Peoples Republic of China as detailed in the following Organizational Chart. The Company had previously operated its business through its subsidiaries Kiwa Bio-Tech Products (Shandong) Co., Ltd. (“Kiwa Shandong”) and Tianjin Kiwa Feed Co., Ltd. (“Kiwa Tianjin “). Kiwa Tianjin has been dissolved since July 11, 2012. On February 11, 2017, the Company entered an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) to transfer all of shareholders’ right, title and interest in Kiwa Shandong to the Transferee for USD $1.00. On April 12, 2017, the government processing of transfer has been completed.   <img src="image_003.jpg" alt="" />    Business   The Company’s business plan is to develop and market innovative, manufacture, distribute cost-effective and environmentally safe bio-technological products for agriculture markets primarily in China. The Company has acquired technologies to produce and market bio-fertilizer.

2. Summaries of Significant Accounting Policies   Principle of Consolidation   These consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries, Kiwa BVI, Hong Kong Baina Group Holding Company, Kiwa Baiao Bio-Tech (Beijing) Co., Ltd, Kiwa Baiao Bio-Tech (Shandong) Co., Ltd (“Kiwa Shandong”), Kiwa Bio-Tech Products (Shenzhen) Co., Ltd and Kiwa Bio-Tech Products (Hebei) Co., Ltd. All significant inter-company balances or transactions are eliminated on consolidation.   Reverse Split   On January 14, 2016, the Company filed a Certificate of Amendment of its Certificate of Incorporation with the State of Delaware with reference to a 1-for-200 reverse stock split with respect to its Common Stock with effective date of January 28, 2016. In connection with the reverse split, the Company’s authorized capital was amended to be 120,000,000 shares, comprising 100,000,000 shares of Common Stock par value $0.001 and 20,000,000 shares of Preferred Stock par value $0.001. All relevant information relating to numbers of shares, options and per share information have been retrospectively adjusted to reflect the reverse stock split for all periods presented.    Use of Estimates   The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant accounting estimates include the valuation of securities issued, deferred tax assets and related valuation allowance.   Certain of our estimates, including evaluating the collectability of accounts receivable and the fair market value of long-lived assets, could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. We re-evaluate all of our accounting estimates annually based on these conditions and record adjustments when necessary.   Cash and Cash Equivalents   Cash and cash equivalents consist of all cash balances and highly liquid investments with an original maturity of three months or less. Because of the short maturity of these investments, the carring amounts approximate their fair value. Restricted cash is excluded from cash and cash equivalents.   Accounts Receivables   Accounts receivables represent customer accounts receivables. The allowance for doubtful accounts is based on a combination of current sales, historical charge offs and specific accounts identified as high risk. Uncollectible accounts receivable are charged against the allowance for doubtful accounts when all reasonable efforts to collect the amounts due have been exhausted. Such allowances, if any, would be recorded in the period the impairment is identified.   Allowance for doubtful accounts   The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. There was no allowance for doubtful accounts at June 30, 2017 and December 31, 2016.   Property, plant and equipment   Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Gains or losses on disposals are reflected as gain or loss in the year of disposal. The cost of improvements that extend the life of property, plant and equipment are capitalized. These capitalized costs may include structural improvements, equipment and fixtures. All ordinary repair and maintenance costs are expensed as incurred. Depreciation for financial reporting purposes is provided using the straight-line method over the estimated useful lives of the assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Useful Life</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(In years)</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Buildings</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">30 - 35</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Machinery and equipment</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">5 - 10</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; text-align: justify; line-height: 107%">Automobiles</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; text-align: center; line-height: 107%"> </td> <td style="width: 26%; text-align: center; line-height: 107%">8</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Office equipment</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">2 - 5</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Computer software</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">3</td> <td style="line-height: 107%"> </td></tr> </table>     Impairment of Long-Lived Assets   The Company’s long-lived assets consist of property, equipment and intangible assets. The Company evaluates its investment in long-lived assets, including property and equipment, for recoverability whenever events or changes in circumstances indicate the net carrying amount may not be recoverable. Judgments regarding potential impairment are based on legal factors, market conditions and operational performance indicators, among others. In assessing the impairment of property and equipment, the Company makes assumptions regarding the estimated future cash flows and other factors to determine the fair value of the respective assets.   Goodwill and Other Intangibles   In accordance with Accounting Standards Update (ASU) No. 2014-02, management evaluates goodwill on an annual basis in the fourth quarter of more frequently if management believes indicators of impairment exist. Such indicators could, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. If management concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, management conducts a two-step quantitative goodwill impairment test. The first step of the impairment test involves comparing the fair value of the applicable reporting unit with its carrying value. The Company estimates the fair value of its reporting units using a combination of the income, or discounted cash flows, approach and the market approach, with utilizes comparable companies’ data. If the carrying amount of a reporting unit exceeds the reporting unit’s fair value, management performs the second step of the goodwill impairment test. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit’s goodwill with the carrying value of that goodwill. The amount, by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss. The Company’s evaluation of goodwill completed during the three and six months ended June 30, 2017 resulted in no impairment losses.   Fair Value of Financial Instruments   The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820- 10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value with U.S. GAAP, and expands disclosures about fair value measurements.   To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify; line-height: 107%"> </td> <td style="width: 24px; text-align: justify; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 1: quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 2: pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 3: Pricing inputs that are generally observable inputs and not corroborated by market data.</td></tr> </table>   Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.   The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.    The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.   The carrying amount of the Company’s financial assets and liabilities, such as cash and cash equivalent, prepaid expenses, accounts payable and accrued expenses, approximate their fair value because of the short maturity of those instruments.   Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.   It is not however practical to determine the fair value of advances from stockholders, if any, due to their related party nature.   Revenue Recognition   The Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.   The Company derives its revenues from sales contracts with its customers with revenues being recognized upon delivery of products. Persuasive evidence of an arrangement is demonstrated via invoice; and the sales price to the customer is fixed upon acceptance of the purchase order and there is no separate sales rebate, discount, or volume incentive.   Advertising Costs   The Company charges all advertising costs to expense as incurred. The total amounts of advertising costs charged to selling, general and administrative expense were $58,419 and nil for the six months ended June 30, 2017 and 2016, and were $935 and nil for the three months ended June 30, 2017 and 2016, respectively.   Research and Development Costs   Research and development costs are charged to expense as incurred. During the six months ended June 30, 2017 and 2016, research and development costs were $72,724 and $151,769, respectively. During the three months ended June 30, 2017 and 2016, research and development costs were $36,433 and $74,776, respectively.   Shipping and Handling Costs   Substantially all costs of shipping and handling of products to customers are included in selling expense. Shipping and handling costs for the three and six months ended June 30, 2017 and 2016 were nil, respectively.   Income Taxes   The Company accounts for income taxes under the provisions of FASB ASC Topic 740, “Income Tax,” which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the difference between the tax bases of assets and liabilities and their reported amounts in the financial statements. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company establishes a valuation when it is more likely than not that the assets will not be recovered.    ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. We have no material uncertain tax positions for any of the reporting periods presented.   Stock Based Compensation   The Company accounts for share-based compensation awards to employees in accordance with FASB ASC Topic 718, “Compensation – Stock Compensation”, which requires that share-based payment transactions with employees be measured based on the grant-date fair value of the equity instrument issued and recognized as compensation expense over the requisite service period.   The Company accounts for share-based compensation awards to non-employees in accordance with FASB ASC Topic 718 and FASB ASC Subtopic 505-50, “Equity-Based Payments to Non-employees”. Under FASB ASC Topic 718 and FASB ASC Subtopic 505-50, stock compensation granted to non-employees has been determined as the fair value of the consideration received or the fair value of equity instrument issued, whichever is more reliably measured and is recognized as an expense as the goods or services are received.   Foreign Currency Translation and Other Comprehensive Income   The Company uses United States dollars (“US Dollar” or “US$” or “$”) for financial reporting purposes. However, the Company maintains the books and records in its functional currency, Chinese Renminbi (“RMB”), being the functional currency of the economic environment in which its operations are conducted. In general, the Company translates its assets and liabilities into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statement of comprehensive loss and the statement of cash flow are translated at average exchange rates during the reporting period. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the Company’s financial statements are recorded as accumulated other comprehensive income.   Other comprehensive income for the six months ended June 30, 2017 and 2016 represented foreign currency translation adjustments and were included in the consolidated statements of comprehensive loss.   The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the consolidated financial statements were as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">As of June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">As of December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Balance sheet items, except for equity accounts</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.7832</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.9472</td> <td style="line-height: 107%"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Six months ended June 30</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Items in the statements of comprehensive loss</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.8753</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.5345</td> <td style="line-height: 107%"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   Earnings Per Common Share   Net income per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the period.   Diluted net income per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.    Related Parties   The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly Influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.   The consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the consolidated financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.   Commitments and Contingencies   The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.   If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.   Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows.   Cash Flows Reporting   The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.    Subsequent Events   The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.   Recent Accounting Pronouncements   In May 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), Revenue from Contracts with Customers. ASU 2014-09 will eliminate transaction- and industry-specific revenue recognition guidance under current GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. ASU 2014-09 also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. Based on the FASB’s Exposure Draft Update issued on April 29, 2015, and approved in July 2015, Revenue from Contracts With Customers (Topic 606): Deferral of the Effective Date, ASU 2014-09 is now effective for reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The adoption of ASU 2014-09 is not expected to have any impact on the Company’s financial statement presentation or disclosures.   In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term. ASU 2016-02 requires classification of all cash payments within operating activities in the statement of cash flows. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. ASU 2016-02 is effective for fiscal years beginning after December IS, 2018, including interim periods within those fiscal years. Early application is permitted. The Company has not yet evaluated the impact of the adoption of ASU 2016-02 on the Company’s financial statement presentation or disclosures.   In January 2017, the FASB issued ASU 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” The amendments in this guidance are clarifying the definition of a business to assist entities when determining whether an integrated set of assets and activities meets the definition of a business. The update provides that when substantially all the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The adoption of this new guidance is not expected to have a material impact on our consolidated financial statements.   In January 2017, the FASB issued ASU 2017-04—Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The amendments in this guidance to eliminate the requirement to calculate the implied fair value of goodwill to measure goodwill impairment charge (Step 2). As a result, an impairment charge will equal the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the amount of goodwill allocated to the reporting unit. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The amendment should be applied on a prospective basis. The guidance is effective for goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for goodwill impairment tests performed after January 1, 2017. The impact of this guidance for the Company will depend on the outcomes of future goodwill impairment tests.    In May 2017, the FASB issued Accounting Standards Update No. 2017-09 (ASU 2017-09), Compensation — Stock Compensation (Topic 718) Scope of Modification Accounting. The amendments in ASU 2017-09 provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The adoption of ASU 2017-09 which will become effective for annual periods beginning after December 15, 2017 and for interim periods within those annual periods, is not expected to have any impact on the Company’s financial statement presentation or disclosures.   Management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

13. Convertible Notes Payable   Convertible notes payable consists $ 150,250 of 6% secured convertible notes issued to FirsTrust Group Inc. on June 29, 2006 , $145,127 of 15% convertible note issued to Mr. Geng Liu on January 17, 2017 and $810,827 of 15% convertible note issued to Mr. Junwei Zheng on May 9, 2017.   6% secured convertible notes   In 2006, we completed a $2.45 million 6% Secured Convertible Note (“6% Convertible Note”) transaction with six institutional investors, including Nite Capital LP, which purchased a total of $300,000 of the Note in three tranches ($105,000, $90,000, $105,000 respectively). The 6% Convertible Note allows the note holder to convert into shares of our common stock. We filed a registration statement under the Securities Act covering the resale of the shares issued upon conversion of the 6% Notes in 2006 and the registration statement was declared effective on October 13, 2006.   On March 18, 2008, FirsTrust Group, Inc. purchased three remaining 6% Convertible Notes, totaling $168,000 ($59,100, $50,400 and $59,100 respectively), from Nite Capital for a cash payment of $100,000. As of June 30, 2017, there is no other outstanding 6% Note than those owned by FirsTrust Group. The total outstanding Convertible Note payable to FirsTrust is $150,250, and the total accumulated interest and penalty is $194,537 and $523,141, respectively.   15% convertible notes- Geng Liu   On January 17, 2017, the Company entered a Convertible Note Agreement with an individual person with principal of RMB 3 million or approximately $435,380. The note bears interest at 15% per annum and will mature on January 16, 2018. Before the maturity date, the Note holder has an option to convert partial or all of the outstanding principal and accrued interest to the Company’s common shares with a conversion price of $0.90 per share. As of June 30, 2017, the Company has received partial principal totaled $145,127 (RMB 1 million). The Company accrued $5,442 and $8,472 interest expense on this convertible notes for the three and six months ended June 30, 2017, respectively.   15% convertible notes- Junwei Zheng   On May 9, 2017, the Company entered a Convertible Note Agreement with an individual person with principal of RMB 30 million or approximately $4.5 million. The note bears interest at 15% per annum and will mature on May 8, 2019. Before the maturity date, the Note holder has an option to convert partial or all of the outstanding principal and accrued interest to the Company’s common shares with a conversion price of $3.5 per share. As of June 30, 2017, the Company has received partial principal totaled $810,827 (RMB 5.5 million). The Company accrued $17,328 interest expense on this convertible notes for both of the six months and three months ended June 30, 2017.

14. Note Payable   On May 29, 2007, the Company issued a $360,000 promissory note (the “Promissory Note”) to an unrelated individual (the “Original Note holder”). This note bears interest at 18% per annum and was due on July 27, 2007. This note is currently in default and bears interest of 25% per annum (the “Default rate”) until paid in full. This note is secured by a pledge of 6,178,336 (post-reverse split 30,892) shares of the Company’s common stock owned by Investlink (China) Limited (the “Pledged Shares”). The Company accrued $45,000 and $45,000 interest expense on note payable for the six months ended June 30, 2017 and 2016, and $22,500 and $22,500 interest expense on note payable for the three months ended June 30, 2017 and 2016, respectively.   As of December 31, 2016, the Original Note holder informed us that all right, title and interests in the Promissory Note has been assigned and transferred to FirsTrust Group, Inc. (“FirsTrust”). As of June 30, 2017, all of $360,000 of Promissory Note to FirsTrust is still outstanding, and total interest of the Promissory Note is $ 904,300. We have begun preliminary discussion with FirsTrust with regards to a potential settlement of the Note, but no agreement has been reached. As of June 30, 2017, with the Company’s acknowledgement, FirsTrust has taken possession of 30,892 Pledged Share from Investline (China) Limited according to the default clause of the Promissory Note.

16. Stockholders’ Equity   In March, 2016, the Company issued 3,140,000 shares of common stock to Mr. Li and Ms. Wang for debt and salary payable settlement for an aggregate amount of $3,141,000. In addition, the Company issued 101,947 common shares to Jimmy Zhou, former CEO in August 2016, to settle payable to him for $50,974. All of issuances of common shares for settlement of debts were based the stock price on the transaction dates.   During the year ended December 31, 2016, the Company issued 1,650,000 common shares for cash at $0.8 per share for an aggregate subscribe price equivalent to $1,320,000, of which $759,659 has received while approximately $560,341 remaining subscribe receivable at December 31, 2016. The remaining subscribe receivable was totally received in August 3, 2017.   On November 15, 2016, the Company completed another private offering of common stock to an accredited investor for 125,000 shares of its common stock and warrants to purchase 300,000 shares of Company common stock at an exercise price of $3.00 per share prior to November 15, 2021. The Company may adjust the exercise price for some or all of the warrants under certain terms and conditions. We have determined the issued warrants do not meet the definition of a derivative security, and thus allocated the net proceeds of the sale of the common stock to the par value of the common stock, with the remainder to additional paid in capital.   During the year ended December 31, 2016, the Company issued 1,710,808 common shares to four consulting companies and three individuals as compensation for their consulting service received. The agreements have the service periods from 6 months to 36 months with a total of $1,688,300 that was determined as fair value at the time of execution of the agreement. The total services fee will be recognized based straight-line amortization method over the service term. The Company recorded $331,800 as consulting service expense for the six months ended June 30, 2017 and $254,250 approximately for the year ended December 31, 2016.   In February, 2017, the Company issued 1,000,000 common shares to Mr. Junwei Zheng for cash at $1.00 per share for an aggregate price to $1,000,000, all of which has been received as of June 30, 2017.   On February 15, 2017, the Company entered a consulting agreement with Mr. Yuan Wang to assist the Company in financing projects. The agreement has one year term with a total of $85,400 that was determined as fair value at the time of execution of the agreement. The total services fee will be recognized based straight-line amortization method over the service term. On March 3, 2017, the Company issued 70,000 common shares to Mr. Yuan Wang based on market price of $1.22 per share. The Company realized $32,025 as a compensation for Mr. Wang’s consulting service for the six months ended June 30, 2017.   On May 25, 2017, the Company issued 19,380 common shares to an individual to assist the Company in financing projects based on market price of $2.74 per share. The agreement has one year term with a total of $53,101 that was determined as fair value at the time of execution of the agreement. The total services fee will be recognized based straight-line amortization method over the service term. The Company recorded $5,237 as consulting service expense for the six months ended June 30, 2017.   On June 1, 2017, the Company issued 15,108 common shares to an individual to assist the Company in technical support based on market price of $2.78 per share. The agreement has one year term with a total of $41,396 that was determined as fair value at the time of execution of the agreement. The total services fee will be recognized based straight-line amortization method over the service term. The Company recorded $3,402 as consulting service expense for the six months ended June 30, 2017.    On June 13, 2017, the Company issued 96,900 common shares to Mr. Yuan Wang for cash at $3.00 per share for an aggregate price to $290,700, all of which has been received as of June 30, 2017.   On June 30, 2017, the Company issued 97,850 common shares to ten employees for cash at $1.95 per share for an aggregate price to $190,807, all of which has been received as of June 30, 2017. The Company determined the fair price per common stock was $3.0 per share, thus the difference of $1.05 per share between fair price per share ($3.00) and the employees purchase price per share ($1.95), totaled $102,273 was recognized as expense of employee benefits and accordingly, credited the same amount to APIC.   Subsequently the Company issued 98,000 shares of common stock for cash $294,000, and 88,000 shares of common stock for consulting service. Please refer to Note 22 Subsequent Events for additional information.

17. Stock-based Compensation   On March 15, 2017, the Board of Directors approved a new stock option plan with ten years’ term. As of June 30, 2017, the Company has not granted any incentive compensation under this plan.

20. Commitments and Contingencies   The Company has the following material contractual obligations:   (1) Investment in manufacturing facilities in Penglai City, Shandong Province in China   On June 8, 2017, the Company entered an equity purchase agreement with Yantai Peng Hao New Materials Technology Co. Ltd. (“Acquirer”), which relates to the acquisition of a new factory for purchase price of about $2.2 million (approximately RMB 15 million). The factory to be acquired by the Company will be completed in accordance with the Company’s construction plan to facilitate the production design of combining of microbial fermentation and terminal fertilizer products.   Pursuant to the payment terms of purchase agreement, the Company made the first payment of $147,423 (approximately RMB 1,000,000) to the Acquirer on June, 2017 and will make the second payment of RMB 10,000,000 as long as the Company obtains the land use right certificate and will make the final payment of RMB 4,000,000 after the government processing has been completed.   (2) Strategic cooperation with the institutes in China   On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015 and will expire on November 19, 2018.   (3) Distribution agreement with Kangtan Gerui Bio-Tech in China   On December 17, 2015, Kiwa Bio-Tech Products Group Corporation (the “Company”) entered into a distribution agreement (the “Agreement”) with Kangtan Gerui (Beijing) Bio-Tech Co., Ltd. (“Gerui”) and formally awarded Gerui a right to sell and distribute the Company’s fertilizer products in 3 major agricultural regions of China— Hainan Province, Hunan Province and Xinjiang Autonomous Region. The Company’s Research and Development department has been conducting application experiments in Hainan and Hunan Provinces since August 2015, in accordance with the market requirements. The experiment data indicates that the Company’s fertilizer products have fulfilled the requirements of reduction of content of heavy metals in soil and improve crop yield. Gerui was founded in Beijing in April 2015 and relies on the sales network of China’s Supply and Marketing Cooperatives system. Currently, the Company and Gerui do not hold any interest in each other; however, a collaboration and integration may take place in the future. The term of the Agreement is for a period of three years commencing December 17, 2015. In September 2016, Kiwa Baiao Bio-Tech (Beijing) Co., Ltd obtained a fertilizer sales permit from the Chinese government and began to sale the products directly to customers in those 3 major agricultural regions.   (4) Lease payments   (1) On April 29, 2016, Kiwa Baiao Bio-Tech (Beijing) Co., Ltd. entered an office lease agreement with two-year term. Monthly lease payment and building management fee totaled RMB 77,867 or approximately USD $11,303.   (2) In June 20, 2017, Kiwa Bio-Tech (Shenzhen) Co., Ltd, a newly established subsidiary entered an office lease agreement with two-year term. Monthly lease payment is RMB 115,000 or approximately of USD $16,954. And the previous lease agreement terminated automatically since the landloard is the same one.   (3) On May 5, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with 13 months term. Monthly lease payment totaled USD $680.   (4) On July 1, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with one-year term. Monthly lease payment totaled USD $1,087.   The future lease payments at June 30, 2017 are summarized below.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Beijing Office</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Shenzhen Office</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">USA Office</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 24%; text-align: center; line-height: 107%">2017</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">68,876</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">101,722</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">10,605</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">181,203</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%">2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">45,917</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">203,444</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">9,925</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">259,286</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%">2019</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">101,722</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">101,722</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%">Thereafter </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>

19. Income Tax   In accordance with the current tax laws in China, Kiwa Shandong is subject to a corporate income tax rate of 25% on its taxable income. However, Kiwa Shandong has not provided for any corporate income taxes since it had no taxable income for the six months ended June 30, 2017 and 2016.   Kiwa Baiao Co., Ltd., is also subject to a corporation income tax rate of 25% on its taxable income. For the six months ended June 30, 2017, it recorded income tax provision for RMB 4,112,924 or approximately $598,222. For the three months ended June 30, 2017, it recorded income tax provision for RMB 2,601,847 or approximately $379,973.   Provision for taxes $800 to the minimum California state franchise tax. In accordance with the relevant tax laws in the British Virgin Islands, Kiwa BVI, as an International Business Company, is exempt from income taxes.    A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Three months ended June 30,</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Six months ended June 30,</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%; line-height: 107%">Pre-tax income</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">5,396,950</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">181,975</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">5,924,464</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">238,105</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">U.S. federal corporate income tax rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34</td> <td style="line-height: 107%">%</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">34</td> <td style="line-height: 107%">%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Income tax computed at U.S. federal corporation income tax rate</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">1,834,963</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">61,872</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">2,014,318</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">80,956</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Reconciling items:</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Rate differential for PRC earnings</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(124,683</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">8,770</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(202,353</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">13,668</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Change of valuation allowance</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">195,403</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">80,006</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">305,935</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">146,608</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Non-deductible expenses</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,525,710</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(150,648</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(1,518,877</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(241,232</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Effective tax expenses</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">379,973</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">599,022</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>   The Company had deferred tax assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify; line-height: 107%">Net operating losses carried forward</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">3,458,902</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">3,473,331</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Less: Valuation allowance</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(3,458,902</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">(3,473,331</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Net deferred tax assets</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>   As of June 30, 2017 and December 31, 2016, the Company had approximately $3.4 million and $3.4 million net operating loss carryforwards available to reduce future taxable income. Net operating loss of the Company could be carried forward and taken against any taxable income for a period of not more than twenty years from the year of the initial loss pursuant to Section 172 of the Internal Revenue Code of 1986, as amended. The net operating loss of Kiwa Shandong could be carried forward for a period of not more than five years from the year of the initial loss pursuant to relevant PRC tax laws and regulations. It is more likely than not that the deferred tax assets cannot be utilized in the future because there will not be significant future earnings from the entity which generated the net operating loss. Therefore, the Company recorded a full valuation allowance on its deferred tax assets.   As of June 30, 2017 and December 31, 2016, the Company has no material unrecognized tax benefits which would favorably affect the effective income tax rate in future periods and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during six months ended June 30, 2017 and December 31, 2016, and no provision for interest and penalties is deemed necessary as of June 30, 2017 and December 31, 2016.   According to the PRC Tax Administration and Collection Law, the statute of limitations is three years if the underpayment of taxes is due to computational errors made by the taxpayer or its withholding agent. The statute of limitations extends to five years under special circumstances, which are not clearly defined. In the case of a related party transaction, the statute of limitation is ten years. There is no statute of limitation in the case of tax evasion.

22. Subsequent Events   On July 1, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with two-year term. Monthly lease payment totaled USD $1,087.   On July 19, 2017, the Company entered into Common Stock Purchase Agreement with Junwei Zheng. Pursuant to the Agreement, the Company will issue total 245,000 shares of restricted common stock at $3.00 per share price for an aggregate amount of $735,000. As of August 14, 2017, the Company has not received the amount yet.   On July 19, 2017, the Company entered into Common Stock Purchase Agreement with Quanzhen Shen. Pursuant to the Agreement, the Company will issue total 98,000 shares of restricted common stock at $3.00 per share price for an aggregate amount of $294,000. The Company has received the full amount.   On July 19, 2017, the Company issued 49,000 common shares to Quanzhen Shen for her consulting service to assist the Company in financing projects. The number of shares was determined based on the fair value of the service. The agreement has one year term.   On July 18, 2017, the Company issued 39,000 common shares to Yuan Wang in assistance with the Company financing projects. The number of shares was determined based on the fair value of the service. The agreement has one year term.   On August 3, 2017, the Company fully collected $487,627 (RMB 3,360,000) of the entire subscribe receivable balance at December 31, 2016.   The Company has evaluated the existence of significant events subsequent to the balance sheet date through the date these financial statements were issued and has determined that, other than as stated above, there were no subsequent events or transactions which would require recognition or disclosure in the financial statements, other than noted herein.

Principle of Consolidation   These consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries, Kiwa BVI, Hong Kong Baina Group Holding Company, Kiwa Baiao Bio-Tech (Beijing) Co., Ltd, Kiwa Baiao Bio-Tech (Shandong) Co., Ltd (“Kiwa Shandong”), Kiwa Bio-Tech Products (Shenzhen) Co., Ltd and Kiwa Bio-Tech Products (Hebei) Co., Ltd. All significant inter-company balances or transactions are eliminated on consolidation.

Reverse Split   On January 14, 2016, the Company filed a Certificate of Amendment of its Certificate of Incorporation with the State of Delaware with reference to a 1-for-200 reverse stock split with respect to its Common Stock with effective date of January 28, 2016. In connection with the reverse split, the Company’s authorized capital was amended to be 120,000,000 shares, comprising 100,000,000 shares of Common Stock par value $0.001 and 20,000,000 shares of Preferred Stock par value $0.001. All relevant information relating to numbers of shares, options and per share information have been retrospectively adjusted to reflect the reverse stock split for all periods presented.

Use of Estimates   The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant accounting estimates include the valuation of securities issued, deferred tax assets and related valuation allowance.   Certain of our estimates, including evaluating the collectability of accounts receivable and the fair market value of long-lived assets, could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. We re-evaluate all of our accounting estimates annually based on these conditions and record adjustments when necessary.

Foreign Currency Translation and Other Comprehensive Income   The Company uses United States dollars (“US Dollar” or “US$” or “$”) for financial reporting purposes. However, the Company maintains the books and records in its functional currency, Chinese Renminbi (“RMB”), being the functional currency of the economic environment in which its operations are conducted. In general, the Company translates its assets and liabilities into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statement of comprehensive loss and the statement of cash flow are translated at average exchange rates during the reporting period. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the Company’s financial statements are recorded as accumulated other comprehensive income.   Other comprehensive income for the six months ended June 30, 2017 and 2016 represented foreign currency translation adjustments and were included in the consolidated statements of comprehensive loss.   The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the consolidated financial statements were as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">As of June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">As of December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Balance sheet items, except for equity accounts</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.7832</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">6.9472</td> <td style="line-height: 107%"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Six months ended June 30</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify; line-height: 107%">Items in the statements of comprehensive loss</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">6.8753</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">6.5345</td> <td style="width: 1%; line-height: 107%"> </td></tr> </table>

Impairment of Long-Lived Assets   The Company’s long-lived assets consist of property, equipment and intangible assets. The Company evaluates its investment in long-lived assets, including property and equipment, for recoverability whenever events or changes in circumstances indicate the net carrying amount may not be recoverable. Judgments regarding potential impairment are based on legal factors, market conditions and operational performance indicators, among others. In assessing the impairment of property and equipment, the Company makes assumptions regarding the estimated future cash flows and other factors to determine the fair value of the respective assets.

Revenue Recognition   The Company applies paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.   The Company derives its revenues from sales contracts with its customers with revenues being recognized upon delivery of products. Persuasive evidence of an arrangement is demonstrated via invoice; and the sales price to the customer is fixed upon acceptance of the purchase order and there is no separate sales rebate, discount, or volume incentive.

7. Property, Plant and Equipment   Property, plant and equipment, net consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Office equipment</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">942</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">942</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Furniture</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">10,260</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">8,276</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Leasehold improvement</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">72,174</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">70,871</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total Property, plant and equipment</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">83,376</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">80,089</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Less: accumulated depreciation</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(40,064</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(20,311</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less: impairment of long-lived assets</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Property, plant and equipment - net</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">43,312</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">59,778</td> <td style="line-height: 107%"> </td></tr> </table>   Depreciation expense was $17,787 and $ 3,073 for the six months ended June 30, 2017 and 2016, and $8,318 and $3,073 for the three months ended June 30, 2017 and 2016, respectively.   Impairment of long-lived assets was nil for the three and six months ended June 30, 2017 and 2016, respectively.   All of our property, plant and equipment have been held as collateral to secure the 6% Notes (see Note 14).

12. Unsecured Loans Payable   Unsecured loan payable mainly represents the payables of the subsidiary company - Kiwa Shandong, which hadn’t achieved active operation for a lengh of years. As of December 31, 2016, construction costs payable was $1,655,343.   On February 11, 2017, the Company entered an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) to transfer all of shareholders’ right, title and interest, as well as all the obligations in Kiwa Shandong to the Transferee for USD $1.00. On April 12, 2017, the transaction was completed.

Cash and Cash Equivalents   Cash and cash equivalents consist of all cash balances and highly liquid investments with an original maturity of three months or less. Because of the short maturity of these investments, the carring amounts approximate their fair value. Restricted cash is excluded from cash and cash equivalents.

Recent Accounting Pronouncements   In May 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update No. 2014-09 (ASU 2014-09), Revenue from Contracts with Customers. ASU 2014-09 will eliminate transaction- and industry-specific revenue recognition guidance under current GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. ASU 2014-09 also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. Based on the FASB’s Exposure Draft Update issued on April 29, 2015, and approved in July 2015, Revenue from Contracts With Customers (Topic 606): Deferral of the Effective Date, ASU 2014-09 is now effective for reporting periods beginning after December 15, 2017, with early adoption permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. Entities will be able to transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. The adoption of ASU 2014-09 is not expected to have any impact on the Company’s financial statement presentation or disclosures.   In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term. ASU 2016-02 requires classification of all cash payments within operating activities in the statement of cash flows. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. ASU 2016-02 is effective for fiscal years beginning after December IS, 2018, including interim periods within those fiscal years. Early application is permitted. The Company has not yet evaluated the impact of the adoption of ASU 2016-02 on the Company’s financial statement presentation or disclosures.   In January 2017, the FASB issued ASU 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” The amendments in this guidance are clarifying the definition of a business to assist entities when determining whether an integrated set of assets and activities meets the definition of a business. The update provides that when substantially all the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The adoption of this new guidance is not expected to have a material impact on our consolidated financial statements.   In January 2017, the FASB issued ASU 2017-04—Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The amendments in this guidance to eliminate the requirement to calculate the implied fair value of goodwill to measure goodwill impairment charge (Step 2). As a result, an impairment charge will equal the amount by which a reporting unit’s carrying amount exceeds its fair value, not to exceed the amount of goodwill allocated to the reporting unit. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The amendment should be applied on a prospective basis. The guidance is effective for goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for goodwill impairment tests performed after January 1, 2017. The impact of this guidance for the Company will depend on the outcomes of future goodwill impairment tests.    In May 2017, the FASB issued Accounting Standards Update No. 2017-09 (ASU 2017-09), Compensation — Stock Compensation (Topic 718) Scope of Modification Accounting. The amendments in ASU 2017-09 provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The adoption of ASU 2017-09 which will become effective for annual periods beginning after December 15, 2017 and for interim periods within those annual periods, is not expected to have any impact on the Company’s financial statement presentation or disclosures.   Management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

Research and Development Costs   Research and development costs are charged to expense as incurred. During the six months ended June 30, 2017 and 2016, research and development costs were $72,724 and $151,769, respectively. During the three months ended June 30, 2017 and 2016, research and development costs were $36,433 and $74,776, respectively.

Advertising Costs   The Company charges all advertising costs to expense as incurred. The total amounts of advertising costs charged to selling, general and administrative expense were $58,419 and nil for the six months ended June 30, 2017 and 2016, and were $935 and nil for the three months ended June 30, 2017 and 2016, respectively.

Property, plant and equipment   Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Gains or losses on disposals are reflected as gain or loss in the year of disposal. The cost of improvements that extend the life of property, plant and equipment are capitalized. These capitalized costs may include structural improvements, equipment and fixtures. All ordinary repair and maintenance costs are expensed as incurred. Depreciation for financial reporting purposes is provided using the straight-line method over the estimated useful lives of the assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Useful Life</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(In years)</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Buildings</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">30 - 35</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Machinery and equipment</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">5 - 10</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; text-align: justify; line-height: 107%">Automobiles</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; text-align: center; line-height: 107%"> </td> <td style="width: 26%; text-align: center; line-height: 107%">8</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Office equipment</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">2 - 5</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Computer software</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">3</td> <td style="line-height: 107%"> </td></tr> </table>

Shipping and Handling Costs   Substantially all costs of shipping and handling of products to customers are included in selling expense. Shipping and handling costs for the three and six months ended June 30, 2017 and 2016 were nil, respectively.

Depreciation for financial reporting purposes is provided using the straight-line method over the estimated useful lives of the assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="text-align: center; line-height: 107%">Useful Life</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">(In years)</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Buildings</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">30 - 35</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Machinery and equipment</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">5 - 10</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; text-align: justify; line-height: 107%">Automobiles</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; text-align: center; line-height: 107%"> </td> <td style="width: 26%; text-align: center; line-height: 107%">8</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Office equipment</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">2 - 5</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Computer software</td> <td style="line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%">3</td> <td style="line-height: 107%"> </td></tr> </table>

Property, plant and equipment, net consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Office equipment</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">942</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">942</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Furniture</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">10,260</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">8,276</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Leasehold improvement</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">72,174</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">70,871</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Total Property, plant and equipment</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">83,376</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">80,089</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Less: accumulated depreciation</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(40,064</td> <td style="line-height: 107%">)</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">(20,311</td> <td style="line-height: 107%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less: impairment of long-lived assets</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Property, plant and equipment - net</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">43,312</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">59,778</td> <td style="line-height: 107%"> </td></tr> </table>

58419

935

P30Y

P35Y

P5Y

P10Y

P8Y

P2Y

P3Y

P5Y

0.06

80089

83376

942

8276

70871

942

10260

72174

20311

40064

255539

50974

3141000

10. Construction Costs Payable   Construction costs payable mainly represents the payables which had been carried on Kiwa Shandong’s book for a length of years. As of December 31, 2016, construction costs payable was $255,539.   On February 11, 2017, the Company entered an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) to transfer all of shareholders’ right, title and interest, as well as all the obligations in Kiwa Shandong to the Transferee for USD $1.00. On April 12, 2017, the transaction was completed and the balance was removed.

-1518877

-241232

-1525710

-150648

305935

146608

195403

80006

2014318

80956

1834963

61872

0.34

11303

77867

115000

16954

680

1087

1.00

Allowance for doubtful accounts   The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts. The Company’s estimate is based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change. There was no allowance for doubtful accounts at June 30, 2017 and December 31, 2016.

Related Parties   The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly Influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.   The consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the consolidated financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Commitments and Contingencies   The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.   If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.   Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows.

Stock Based Compensation   The Company accounts for share-based compensation awards to employees in accordance with FASB ASC Topic 718, “Compensation – Stock Compensation”, which requires that share-based payment transactions with employees be measured based on the grant-date fair value of the equity instrument issued and recognized as compensation expense over the requisite service period.   The Company accounts for share-based compensation awards to non-employees in accordance with FASB ASC Topic 718 and FASB ASC Subtopic 505-50, “Equity-Based Payments to Non-employees”. Under FASB ASC Topic 718 and FASB ASC Subtopic 505-50, stock compensation granted to non-employees has been determined as the fair value of the consideration received or the fair value of equity instrument issued, whichever is more reliably measured and is recognized as an expense as the goods or services are received.

Cash Flows Reporting   The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.

Subsequent Events   The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

Goodwill and Other Intangibles   In accordance with Accounting Standards Update (ASU) No. 2014-02, management evaluates goodwill on an annual basis in the fourth quarter of more frequently if management believes indicators of impairment exist. Such indicators could, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. If management concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, management conducts a two-step quantitative goodwill impairment test. The first step of the impairment test involves comparing the fair value of the applicable reporting unit with its carrying value. The Company estimates the fair value of its reporting units using a combination of the income, or discounted cash flows, approach and the market approach, with utilizes comparable companies’ data. If the carrying amount of a reporting unit exceeds the reporting unit’s fair value, management performs the second step of the goodwill impairment test. The second step of the goodwill impairment test involves comparing the implied fair value of the affected reporting unit’s goodwill with the carrying value of that goodwill. The amount, by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss. The Company’s evaluation of goodwill completed during the three and six months ended June 30, 2017 resulted in no impairment losses.

P2Y P2Y P13M P1Y P3M

1.00

30000

4112

1650000

1000000

19380

15108

96900

97850

98000

1320000

1000000

290700

190807

294000

0.8

1.00

1.22

2.74

2.78

3.00

1.95

3.00

759659

560341

487627

3360000

Earnings Per Common Share   Net income per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the period.   Diluted net income per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

300000

3.00

2021-11-15

Accounts Receivables   Accounts receivables represent customer accounts receivables. The allowance for doubtful accounts is based on a combination of current sales, historical charge offs and specific accounts identified as high risk. Uncollectible accounts receivable are charged against the allowance for doubtful accounts when all reasonable efforts to collect the amounts due have been exhausted. Such allowances, if any, would be recorded in the period the impairment is identified.

Income Taxes   The Company accounts for income taxes under the provisions of FASB ASC Topic 740, “Income Tax,” which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the difference between the tax bases of assets and liabilities and their reported amounts in the financial statements. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company establishes a valuation when it is more likely than not that the assets will not be recovered.    ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. We have no material uncertain tax positions for any of the reporting periods presented.

The future lease payments at June 30, 2017 are summarized below.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Beijing Office</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Shenzhen Office</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">USA Office</td> <td style="text-align: center; line-height: 107%"> </td> <td style="text-align: center; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">Total</td> <td style="text-align: center; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 24%; text-align: center; line-height: 107%">2017</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">68,876</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">101,722</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">10,605</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">181,203</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%">2018</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">45,917</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">203,444</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">9,925</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">259,286</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center; line-height: 107%">2019</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">101,722</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">101,722</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 107%">Thereafter </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> </table>

4723511

12589248

-38916

18651

-19489400

-14343604

-127884

-307350

13789990

15741427

8729

10028

500

10324724

10854896

1019583

865793

1042661

1124638

482327 523140

919255

616908

1688353

1225869

1655343

150250

1106205

150250

145127

810827

150250

100798 83798 1122754

255539

12883

35715

17183

1318802

4697764

4723511

12589248

128409

259756

34112

59778

43312

4595102

12329492

1805044 1255218

1561331

1471291

92504

66769

1122754

9425359

8728981

10028219

8728981

10028219

11033303

5623035

11360700

3550696

9564506

3766705

9865031

2617584

0.49

0.04

0.45

0.05

0.56

0.06

0.51

0.07

5382830

332210

5106887

311174

599022

4112924

379973

2601847

800

1410123

238105

883587

181975

-124244

-94551

-72921

-47548

83430

56443

52346

28325

40814 38108 20575 19223

-710095

-443085

1534367

-377439

956508

-213562

1258606

377439

754685

213562

1095396

225670

664019

138786

90485

54232

2792973

1711193

6034924

3970915

8827897

5682108

-83430

-56443

-40813 -38108

17787

3073

8318

3073

8164649

54940

-126080

1210111

-585523

-26626

3302256

49999

-19089

-468631

78080

-320211

29982

-1061367

153033

-166874

469297

-2199087

-148931

17000

40500

471754

184324

1481508

176000

2454463

216500

-49509

22852

58085

11646

3141000

411846

955955

147423

1000000

810827

5500000

5. Other Receivable   Other receivable consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Due from customer-Kangtan Gerui (Beijing) Bio-Tech Co., Ltd.</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">1,338,111</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">1,522,435</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Advance to employees</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">105,171</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">31,700</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Others</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">28,009</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">7,196</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less: Allowance for doubtful debts</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Other receivable, net</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,471,291</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,561,331</td> <td style="line-height: 107%"> </td></tr> </table>   Due from customer-Kangtan Gerui (Beijing) Bio-Tech Co.,Ltd. represents the remaining balance of advancement for production of fertilizers during the first through the third quarter of 2016. In September 2016, the Company obtained a fertilizer sales permit from Chinese government and began to sell the products by their own and gradually decrease the business cooperation with Gerui.   For the six months ended June 30, 2017, the Company has collected $184,324 advancement from Gerui and management has determined that no allowance for doubtful debts was necessary.

3. Accounts Receivable, net   Accounts receivable consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Accounts receivable</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">9,425,359</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">1,122,754</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less: Allowance for doubtful debts</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Accounts receivable, net</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">9,425,359</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,122,754</td> <td style="line-height: 107%"> </td></tr> </table>   As of June 30, 2017 and December 31, 2016, the management has determined that no allowance for doubtful debts was necessary.

15. Other Payable   Other payable includes the payables to two unrelated potential investors and other liabilities. As of June 30, 2017, two potential investors have made the payments approximately $471,754 to the Company and the investment agreements have not been finalized. Other payable were $865,793 and $1,019,583 at June 30, 2017 and December 31, 2017, respectively,

Accounts receivable consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Accounts receivable</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">9,425,359</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">1,122,754</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less: Allowance for doubtful debts</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Accounts receivable, net</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">9,425,359</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,122,754</td> <td style="line-height: 107%"> </td></tr> </table>

Other receivable consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Due from customer-Kangtan Gerui (Beijing) Bio-Tech Co., Ltd.</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">1,338,111</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 16%; text-align: right; line-height: 107%">1,522,435</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Advance to employees</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">105,171</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">31,700</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Others</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">28,009</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">7,196</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Less: Allowance for doubtful debts</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Other receivable, net</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,471,291</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">1,561,331</td> <td style="line-height: 107%"> </td></tr> </table>

-57567

-94105

-89910

-129199

-372465

1122754

9425359

1122754

9425359

83798

100798

0.90

3.50

0.90

3.5

1710808

70000

88000

P1Y P1Y P1Y P2Y P1Y P1Y 2017 1688300 85400 53101 41396

331800

32025

5237

3402

P10Y

181203

68876

101722

10605

259286

45212

203444

9925

10459217 0001159275 Kiwa Shandong to the Transferee for USD $1.00.

34519

33907

39301

0.09

0.06

0.05

0.07

0.47

0.46

0.08

0.04

0.05

0.41

0.40

811101

238105

503614

181975

4514161

4513363

37412

-13018

1047

145449

34112

35114

147423 160461 233598 -1672666

-147782

-78775

-258213

4. Prepaid Expense   Prepaid expenses consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="text-align: right; line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Prepaid office rent</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">28,021</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">12,504</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Prepaid government filing expense</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">33,588</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">5,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Prepaid packaging expense</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">75,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Prepayment for purchasing furniture</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">5,160</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt double; line-height: 107%">$</td> <td style="border-bottom: black 1.5pt double; text-align: right; line-height: 107%">66,769</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">92,504</td> <td style="line-height: 107%"> </td></tr> </table> 8. Deposit for long-term investment   On June 8, 2017, the Company entered an equity purchase agreement with Yantai Peng Hao New Materials Technology Co. Ltd., which relates to the acquisition of a new factory for purchase price of about $2.2 million (approximately RMB 15 million). The factory to be acquired by the Company will be completed in accordance with the Company’s construction plan to facilitate the production design of combining of microbial fermentation and terminal fertilizer products.   Pursuant to the payment terms of purchase agreement, the Company made the first payment of $147,423 (approximately RMB 1,000,000) to Yantai Peng Hao New Materials Technology Co. Ltd. on June 30, 2017.

9. Goodwill and other intangibles   On November 30, 2015, Kiwa Bio-tech Products Group Ltd in BVI (“Kiwa BVI”) entered an acquisition agreement with shareholders of Caber Holdings Ltd. (“Acquiree”) in Hong Kong to acquire 100 percent entity interest of the acquiree, including a wholly owned subsidiary, Oriental Baina Co., Ltd. in Beijing for US$30,000. The acquisition was completed in January, 2016. On the acquisition date, there was no any asset or liability acquired, and thus no fair value was allocated to asset and liability. Including legal fee and government fees, the total payment of approximately $34,112 ($30,000 plus legal fee and government fees totaled $4,112) was recorded as goodwill. The fair value of the goodwill is tested prior to June 30, 2017 and management determined there is no impairment to the goodwill as of June 30, 2017.   The Company purchased the computer software in May, 2017, which cost was $ 1,061. Amortization expense for the three and six months ended June 30, 2017 was $59 and nil.

21. Discontinued Operation   On February 11, 2017, the Company executed an Equity Transfer Agreement with Dian Shi Cheng Jing (Beijing) Technology Co. (“Transferee”) whereby the Company transferred all of its right, title and interest in Kiwa Bio-Tech Products (Shandong) Co., Ltd. (“Shandong”) to the Transferee for the RMB equivalent of US$1.00. The government processing of the transaction has been completed on April 12, 2017. This transaction was completed and effective on April 12, 2017. The Company recorded a net gain of approximately $4,514,161 during the six months ended June 30, 2017 and approximately $4,513,363 during the three months ended June 30, 2017 based on the discharge of the excess liabilities over the assets of the Kiwa Shandong.

18. Statutory Reserves   The Company is required to make appropriations to reserve funds, comprising the statutory surplus reserve, statutory public welfare fund and discretionary surplus reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (the “PRC GAAP”). Appropriation to the statutory surplus reserve should be at least 10% of the after tax net income determined in accordance with the PRC GAAP until the reserve is equal to 50% of the entities’ registered capital or members’ equity. In accordance with the Chinese Company Law, the Company allocated 10% of income after taxes to the statutory surplus reserve for the six months ended June 30, 2017 and the year ended December 31, 2016, statutory reserve activity is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Balance – January 1, 2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 71%; text-align: justify; line-height: 107%">Addition to statutory reserve in 2016</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="width: 26%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">127,884</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%"> Balance – December 31, 2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">127,884</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Addition to statutory reserve for the six months ended June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">179,466</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Balance – June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">307,350</td> <td style="line-height: 107%"> </td></tr> </table> the year ended December 31, 2016, statutory reserve activity is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Balance – January 1, 2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%">$</td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 71%; text-align: justify; line-height: 107%">Addition to statutory reserve in 2016</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="width: 26%; border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">127,884</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%"> Balance – December 31, 2016</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">127,884</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 107%">Addition to statutory reserve for the six months ended June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">179,466</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 107%">Balance – June 30, 2017</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">307,350</td> <td style="line-height: 107%"> </td></tr> </table> 6. Advance to suppliers   Since currently the Company does not have manufacturing facility, it has contracted with several third parties to produce fertilizer products. Pursuant to the agreements entered by the Company and those third party companies, the Company was required to make partially prepayments in advance of purchase or completion of productions. As of June 30, 2017 and December 31, 2016, such advance to suppliers was $ 1,255,218 and $1,805,044, respectively. Prepaid expenses consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">June 30, 2017</td> <td style="text-align: right; line-height: 107%"> </td> <td style="text-align: right; line-height: 107%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%">December 31, 2016</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 107%">Prepaid office rent</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">28,021</td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%"> </td> <td style="width: 1%; line-height: 107%">$</td> <td style="width: 16%; text-align: right; line-height: 107%">12,504</td> <td style="width: 1%; line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Prepaid government filing expense</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">33,588</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">5,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%">Prepaid packaging expense</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="text-align: right; line-height: 107%">75,000</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">Prepayment for purchasing furniture</td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">5,160</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 107%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%">-</td> <td style="line-height: 107%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 1.5pt double; line-height: 107%">$</td> <td style="border-bottom: black 1.5pt double; text-align: right; line-height: 107%">66,769</td> <td style="line-height: 107%"> </td> <td style="line-height: 107%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 107%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%">92,504</td> <td style="line-height: 107%"> </td></tr> </table>

12504

28021

5000 33588 75000 5160

1561331

1471291

1338111

1522435

105171

31700

28009

7196

2200000

15000000

147423

1000000

1061

500000

920000

442269

3000000

4500000

30000000

30892 105000 90000 105000 168000 300000 59100 50400 59100

2450000

100000

194537 523141

145127

1000000

5500000

810827

Appropriation to the statutory surplus reserve should be at least 10% of the after tax net income determined in accordance with the PRC GAAP until the reserve is equal to 50% of the entities’ registered capital or members’ equity. 0.10

127884

307350

179466 127884

5924464

238105

5396950

181975

2200000

15000000

147423 1000000 10000000 4000000

101722

1087

245000

98000

735000

294000

49000

39000

102743

Fair Value of Financial Instruments   The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820- 10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value with U.S. GAAP, and expands disclosures about fair value measurements.   To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify; line-height: 107%"> </td> <td style="width: 24px; text-align: justify; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 1: quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 2: pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%"> </td> <td style="text-align: justify; line-height: 107%">●</td> <td style="text-align: justify; line-height: 107%">Level 3: Pricing inputs that are generally observable inputs and not corroborated by market data.</td></tr> </table>   Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.   The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.    The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.   The carrying amount of the Company’s financial assets and liabilities, such as cash and cash equivalent, prepaid expenses, accounts payable and accrued expenses, approximate their fair value because of the short maturity of those instruments.   Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated.   It is not however practical to determine the fair value of advances from stockholders, if any, due to their related party nature.

3.00

EX-101.SCH 8 kwbt-20170630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Description of Business and Organization link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summaries of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Accounts Receivable, Net link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Prepaid Expense link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Other Receivable link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Advance to Suppliers link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Deposit for Long-Term Investment link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Goodwill and Other Intangibles link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Construction Costs Payable link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Unsecured Loans Payable link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Note Payable link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Other Payable link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Stockholders' Deficiency link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Statutory Reserves link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Income Tax link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Discontinued Operation link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Summaries of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Summaries of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Accounts Receivable, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Prepaid Expense (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Other Receivable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Statutory Reserves (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Income Tax (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Description of Business and Organization (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Summaries of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Summaries of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Summaries of Significant Accounting Policies - Schedule of Foreign Currency Exchange Rate (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Accounts Receivable, Net - Schedule of Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Prepaid Expense - Schedule of Prepaid Expense (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Other Receivable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Other Receivable - Schedule of Other Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Advance to Suppliers (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Property, Plant and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Deposit for Long-Term Investment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Goodwill and Other Intangibles (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Construction Costs Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Unsecured Loans Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Note Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Other Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Stockholders' Deficiency (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Stock-based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Statutory Reserves (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - Statutory Reserves - Schedule of Statutory Reserve Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - Income Tax (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - Income Tax - Schedule of Reconciliation of U.S. Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - Income Tax - Schedule of Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - Commitments and Contingencies - Schedule of Future Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - Discontinued Operation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 kwbt-20170630_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 kwbt-20170630_def.xml XBRL DEFINITION FILE EX-101.LAB 11 kwbt-20170630_lab.xml XBRL LABEL FILE Related Party [Axis] Kiwa-CAU R&D Center [Member] Related Party Transaction [Axis] Trade Transaction [Member] Currency [Axis] RMB [Member] CAAS IARRP and IAED Institutes [Member] Two Institutes In China [Member] Unrelated Individual [Member] Investlink (China) Limited [Member] Debt Instrument [Axis] 6% Notes [Member] Title of Individual [Axis] Jimmy Zhou [Member] Property, Plant and Equipment, Type [Axis] Buildings [Member] Range [Axis] Minimum [Member] Maximum [Member] Machinery And Equipment [Member] Automobiles [Member] Office Equipment [Member] Computer Software [Member] Mr. Li And Ms. Wang [Member] Income Statement Location [Axis] Balance Sheet Items, Except For Equity Accounts [Member] Items In The Statements of Comprehensive Loss [Member] Legal Entity [Axis] Kiwa Baiao Bio-Tech (Beijing) Co., Ltd [Member] Lease Arrangement, Type [Axis] Office Lease Agreement [Member] Furniture [Member] Leasehold Improvement [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Acquisition Agreement [Member] Sale of Stock [Axis] Private Offering [Member] Accredited Investor [Member] Equity Transfer Agreement [Member] Concentration Risk Benchmark [Axis] Due from customer-Kangtan Gerui [Member] Advance to Employees [Member] Yvonne Wang [Member] Dian Shi Cheng Jing (Beijing) Technology Co [Member] FirsTrust Group, Inc [Member] Mr. Geng Liu [Member] Two Unrelated Potential Investors [Member] Mr. Junwei Zheng [Member] Consulting Agreement [Member] Mr. Yuan Wang [Member] Board of Directors [Member] RMB [Member] Beijing Office [Member] Shenzhen Office [Member] Gerui [Member] Others [Member] Yantai Peng Hao New Materials Technology Co. Ltd [Member] Equity Purchase Agreement [Member] Finite-Lived Intangible Assets by Major Class [Axis] Computer Software [Member] Ms. Wang [Member] Geng Liu [Member] Convertible Loan Agreement [Member] Junwei Zheng [Member] FirsTrust [Member] Investline (China) Limited [Member] 6% Secured Convertible Note [Member] Six Institutional Investors [Member] Nite Capital LP [Member] Vesting [Axis] Share-based Compensation Award, Tranche One [Member] Share-based Compensation Award, Tranche Two [Member] Share-based Compensation Award, Tranche Three [Member] 6% Convertible Note [Member] Convertible Note Agreement [Member] 15% Convertible Notes [Member] Equity Components [Axis] Financing Projects [Member] Technical Support [Member] Ten Employees [Member] Consultant [Member] Income Tax Authority [Axis] California State Franchise Tax [Member] First Payment [Member] Second Payment [Member] Final Payment [Member] Kiwa Baiao Bio-Tech (Shenzhen) Co., Ltd [Member] Apartment Lease [Member] Kiwa Baiao Bio-Tech Product Group [Member] USA Office [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Quanzhen Shen [Member] Common Stock Purchase Agreement [Member] Yuan Wang [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Accounts receivable, net Prepaid expenses Other receivable Rent Deposit-current Advance to suppliers Total current assets OTHER ASSETS Property, plant and equipment, net Rent Deposit-non current Deposit for Long-Term Investment Goodwill and Intangible Assets Total non-current assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) Current liabilities Accounts payable Accrued expenses Advances from customers Construction costs payable Due to related parties - trade R&D expense payable Due to related parties - non-trade Convertible notes payable Notes payable Unsecured loans payable Salary payable Taxes payable Penalty payable Interest payable Other payables Total current liabilities SHAREHOLDER'S EQUITY (DEFICIENCY) Preferred stock - $0.001 par value, Authorized 20,000,000 shares. Issued and outstanding 500,000 and 500,000 shares at June 30, 2017 and December 31, 2016, respectively. Common stock - $0.001 per value. Authorized 100,000,000 shares. Issued and outstanding $10,028,219 and 8,728,981 shares at June 30, 2017 and December 31, 2016, respectively Additional paid-in capital Statutory Reserve Accumulated deficit Accumulated other comprehensive gain (loss) Total stockholders' equity (deficiency) Total liabilities and shareholder's equity Preferred Stock, par value Preferred Stock, shares authorized Preferred Stock, shares issued Preferred Stock, shares outstanding Common Stock, par value Common Stock, shares authorized Common Stock, shares issued Common Stock, shares outstanding Income Statement [Abstract] Revenue Cost of goods sold Gross Profit Operating expenses Selling expense Research and development General and administrative Total operating expenses Operating income (loss) Other Income License revenue Other expense Penalty expense Interest expense Total other expense Income from continuing operations before income taxes Income taxes Income from continuing operations Discontinued operations Gain from discontinued operations, net of taxes Net Income Other comprehensive income Foreign currency translation adjustment Total comprehensive income Earnings per share – Basis: Income from continuing operations Discontinued operations Net Income Earnings per share – Diluted: Income from continuing operations EX-101.PRE 12 kwbt-20170630_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2017	Aug. 14, 2017
Document And Entity Information
Entity Registrant Name	KIWA BIO-TECH PRODUCTS GROUP CORP
Entity Central Index Key	0001159275
Document Type	10-Q
Document Period End Date	Jun. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		10,459,217
Trading Symbol	KWBT
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2017

XML 14 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 71,554	$ 13,469
Accounts receivable, net	9,425,359	1,122,754
Prepaid expenses	66,769	92,504
Other receivable	1,471,291	1,561,331
Rent Deposit-current	39,301
Advance to suppliers	1,255,218	1,805,044
Total current assets	12,329,492	4,595,102
OTHER ASSETS
Property, plant and equipment, net	43,312	59,778
Rent Deposit-non current	33,907	34,519
Deposit for Long-Term Investment	147,423
Goodwill and Intangible Assets	35,114	34,112
Total non-current assets	259,756	128,409
Total assets	12,589,248	4,723,511
Current liabilities
Accounts payable	4,697,764	1,318,802
Accrued expenses	17,183	35,715
Advances from customers		12,883
Construction costs payable		255,539
Due to related parties - trade		1,122,754
R&D expense payable	233,598	160,461
Due to related parties - non-trade	83,798	100,798
Convertible notes payable	1,106,205	150,250
Notes payable	360,000	360,000
Unsecured loans payable		1,655,343
Salary payable	1,225,869	1,688,353
Taxes payable	616,908	919,255
Penalty payable	523,140	482,327
Interest payable	1,124,638	1,042,661
Other payables	865,793	1,019,583
Total current liabilities	10,854,896	10,324,724
SHAREHOLDER'S EQUITY (DEFICIENCY)
Preferred stock - $0.001 par value, Authorized 20,000,000 shares. Issued and outstanding 500,000 and 500,000 shares at June 30, 2017 and December 31, 2016, respectively.	500	500
Common stock - $0.001 per value. Authorized 100,000,000 shares. Issued and outstanding $10,028,219 and 8,728,981 shares at June 30, 2017 and December 31, 2016, respectively	10,028	8,729
Additional paid-in capital	15,741,427	13,789,990
Statutory Reserve	307,350	127,884
Accumulated deficit	(14,343,604)	(19,489,400)
Accumulated other comprehensive gain (loss)	18,651	(38,916)
Total stockholders' equity (deficiency)	1,734,352	(5,601,213)
Total liabilities and shareholder's equity	$ 12,589,248	$ 4,723,511

XML 15 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	20,000,000	20,000,000
Preferred Stock, shares issued	500,000	500,000
Preferred Stock, shares outstanding	500,000	500,000
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	10,028,219	8,728,981
Common Stock, shares outstanding	10,028,219	8,728,981

XML 16 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Revenue	$ 5,682,108		$ 8,827,897
Cost of goods sold	(3,970,915)		(6,034,924)
Gross Profit	1,711,193		2,792,973
Operating expenses
Selling expense	54,232		90,485
Research and development	36,433	74,776	72,724	151,769
General and administrative	664,019	138,786	1,095,396	225,670
Total operating expenses	754,685	213,562	1,258,606	377,439
Operating income (loss)	956,508	(213,562)	1,534,367	(377,439)
Other Income
License revenue		443,085		710,095
Other expense
Penalty expense	(20,575)	(19,223)	(40,814)	(38,108)
Interest expense	(52,346)	(28,325)	(83,430)	(56,443)
Total other expense	(72,921)	(47,548)	(124,244)	(94,551)
Income from continuing operations before income taxes	883,587	181,975	1,410,123	238,105
Income taxes	(379,973)		(599,022)
Income from continuing operations	503,614	181,975	811,101	238,105
Discontinued operations
Gain from discontinued operations, net of taxes	4,513,363		4,514,161
Net Income	5,016,977	181,975	5,325,262	238,105
Other comprehensive income
Foreign currency translation adjustment	89,910	129,199	57,567	94,105
Total comprehensive income	$ 5,106,887	$ 311,174	$ 5,382,830	$ 332,210
Earnings per share – Basis:
Income from continuing operations	$ 0.05	$ 0.07	$ 0.09	$ 0.06
Discontinued operations	0.46		0.47
Net Income	0.51	0.07	0.56	0.06
Earnings per share – Diluted:
Income from continuing operations	0.05	0.05	0.08	0.04
Discontinues operations	0.40		0.41
Net Income	$ 0.45	$ 0.05	$ 0.49	$ 0.04
Weighted average number of common shares outstanding - basic	9,865,031	2,617,584	9,564,506	3,766,705
Weighted average number of common shares outstanding - diluted	11,360,700	3,550,696	11,033,303	5,623,035

XML 17 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net income	$ 5,325,262	$ 238,105
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation	17,787	3,073
Amortization	58
Provision for penalty payable	40,813	38,108
Accrued interest on convertible notes	83,430	56,443
Employee benefits	102,743
Consulting fee	372,465
Changes in operating assets and liabilities:
Accounts receivable	(8,164,649)	(54,940)
Other receivables	126,080	(1,210,111)
Advance to supplier	585,523
Rent & Utility Deposit	(37,412)
Prepaid expenses	26,626
Accounts payable	3,302,256	49,999
Advance from customers	(13,018)
Accrued expenses	(19,089)
Salary payable	(468,631)	78,080
Taxes payable	(320,211)	29,982
Due to related parties - trade	(1,061,367)	153,033
Other payable	(166,874)	469,297
Loan payable	(1,672,666)
Construction cost payable	(258,213)
Net cash used in operating activities	(2,199,087)	(148,931)
Cash flows from investing activities:
Purchase of intangible assets	(1,047)
Investment in subsidiary	(145,449)
Purchase of property plant and equipment	(1,286)	(78,775)
Net cash used by investing activities	(147,782)	(78,775)
Cash flows from financing activities:
Proceeds from related parties, net of payments to related parties	17,000	40,500
Proceeds from sales of common stock	1,481,508	176,000
Proceeds from convertible note	955,955
Net cash provided by financing activities	2,454,463	216,500
Effect of exchange rate change	(49,509)	22,852
Cash and cash equivalents:
Net increase	58,085	11,646
Balance at beginning of period	13,469	721
Balance at end of period	71,554	12,367
Non-cash financing activities:
Issuance of common stock for debts settlement		3,141,000
Issuance of common stock for consulting service	179,897
Supplemental Disclosures of Cash flow Information:
Cash paid for interest
Cash paid for income taxes	$ 411,846

XML 18 R6.htm IDEA: XBRL DOCUMENT

Description of Business and Organization

6 Months Ended

Jun. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business and Organization

1. Description of Business and Organization

Organization

Business

XML 19 R7.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Summaries of Significant Accounting Policies

2. Summaries of Significant Accounting Policies

Principle of Consolidation

Reverse Split

Use of Estimates

Cash and Cash Equivalents

Accounts Receivables

Allowance for doubtful accounts

Property, plant and equipment

	Useful Life
	(In years)
Buildings		30 - 35
Machinery and equipment		5 - 10
Automobiles		8
Office equipment		2 - 5
Computer software		3

Impairment of Long-Lived Assets

Goodwill and Other Intangibles

Fair Value of Financial Instruments

	●	Level 1: quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

	●	Level 2: pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

	●	Level 3: Pricing inputs that are generally observable inputs and not corroborated by market data.

It is not however practical to determine the fair value of advances from stockholders, if any, due to their related party nature.

Revenue Recognition

Advertising Costs

Research and Development Costs

Shipping and Handling Costs

Income Taxes

Stock Based Compensation

Foreign Currency Translation and Other Comprehensive Income

Other comprehensive income for the six months ended June 30, 2017 and 2016 represented foreign currency translation adjustments and were included in the consolidated statements of comprehensive loss.

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the consolidated financial statements were as follows:

	As of June 30, 2017		As of December 31, 2016
Balance sheet items, except for equity accounts		6.7832		6.9472

	Six months ended June 30
	2017		2016
Items in the statements of comprehensive loss		6.8753		6.5345

Earnings Per Common Share

Related Parties

Commitments and Contingencies

Cash Flows Reporting

Subsequent Events

Recent Accounting Pronouncements

XML 20 R8.htm IDEA: XBRL DOCUMENT

Accounts Receivable, Net

6 Months Ended

Jun. 30, 2017

Accounts Receivable, Net [Abstract]

Accounts Receivable, Net

3. Accounts Receivable, net

Accounts receivable consisted of the following:

	June 30, 2017		December 31, 2016
Accounts receivable	$	9,425,359	$	1,122,754
Less: Allowance for doubtful debts		-		-
Accounts receivable, net	$	9,425,359	$	1,122,754

As of June 30, 2017 and December 31, 2016, the management has determined that no allowance for doubtful debts was necessary.

XML 21 R9.htm IDEA: XBRL DOCUMENT

Prepaid Expense

6 Months Ended

Jun. 30, 2017

Notes to Financial Statements

Prepaid Expense

4. Prepaid Expense

Prepaid expenses consisted of the following:

	June 30, 2017		December 31, 2016
Prepaid office rent	$	28,021	$	12,504
Prepaid government filing expense		33,588		5,000
Prepaid packaging expense		-		75,000
Prepayment for purchasing furniture		5,160		-
	$	66,769	$	92,504

XML 22 R10.htm IDEA: XBRL DOCUMENT

Other Receivable

6 Months Ended

Jun. 30, 2017

Receivables [Abstract]

Other Receivable

5. Other Receivable

Other receivable consisted of the following:

	June 30, 2017		December 31, 2016
Due from customer-Kangtan Gerui (Beijing) Bio-Tech Co., Ltd.		1,338,111		1,522,435
Advance to employees		105,171		31,700
Others		28,009		7,196
Less: Allowance for doubtful debts		-		-
Other receivable, net	$	1,471,291	$	1,561,331

For the six months ended June 30, 2017, the Company has collected $184,324 advancement from Gerui and management has determined that no allowance for doubtful debts was necessary.

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

XML 23 R11.htm IDEA: XBRL DOCUMENT

Advance to Suppliers

6 Months Ended

Jun. 30, 2017

Notes to Financial Statements

Advance to Suppliers

6. Advance to suppliers

XML 24 R12.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment

6 Months Ended

Jun. 30, 2017

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

7. Property, Plant and Equipment

Property, plant and equipment, net consisted of the following:

	June 30, 2017			December 31, 2016
Office equipment	$	942		$	942
Furniture		10,260			8,276
Leasehold improvement		72,174			70,871
Total Property, plant and equipment	$	83,376		$	80,089
Less: accumulated depreciation		(40,064	)		(20,311	)
Less: impairment of long-lived assets		-			-
Property, plant and equipment - net	$	43,312		$	59,778

Depreciation expense was $17,787 and $ 3,073 for the six months ended June 30, 2017 and 2016, and $8,318 and $3,073 for the three months ended June 30, 2017 and 2016, respectively.

Impairment of long-lived assets was nil for the three and six months ended June 30, 2017 and 2016, respectively.

All of our property, plant and equipment have been held as collateral to secure the 6% Notes (see Note 14).

XML 25 R13.htm IDEA: XBRL DOCUMENT

Deposit for Long-Term Investment

6 Months Ended

Jun. 30, 2017

Investments Schedule [Abstract]

Deposit for Long-Term Investment

8. Deposit for long-term investment

XML 26 R14.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangibles

6 Months Ended

Jun. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangibles

9. Goodwill and other intangibles

The Company purchased the computer software in May, 2017, which cost was $ 1,061. Amortization expense for the three and six months ended June 30, 2017 was $59 and nil.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

XML 27 R15.htm IDEA: XBRL DOCUMENT

Construction Costs Payable

6 Months Ended

Jun. 30, 2017

Construction Costs Payable

Construction Costs Payable

10. Construction Costs Payable

Construction costs payable mainly represents the payables which had been carried on Kiwa Shandong’s book for a length of years. As of December 31, 2016, construction costs payable was $255,539.

XML 28 R16.htm IDEA: XBRL DOCUMENT

Related Party Transactions

6 Months Ended

Jun. 30, 2017

Related Party Transactions

11. Related Party Transactions

(1). Amounts due to related parties

Amounts due to related parties consisted of the following as of June 30, 2017 and December 31, 2016:

Item

Nature

Notes

June 30, 2017

December 31, 2016

Kiwa-CAU R&D Center

Trade

(b)

1,122,754

CAAS IARRP and IAED Institutes

Trade

(c)

160,461

Total

1,283,215

(a) Yvonne Wang

The Company recorded nil and $36,363 research and development expenses related to this Kiwa-CAU R&D Center for the six months ended June 30, 2017 and 2016, respectively.

The Company recorded $36,291and $38,764 research and development expenses related to the institutes, for the six months ended June 30, 2017 and 2016, respectively.

(2). Convertible Note Payables

(a). Geng Liu

Geng Liu became a shareholder of the Company and has held 500,000 shares of common stock since September, 2016

(b). Junwei Zheng

Junwei Zheng became a shareholder of the Company and has held 920,000 shares of common stock since March, 2017

XML 29 R17.htm IDEA: XBRL DOCUMENT

Unsecured Loans Payable

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Unsecured Loans Payable

12. Unsecured Loans Payable

XML 30 R18.htm IDEA: XBRL DOCUMENT

Convertible Notes Payable

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Convertible Notes Payable

13. Convertible Notes Payable

6% secured convertible notes

15% convertible notes- Geng Liu

15% convertible notes- Junwei Zheng

XML 31 R19.htm IDEA: XBRL DOCUMENT

Note Payable

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Note Payable

14. Note Payable

XML 32 R20.htm IDEA: XBRL DOCUMENT

Other Payable

6 Months Ended

Jun. 30, 2017

Other Liabilities Disclosure [Abstract]

Other Payable

15. Other Payable

XML 33 R21.htm IDEA: XBRL DOCUMENT

Stockholders' Deficiency

6 Months Ended

Jun. 30, 2017

Equity [Abstract]

Stockholders' Deficiency

16. Stockholders’ Equity

In February, 2017, the Company issued 1,000,000 common shares to Mr. Junwei Zheng for cash at $1.00 per share for an aggregate price to $1,000,000, all of which has been received as of June 30, 2017.

On June 13, 2017, the Company issued 96,900 common shares to Mr. Yuan Wang for cash at $3.00 per share for an aggregate price to $290,700, all of which has been received as of June 30, 2017.

XML 34 R22.htm IDEA: XBRL DOCUMENT

Stock-based Compensation

6 Months Ended

Jun. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based Compensation

17. Stock-based Compensation

On March 15, 2017, the Board of Directors approved a new stock option plan with ten years’ term. As of June 30, 2017, the Company has not granted any incentive compensation under this plan.

XML 35 R23.htm IDEA: XBRL DOCUMENT

Statutory Reserves

6 Months Ended

Jun. 30, 2017

Notes to Financial Statements

Statutory Reserves

18. Statutory Reserves

Balance – January 1, 2016	$	-
Addition to statutory reserve in 2016		127,884
Balance – December 31, 2016		127,884
Addition to statutory reserve for the six months ended June 30, 2017		179,466
Balance – June 30, 2017	$	307,350

XML 36 R24.htm IDEA: XBRL DOCUMENT

Income Tax

6 Months Ended

Jun. 30, 2017

Income Tax Disclosure [Abstract]

Income Tax

19. Income Tax

A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:

	Three months ended June 30,						Six months ended June 30,
	2017			2016			2017			2016

Pre-tax income	$	5,396,950		$	181,975		$	5,924,464		$	238,105
U.S. federal corporate income tax rate		34	%		34	%		34	%		34	%
Income tax computed at U.S. federal corporation income tax rate		1,834,963			61,872			2,014,318			80,956
Reconciling items:
Rate differential for PRC earnings		(124,683	)		8,770			(202,353	)		13,668
Change of valuation allowance		195,403			80,006			305,935			146,608
Non-deductible expenses		(1,525,710	)		(150,648	)		(1,518,877	)		(241,232	)
Effective tax expenses	$	379,973		$	-		$	599,022		$	-

The Company had deferred tax assets as follows:

	June 30, 2017			December 31, 2016

Net operating losses carried forward	$	3,458,902		$	3,473,331
Less: Valuation allowance		(3,458,902	)		(3,473,331	)

Net deferred tax assets	$	-		$	-

XML 37 R25.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

6 Months Ended

Jun. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

20. Commitments and Contingencies

The Company has the following material contractual obligations:

(1) Investment in manufacturing facilities in Penglai City, Shandong Province in China

(2) Strategic cooperation with the institutes in China

(3) Distribution agreement with Kangtan Gerui Bio-Tech in China

(4) Lease payments

(3) On May 5, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with 13 months term. Monthly lease payment totaled USD $680.

(4) On July 1, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with one-year term. Monthly lease payment totaled USD $1,087.

The future lease payments at June 30, 2017 are summarized below.

	Beijing Office		Shenzhen Office		USA Office		Total
2017	$	68,876	$	101,722	$	10,605	$	181,203
2018	$	45,917		203,444	$	9,925	$	259,286
2019	$	-	$	101,722	$	-	$	101,722
Thereafter	$	-	$	-	$	-	$	-

XML 38 R26.htm IDEA: XBRL DOCUMENT

Discontinued Operation

6 Months Ended

Jun. 30, 2017

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operation

21. Discontinued Operation

XML 39 R27.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

22. Subsequent Events

On July 1, 2017, Kiwa Bio-Tech Products Group Corporation entered an office lease agreement with two-year term. Monthly lease payment totaled USD $1,087.

On August 3, 2017, the Company fully collected $487,627 (RMB 3,360,000) of the entire subscribe receivable balance at December 31, 2016.

XML 40 R28.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Principle of Consolidation

Principle of Consolidation

Reverse Split

Reverse Split

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

Accounts Receivables

Accounts Receivables

Allowance for Doubtful Accounts

Allowance for doubtful accounts

Property, Plant and Equipment

Property, plant and equipment

	Useful Life
	(In years)
Buildings		30 - 35
Machinery and equipment		5 - 10
Automobiles		8
Office equipment		2 - 5
Computer software		3

Impairment of Long-lived Assets

Impairment of Long-Lived Assets

Goodwill and Other Intangibles

Goodwill and Other Intangibles

Fair Value of Financial Instruments

Fair Value of Financial Instruments

	●	Level 1: quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

	●	Level 2: pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

	●	Level 3: Pricing inputs that are generally observable inputs and not corroborated by market data.

It is not however practical to determine the fair value of advances from stockholders, if any, due to their related party nature.

Revenue Recognition

Revenue Recognition

Advertising Costs

Advertising Costs

Research and Development Costs

Research and Development Costs

Shipping and Handling Costs

Shipping and Handling Costs

Income Taxes

Income Taxes

Stock Based Compensation

Stock Based Compensation

Foreign Currency Translation and Other Comprehensive Income

Foreign Currency Translation and Other Comprehensive Income

Other comprehensive income for the six months ended June 30, 2017 and 2016 represented foreign currency translation adjustments and were included in the consolidated statements of comprehensive loss.

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the consolidated financial statements were as follows:

	As of June 30, 2017		As of December 31, 2016
Balance sheet items, except for equity accounts		6.7832		6.9472

	Six months ended June 30
	2017		2016
Items in the statements of comprehensive loss		6.8753		6.5345

Earnings Per Common Share

Earnings Per Common Share

Related Parties

Related Parties

Commitments and Contingencies

Commitments and Contingencies

Cash Flows Reporting

Cash Flows Reporting

Subsequent Events

Subsequent Events

Recent Accounting Pronouncements

Recent Accounting Pronouncements

XML 41 R29.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Schedule of Estimated Useful Lives of Assets

Depreciation for financial reporting purposes is provided using the straight-line method over the estimated useful lives of the assets as follows:

	Useful Life
	(In years)
Buildings		30 - 35
Machinery and equipment		5 - 10
Automobiles		8
Office equipment		2 - 5
Computer software		3

Schedule of Foreign Currency Exchange Rate

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the consolidated financial statements were as follows:

	As of June 30, 2017		As of December 31, 2016
Balance sheet items, except for equity accounts		6.7832		6.9472

	Six months ended June 30
	2017		2016
Items in the statements of comprehensive loss		6.8753		6.5345

XML 42 R30.htm IDEA: XBRL DOCUMENT

Accounts Receivable, Net (Tables)

6 Months Ended

Jun. 30, 2017

Accounts Receivable, Net [Abstract]

Schedule of Accounts Receivable

Accounts receivable consisted of the following:

	June 30, 2017		December 31, 2016
Accounts receivable	$	9,425,359	$	1,122,754
Less: Allowance for doubtful debts		-		-
Accounts receivable, net	$	9,425,359	$	1,122,754

XML 43 R31.htm IDEA: XBRL DOCUMENT

Prepaid Expense (Tables)

6 Months Ended

Jun. 30, 2017

Notes to Financial Statements

Schedule of Prepaid Expense

Prepaid expenses consisted of the following:

	June 30, 2017		December 31, 2016
Prepaid office rent	$	28,021	$	12,504
Prepaid government filing expense		33,588		5,000
Prepaid packaging expense		-		75,000
Prepayment for purchasing furniture		5,160		-
	$	66,769	$	92,504

XML 44 R32.htm IDEA: XBRL DOCUMENT

Other Receivable (Tables)

6 Months Ended

Jun. 30, 2017

Other Liabilities Disclosure [Abstract]

Schedule of Other Receivable

Other receivable consisted of the following:

	June 30, 2017		December 31, 2016
Due from customer-Kangtan Gerui (Beijing) Bio-Tech Co., Ltd.		1,338,111		1,522,435
Advance to employees		105,171		31,700
Others		28,009		7,196
Less: Allowance for doubtful debts		-		-
Other receivable, net	$	1,471,291	$	1,561,331

XML 45 R33.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment (Tables)

6 Months Ended

Jun. 30, 2017

Property, Plant and Equipment [Abstract]

Schedule of Property Plant and Equipment

Property, plant and equipment, net consisted of the following:

	June 30, 2017			December 31, 2016
Office equipment	$	942		$	942
Furniture		10,260			8,276
Leasehold improvement		72,174			70,871
Total Property, plant and equipment	$	83,376		$	80,089
Less: accumulated depreciation		(40,064	)		(20,311	)
Less: impairment of long-lived assets		-			-
Property, plant and equipment - net	$	43,312		$	59,778

XML 46 R34.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Tables)

6 Months Ended

Jun. 30, 2017

Schedule of Related Party Transactions

Item

Nature

Notes

June 30, 2017

December 31, 2016

Kiwa-CAU R&D Center

Trade

(b)

1,122,754

CAAS IARRP and IAED Institutes

Trade

(c)

160,461

Total

1,283,215

(a) Yvonne Wang

The Company recorded nil and $36,363 research and development expenses related to this Kiwa-CAU R&D Center for the six months ended June 30, 2017 and 2016, respectively.

The Company recorded $36,291and $38,764 research and development expenses related to the institutes, for the six months ended June 30, 2017 and 2016, respectively.

(2). Convertible Note Payables

(a). Geng Liu

Geng Liu became a shareholder of the Company and has held 500,000 shares of common stock since September, 2016

(b). Junwei Zheng

Junwei Zheng became a shareholder of the Company and has held 920,000 shares of common stock since March, 2017

XML 47 R35.htm IDEA: XBRL DOCUMENT

Statutory Reserves (Tables)

6 Months Ended

Jun. 30, 2017

Notes to Financial Statements

Schedule of Statutory Reserve Activity

the year ended December 31, 2016, statutory reserve activity is as follows:

Balance – January 1, 2016	$	-
Addition to statutory reserve in 2016		127,884
Balance – December 31, 2016		127,884
Addition to statutory reserve for the six months ended June 30, 2017		179,466
Balance – June 30, 2017	$	307,350

XML 48 R36.htm IDEA: XBRL DOCUMENT

Income Tax (Tables)

6 Months Ended

Jun. 30, 2017

Income Tax Disclosure [Abstract]

Schedule of Reconciliation of U.S. Tax Rate

A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:

	Three months ended June 30,						Six months ended June 30,
	2017			2016			2017			2016

Pre-tax income	$	5,396,950		$	181,975		$	5,924,464		$	238,105
U.S. federal corporate income tax rate		34	%		34	%		34	%		34	%
Income tax computed at U.S. federal corporation income tax rate		1,834,963			61,872			2,014,318			80,956
Reconciling items:
Rate differential for PRC earnings		(124,683	)		8,770			(202,353	)		13,668
Change of valuation allowance		195,403			80,006			305,935			146,608
Non-deductible expenses		(1,525,710	)		(150,648	)		(1,518,877	)		(241,232	)
Effective tax expenses	$	379,973		$	-		$	599,022		$	-

Schedule of Deferred Tax Assets

The Company had deferred tax assets as follows:

	June 30, 2017			December 31, 2016

Net operating losses carried forward	$	3,458,902		$	3,473,331
Less: Valuation allowance		(3,458,902	)		(3,473,331	)

Net deferred tax assets	$	-		$	-

XML 49 R37.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Lease Payments

The future lease payments at June 30, 2017 are summarized below.

	Beijing Office		Shenzhen Office		USA Office		Total
2017	$	68,876	$	101,722	$	10,605	$	181,203
2018	$	45,917		203,444	$	9,925	$	259,286
2019	$	-	$	101,722	$	-	$	101,722
Thereafter	$	-	$	-	$	-	$	-

XML 50 R38.htm IDEA: XBRL DOCUMENT

Description of Business and Organization (Details Narrative) - $ / shares	Jun. 30, 2017	Feb. 11, 2017
Percentage of ownership	89.00%
Equity Transfer Agreement [Member]
Sale of stock, price per share		$ 1.00

XML 51 R39.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended
	Jan. 14, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Accounting Policies [Abstract]
Reverse stock split	1-for-200
Authorized capital	120,000,000
Common stock, shares authorized	100,000,000	100,000,000		100,000,000		100,000,000
Common stock, par value	$ 0.001	$ 0.001		$ 0.001		$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000		20,000,000		20,000,000
Preferred stock, par value	$ 0.001	$ 0.001		$ 0.001		$ 0.001
Investment term				3 months
Allowance for doubtful account
Advertising costs		935		58,419
Research and development costs		36,433	74,776	72,724	151,769
Shipping and handling costs
Stock based compensation issued or outstanding

XML 52 R40.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)	6 Months Ended
	Jun. 30, 2017
Buildings [Member] \| Minimum [Member]
Property, plant and equipment useful life (In years)	30 years
Buildings [Member] \| Maximum [Member]
Property, plant and equipment useful life (In years)	35 years
Machinery And Equipment [Member] \| Minimum [Member]
Property, plant and equipment useful life (In years)	5 years
Machinery And Equipment [Member] \| Maximum [Member]
Property, plant and equipment useful life (In years)	10 years
Automobiles [Member]
Property, plant and equipment useful life (In years)	8 years
Office Equipment [Member] \| Minimum [Member]
Property, plant and equipment useful life (In years)	2 years
Office Equipment [Member] \| Maximum [Member]
Property, plant and equipment useful life (In years)	5 years
Computer Software [Member]
Property, plant and equipment useful life (In years)	3 years

XML 53 R41.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies - Schedule of Foreign Currency Exchange Rate (Details)	Jun. 30, 2017	Feb. 11, 2017	Dec. 31, 2016
Foreign currency exchange rate, translation		1.00
Balance Sheet Items, Except For Equity Accounts [Member]
Foreign currency exchange rate, translation	6.7832		6.9472
Items In The Statements of Comprehensive Loss [Member]
Foreign currency exchange rate, translation	6.8753		6.5345

XML 54 R42.htm IDEA: XBRL DOCUMENT

Accounts Receivable, Net - Schedule of Accounts Receivable (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Accounts Receivable Net - Schedule Of Accounts Receivable Details
Accounts receivable	$ 9,425,359	$ 1,122,754
Less: Allowance for doubtful debts
Accounts receivable, net	$ 9,425,359	$ 1,122,754

XML 55 R43.htm IDEA: XBRL DOCUMENT

Prepaid Expense - Schedule of Prepaid Expense (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Notes to Financial Statements
Prepaid office rent	$ 28,021	$ 12,504
Prepaid government filing expense	33,588	5,000
Prepaid packaging expense		75,000
Prepayment for purchasing furniture	5,160
Prepaid expenses	$ 66,769	$ 92,504

XML 56 R44.htm IDEA: XBRL DOCUMENT

Other Receivable (Details Narrative) - USD ($)	6 Months Ended
Other Receivable (Details Narrative) - USD ($)	Jun. 30, 2017	Jun. 30, 2016
Advance from related party	$ 17,000	$ 40,500
Gerui [Member]
Advance from related party	$ 184,324

XML 57 R45.htm IDEA: XBRL DOCUMENT

Other Receivable - Schedule of Other Receivable (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Less: Allowance for doubtful debts
Other receivable, net	1,471,291	1,561,331
Due from customer-Kangtan Gerui [Member]
Other receivable, gross	1,338,111	1,522,435
Advance to Employees [Member]
Other receivable, gross	105,171	31,700
Others [Member]
Other receivable, gross	$ 28,009	$ 7,196

XML 58 R46.htm IDEA: XBRL DOCUMENT

Advance to Suppliers (Details Narrative) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Notes to Financial Statements
Advance to suppliers	$ 1,255,218	$ 1,805,044

XML 59 R47.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 8,318	$ 3,073	$ 17,787	$ 3,073
Impairment on long-lived assets
Percentage of property plant and equipment held as collateral to secure			6.00%

XML 60 R48.htm IDEA: XBRL DOCUMENT

Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Property, plant and equipment - total	$ 83,376	$ 80,089
Less: accumulated depreciation	(40,064)	(20,311)
Less: impairment on long-lived assets
Property, plant and equipment - net	43,312	59,778
Office Equipment [Member]
Property, plant and equipment - total	942	942
Furniture [Member]
Property, plant and equipment - total	10,260	8,276
Leasehold Improvement [Member]
Property, plant and equipment - total	$ 72,174	$ 70,871

XML 61 R49.htm IDEA: XBRL DOCUMENT

Deposit for Long-Term Investment (Details Narrative) - Yantai Peng Hao New Materials Technology Co. Ltd [Member] - Equity Purchase Agreement [Member]			6 Months Ended
	Jun. 08, 2017 USD ($)	Jun. 08, 2017 CNY (¥)	Jun. 30, 2017 USD ($)	Jun. 30, 2017 CNY (¥)
Payments to acquire new factory \| $	$ 2,200,000		$ 147,423
RMB [Member]
Payments to acquire new factory \| ¥		¥ 15,000,000		¥ 1,000,000

XML 62 R50.htm IDEA: XBRL DOCUMENT

Goodwill and Other Intangibles (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended	6 Months Ended
	Nov. 30, 2015	May 31, 2017	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016
Goodwill			$ 34,112	$ 34,112
Legal fee				30,000
Government fees				4,112
Impairment of goodwill
Amortization expense				58
Computer Software [Member]
Purchase of computer software		$ 1,061
Amortization expense			$ 59
Acquisition Agreement [Member]
Acquisition entity interest	100.00%
Acquisition of goodwill	$ 30,000

XML 63 R51.htm IDEA: XBRL DOCUMENT

Construction Costs Payable (Details Narrative) - USD ($)	Feb. 11, 2017	Dec. 31, 2016
Construction costs payable		$ 255,539
Equity Transfer Agreement [Member] \| Dian Shi Cheng Jing (Beijing) Technology Co [Member]
Equity interest transfer, description	Kiwa Shandong to the Transferee for USD $1.00.

XML 64 R52.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details Narrative)			3 Months Ended		6 Months Ended
Related Party Transactions (Details Narrative)	Nov. 05, 2015 USD ($)	Nov. 05, 2015 CNY (¥)	Jun. 30, 2017 USD ($) shares	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) shares	Jun. 30, 2017 CNY (¥)	Jun. 30, 2016 USD ($)	May 09, 2017 USD ($) $ / shares	Jan. 17, 2017 USD ($) $ / shares	Dec. 31, 2016 USD ($)
Related Party Transaction [Line Items]
Research and development costs			$ 36,433	$ 74,776	$ 72,724		$ 151,769
Proceeds from Convertible Debt					955,955
Interest Expense, Debt			22,500	$ 22,500	45,000		45,000
Yvonne Wang [Member]
Related Party Transaction [Line Items]
Due to related parties			$ 83,798		83,798					$ 100,798
Kiwa-CAU R&D Center [Member]
Related Party Transaction [Line Items]
Related party transaction amount							160,000
Research and development costs							36,363
Kiwa-CAU R&D Center [Member] \| RMB [Member]
Related Party Transaction [Line Items]
Related party transaction amount \| ¥						¥ 1,000,000
CAAS IARRP and IAED Institutes [Member]
Related Party Transaction [Line Items]
Related party transaction amount	$ 160,000
Research and development costs					233,598
CAAS IARRP and IAED Institutes [Member] \| RMB [Member]
Related Party Transaction [Line Items]
Related party transaction amount \| ¥		¥ 1,000,000
Ms. Wang [Member]
Related Party Transaction [Line Items]
Research and development costs					$ 36,291		$ 38,764
Geng Liu [Member]
Related Party Transaction [Line Items]
Common stock, shares subscribed \| shares			500,000		500,000
Geng Liu [Member] \| Convertible Loan Agreement [Member]
Related Party Transaction [Line Items]
Advance from lender									$ 442,269
Debt interest rate									15.00%
Conversion price \| $ / shares									$ 0.90
Proceeds from Convertible Debt					$ 147,423
Interest Expense, Debt			$ 5,442		8,472
Geng Liu [Member] \| RMB [Member] \| Convertible Loan Agreement [Member]
Related Party Transaction [Line Items]
Advance from lender									$ 3,000,000
Proceeds from Convertible Debt					$ 1,000,000
Junwei Zheng [Member]
Related Party Transaction [Line Items]
Common stock, shares subscribed \| shares			920,000		920,000
Junwei Zheng [Member] \| Convertible Loan Agreement [Member]
Related Party Transaction [Line Items]
Advance from lender								$ 4,500,000
Debt interest rate								15.00%
Conversion price \| $ / shares								$ 3.50
Proceeds from Convertible Debt					$ 810,827
Interest Expense, Debt			$ 17,328		17,328
Junwei Zheng [Member] \| RMB [Member] \| Convertible Loan Agreement [Member]
Related Party Transaction [Line Items]
Advance from lender								$ 30,000,000
Proceeds from Convertible Debt					$ 5,500,000

XML 65 R53.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Related Party Transaction [Line Items]
Total		$ 1,283,215
Kiwa-CAU R&D Center [Member] \| Trade Transaction [Member]
Related Party Transaction [Line Items]
Total		1,122,754
CAAS IARRP and IAED Institutes [Member] \| Trade Transaction [Member]
Related Party Transaction [Line Items]
Total		$ 160,461

XML 66 R54.htm IDEA: XBRL DOCUMENT

Unsecured Loans Payable (Details Narrative) - USD ($)	Feb. 11, 2017	Dec. 31, 2016
Unsecured Loans Payable [Line Items]
Unsecured loans payable		$ 1,655,343
Dian Shi Cheng Jing (Beijing) Technology Co [Member] \| Equity Transfer Agreement [Member]
Unsecured Loans Payable [Line Items]
Equity interest transfer, description	Kiwa Shandong to the Transferee for USD $1.00.

XML 67 R55.htm IDEA: XBRL DOCUMENT

Convertible Notes Payable (Details Narrative)							3 Months Ended	6 Months Ended
Convertible Notes Payable (Details Narrative)	May 09, 2017 USD ($) $ / shares	Jan. 17, 2017 USD ($) $ / shares	Jan. 17, 2017 USD ($) $ / shares	Mar. 18, 2008 USD ($)	Jun. 30, 2006 USD ($)	Jun. 29, 2006 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2017 CNY (¥)	May 09, 2017 CNY (¥)	Jan. 17, 2017 CNY (¥)	Dec. 31, 2016 USD ($)
Convertible notes payable							$ 1,106,205	$ 1,106,205				$ 150,250
6% Notes [Member]
Percentage of secured convertible notes issued						6.00%
Notes beard interest						6.00%
Debt instruments maturity date						Jun. 29, 2009
Debt instruments face amount						$ 120,000
FirsTrust Group, Inc [Member]
Convertible notes payable							150,250	150,250
Accumulated interest								194,537
Accumulated penalty								523,141
15% Convertible Notes [Member] \| Geng Liu [Member] \| Convertible Note Agreement [Member]
Notes beard interest		15.00%	15.00%								15.00%
Debt instruments maturity date			Jan. 16, 2018
Debt instruments face amount		$ 435,380	$ 435,380
Debt conversion price \| $ / shares		$ 0.90	$ 0.90
Partial principal								145,127
Accrued interest expense							5,442	8,472
15% Convertible Notes [Member] \| Geng Liu [Member] \| Convertible Note Agreement [Member] \| RMB [Member]
Debt instruments face amount \| ¥											¥ 3,000,000
Partial principal \| ¥									¥ 1,000,000
15% Convertible Notes [Member] \| Mr. Junwei Zheng [Member] \| Convertible Note Agreement [Member]
Notes beard interest	15.00%									15.00%
Debt instruments maturity date	May 08, 2019
Debt instruments face amount	$ 4,500,000
Debt conversion price \| $ / shares	$ 3.5
Partial principal								810,827
Accrued interest expense							$ 17,328	$ 17,328
15% Convertible Notes [Member] \| Mr. Junwei Zheng [Member] \| Convertible Note Agreement [Member] \| RMB [Member]
Debt instruments face amount \| ¥										¥ 30,000,000
Partial principal \| ¥									¥ 5,500,000
FirsTrust Group, Inc [Member]
Convertible notes payable						$ 150,250
Percentage of secured convertible notes issued						6.00%
FirsTrust Group, Inc [Member] \| 6% Convertible Note [Member]
Percentage of secured convertible notes issued				6.00%
Payment acquire debt				$ 168,000
Cash payment				100,000
FirsTrust Group, Inc [Member] \| 6% Convertible Note [Member] \| Share-based Compensation Award, Tranche One [Member]
Payment acquire debt				59,100
FirsTrust Group, Inc [Member] \| 6% Convertible Note [Member] \| Share-based Compensation Award, Tranche Two [Member]
Payment acquire debt				50,400
FirsTrust Group, Inc [Member] \| 6% Convertible Note [Member] \| Share-based Compensation Award, Tranche Three [Member]
Payment acquire debt				$ 59,100
Mr. Geng Liu [Member]
Convertible notes payable		$ 145,127	$ 145,127
Percentage of secured convertible notes issued		15.00%
Mr. Junwei Zheng [Member]
Convertible notes payable	$ 810,827
Percentage of secured convertible notes issued	15.00%
Nite Capital LP [Member] \| 6% Secured Convertible Note [Member] \| Six Institutional Investors [Member]
Secured debt						$ 2,450,000
Payment acquire debt						$ 300,000
Nite Capital LP [Member] \| 6% Secured Convertible Note [Member] \| Six Institutional Investors [Member] \| Share-based Compensation Award, Tranche One [Member]
Payment acquire debt					$ 105,000
Nite Capital LP [Member] \| 6% Secured Convertible Note [Member] \| Six Institutional Investors [Member] \| Share-based Compensation Award, Tranche Two [Member]
Payment acquire debt					90,000
Nite Capital LP [Member] \| 6% Secured Convertible Note [Member] \| Six Institutional Investors [Member] \| Share-based Compensation Award, Tranche Three [Member]
Payment acquire debt					$ 105,000

XML 68 R56.htm IDEA: XBRL DOCUMENT

Note Payable (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended
Note Payable (Details Narrative) - USD ($)	May 29, 2007	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Promissory note		$ 360,000		$ 360,000		$ 360,000
Accrued interest expense		22,500	$ 22,500	45,000	$ 45,000
Unrelated Individual [Member]
Promissory note	$ 360,000
Note interest rate	18.00%
Note maturity date	Jul. 27, 2007
Note default rate	25.00%
Investlink (China) Limited [Member]
Note is secured by pledge shares of common stock	6,178,336
Post-reverse split shares	30,892
FirsTrust [Member]
Promissory note		$ 360,000		360,000
Accrued interest expense				$ 904,300
Investline (China) Limited [Member]
Pledging of shares		30,892		30,892

XML 69 R57.htm IDEA: XBRL DOCUMENT

Other Payable (Details Narrative) - USD ($)	6 Months Ended
Other Payable (Details Narrative) - USD ($)	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Payments from investors	$ 17,000	$ 40,500
Other payables	865,793		$ 1,019,583
Two Unrelated Potential Investors [Member]
Payments from investors	$ 471,754

XML 70 R58.htm IDEA: XBRL DOCUMENT

Stockholders' Deficiency (Details Narrative) - USD ($)							1 Months Ended			6 Months Ended		12 Months Ended
Stockholders' Deficiency (Details Narrative) - USD ($)	Jun. 13, 2017	Jun. 02, 2017	May 25, 2017	Mar. 03, 2017	Feb. 15, 2017	Nov. 15, 2016	Feb. 28, 2017	Aug. 31, 2016	Mar. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Stock issued during period, cash, shares												1,650,000
Share issued price per share												$ 0.8
Stock issued during period cash												$ 1,320,000
Common stock subscription received												759,659
Common stock subscription receivable												$ 560,341
Stock issued for services												1,710,808
Stock issued for services, value										$ 179,897		$ 254,250
Fair value of consulting agreement												1,688,300
Compensation realized for consulting service												$ 331,800
Employee benefits										102,743
Financing Projects [Member]
Stock issued during period, cash, shares			19,380
Share issued price per share			$ 2.74
Fair value of consulting agreement			$ 53,101
Compensation realized for consulting service										5,237
Agreement term			1 year
Technical Support [Member]
Stock issued during period, cash, shares		15,108
Share issued price per share		$ 2.78
Fair value of consulting agreement		$ 41,396
Compensation realized for consulting service										$ 3,402
Agreement term		1 year
Ten Employees [Member]
Stock issued during period, cash, shares										97,850
Share issued price per share										$ 1.95
Stock issued during period cash										$ 190,807
Common stock price per share										$ 3.00
Consulting Agreement [Member]
Fair value of consulting agreement					$ 85,400
Agreement term					1 year
Mr. Junwei Zheng [Member]
Stock issued during period, cash, shares							1,000,000
Share issued price per share							$ 1.00
Stock issued during period cash										$ 1,000,000
Mr. Yuan Wang [Member]
Stock issued during period, cash, shares	96,900
Share issued price per share	$ 3.00			$ 1.22
Stock issued during period cash	$ 290,700
Stock issued for services				70,000
Compensation realized for consulting service										$ 32,025
Mr. Li And Ms. Wang [Member]
Number of common stock shares issued for debt and salary payable settlement									3,140,000
Number of common stock value issued for debt and salary payable settlement									$ 3,141,000
Jimmy Zhou [Member]
Number of common stock shares issued for debt and salary payable settlement								101,947
Number of common stock value issued for debt and salary payable settlement								$ 50,974
Accredited Investor [Member] \| Private Offering [Member]
Stock issued during period						$ 125,000
Warrant to purchase shares of common stock						300,000
Exercise price of warrants						$ 3.00
Warrant term						Nov. 15, 2021
Consultant [Member]
Stock issued during period, cash, shares										98,000
Stock issued during period cash										$ 294,000
Stock issued for services										88,000

XML 71 R59.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Details Narrative)	Mar. 15, 2017
Board of Directors [Member]
Stock option plan term	10 years

XML 72 R60.htm IDEA: XBRL DOCUMENT

Statutory Reserves (Details Narrative)	6 Months Ended
Statutory Reserves (Details Narrative)	Jun. 30, 2017
Statutory Reserves Details Narrative
Statutory reserves description	Appropriation to the statutory surplus reserve should be at least 10% of the after tax net income determined in accordance with the PRC GAAP until the reserve is equal to 50% of the entities’ registered capital or members’ equity.
Income tax statutory surplus percentage	10.00%

XML 73 R61.htm IDEA: XBRL DOCUMENT

Statutory Reserves - Schedule of Statutory Reserve Activity (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Statutory Reserves - Schedule Of Statutory Reserve Activity Details
Balance beginning	$ 127,884
Addition to statutory reserve	179,466	127,884
Balance ending	$ 307,350	$ 127,884

XML 74 R62.htm IDEA: XBRL DOCUMENT

Income Tax (Details Narrative)	3 Months Ended			6 Months Ended			12 Months Ended
Income Tax (Details Narrative)	Jun. 30, 2017 USD ($)	Jun. 30, 2017 CNY (¥)	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2017 CNY (¥)	Jun. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)
Effective income tax rate				25.00%	25.00%
Income tax provision	$ 379,973			$ 599,022
Operating loss carry forwards	3,400,000			3,400,000			$ 3,400,000
Unrecognized tax benefits
Interest or penalties
Provision for interest and penalties
California State Franchise Tax [Member]
Income tax provision				$ 800
RMB [Member]
Income tax provision \| ¥		¥ 2,601,847			¥ 4,112,924

XML 75 R63.htm IDEA: XBRL DOCUMENT

Income Tax - Schedule of Reconciliation of U.S. Tax Rate (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Tax Disclosure [Abstract]
Pre-tax income (loss)	$ 5,396,950	$ 181,975	$ 5,924,464	$ 238,105
U.S. federal corporate income tax rate	34.00%	34.00%	34.00%	34.00%
Income tax computed at U.S. federal corporate income tax rate	$ 1,834,963	$ 61,872	$ 2,014,318	$ 80,956
Rate differential for PRC earnings	(124,683)	8,770	(202,353)	13,668
Change of valuation allowance	195,403	80,006	305,935	146,608
Non-deductible expenses	(1,525,710)	(150,648)	(1,518,877)	(241,232)
Effective tax expense	$ 379,973		$ 599,022

XML 76 R64.htm IDEA: XBRL DOCUMENT

Income Tax - Schedule of Deferred Tax Assets (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Net operating losses carried forward	$ 3,458,902	$ 3,473,331
Less: Valuation allowance	(3,458,902)	(3,473,331)
Net deferred tax assets

XML 77 R65.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative)	Jul. 02, 2017 USD ($)	Jun. 20, 2017 USD ($)	Jun. 20, 2017 CNY (¥)	Jun. 08, 2017 USD ($)	Jun. 08, 2017 CNY (¥)	May 05, 2017 USD ($)	Apr. 29, 2016 USD ($)	Apr. 29, 2016 CNY (¥)	Nov. 05, 2015 USD ($)	Nov. 05, 2015 CNY (¥)
Kiwa Baiao Bio-Tech (Beijing) Co., Ltd [Member] \| Office Lease Agreement [Member]
Payments for Rent \| $							$ 11,303
Lease term							2 years	2 years
Kiwa Baiao Bio-Tech (Shenzhen) Co., Ltd [Member] \| Apartment Lease [Member]
Payments for Rent \| $		$ 16,954
Lease term		2 years	2 years
Kiwa Baiao Bio-Tech Product Group [Member] \| Office Lease Agreement [Member]
Payments for Rent \| $	$ 1,087					$ 680
Lease term	1 year					13 months
CAAS IARRP and IAED Institutes [Member]
Related party transaction, amounts of transaction \| $									$ 160,000
Description of related party transaction									The term of the Agreement is for three years beginning November 20, 2015 and will expire on November 19, 2018.	The term of the Agreement is for three years beginning November 20, 2015 and will expire on November 19, 2018.
RMB [Member] \| Kiwa Baiao Bio-Tech (Shenzhen) Co., Ltd [Member] \| Apartment Lease [Member]
Payments for Rent			¥ 115,000
RMB [Member] \| Kiwa Baiao Bio-Tech (Beijing) Co., Ltd [Member] \| Office Lease Agreement [Member]
Payments for Rent								¥ 77,867
RMB [Member] \| Two Institutes In China [Member]
Related party transaction, amounts of transaction										¥ 1,000,000
RMB [Member] \| CAAS IARRP and IAED Institutes [Member]
Related party transaction, amounts of transaction										¥ 1,000,000
Equity Purchase Agreement [Member]
Acquisition of purchase price \| $				$ 2,200,000
Equity Purchase Agreement [Member] \| First Payment [Member]
Payment of purchase agreement \| $				$ 147,423
Equity Purchase Agreement [Member] \| RMB [Member]
Acquisition of purchase price					¥ 15,000,000
Equity Purchase Agreement [Member] \| RMB [Member] \| First Payment [Member]
Payment of purchase agreement					1,000,000
Equity Purchase Agreement [Member] \| RMB [Member] \| Second Payment [Member]
Payment of purchase agreement					10,000,000
Equity Purchase Agreement [Member] \| RMB [Member] \| Final Payment [Member]
Payment of purchase agreement					¥ 4,000,000

XML 78 R66.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Schedule of Future Lease Payments (Details)	Jun. 30, 2017 USD ($)
2017	$ 181,203
2018	259,286
2019	101,722
Thereafter
Beijing Office [Member]
2017	68,876
2018	45,212
2019
Thereafter
Shenzhen Office [Member]
2017	101,722
2018	203,444
2019	101,722
Thereafter
USA Office [Member]
2017	10,605
2018	9,925
2019
Thereafter

XML 79 R67.htm IDEA: XBRL DOCUMENT

Discontinued Operation (Details Narrative)	3 Months Ended		6 Months Ended
Discontinued Operation (Details Narrative)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Feb. 11, 2017
Discontinued Operations and Disposal Groups [Abstract]
Foreign currency translation					1.00
Discontinued operation net gain	$ 4,513,363		$ 4,514,161

XML 80 R68.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative)	Jul. 19, 2017 USD ($) $ / shares shares	Jul. 18, 2017 shares	Jul. 02, 2017 USD ($)	Aug. 03, 2017 USD ($)	Aug. 03, 2017 CNY (¥)	Dec. 31, 2016 USD ($) $ / shares
Subscription receivable						$ 560,341
Shares issued price per share \| $ / shares						$ 0.8
Subsequent Event [Member]
Agreement term			2 years
Monthly lease payment			$ 1,087
Subscription receivable				$ 487,627
Subsequent Event [Member] \| RMB [Member]
Subscription receivable \| ¥					¥ 3,360,000
Subsequent Event [Member] \| Junwei Zheng [Member]
Shares issued during period restricted shares \| shares	245,000
Shares issued price per share \| $ / shares	$ 3.00
Shares issued during period restricted, value	$ 735,000
Subsequent Event [Member] \| Quanzhen Shen [Member]
Agreement term	1 year
Shares issued during period, shares \| shares	49,000
Subsequent Event [Member] \| Quanzhen Shen [Member] \| Common Stock Purchase Agreement [Member]
Shares issued during period restricted shares \| shares	98,000
Shares issued price per share \| $ / shares	$ 3.00
Shares issued during period restricted, value	$ 294,000
Subsequent Event [Member] \| Yuan Wang [Member]
Agreement term		1 year
Shares issued during period, shares \| shares		39,000

EXCEL 81 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 82 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 83 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 85 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 164 278 1 false 80 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://kiwabiotech.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://kiwabiotech.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://kiwabiotech.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://kiwabiotech.com/role/StatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://kiwabiotech.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - Description of Business and Organization Sheet http://kiwabiotech.com/role/DescriptionOfBusinessAndOrganization Description of Business and Organization Notes 6 false false R7.htm 00000007 - Disclosure - Summaries of Significant Accounting Policies Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPolicies Summaries of Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Accounts Receivable, Net Sheet http://kiwabiotech.com/role/AccountsReceivableNet Accounts Receivable, Net Notes 8 false false R9.htm 00000009 - Disclosure - Prepaid Expense Sheet http://kiwabiotech.com/role/PrepaidExpense Prepaid Expense Notes 9 false false R10.htm 00000010 - Disclosure - Other Receivable Sheet http://kiwabiotech.com/role/OtherReceivable Other Receivable Notes 10 false false R11.htm 00000011 - Disclosure - Advance to Suppliers Sheet http://kiwabiotech.com/role/AdvanceToSuppliers Advance to Suppliers Notes 11 false false R12.htm 00000012 - Disclosure - Property, Plant and Equipment Sheet http://kiwabiotech.com/role/PropertyPlantAndEquipment Property, Plant and Equipment Notes 12 false false R13.htm 00000013 - Disclosure - Deposit for Long-Term Investment Sheet http://kiwabiotech.com/role/DepositForLong-termInvestment Deposit for Long-Term Investment Notes 13 false false R14.htm 00000014 - Disclosure - Goodwill and Other Intangibles Sheet http://kiwabiotech.com/role/GoodwillAndOtherIntangibles Goodwill and Other Intangibles Notes 14 false false R15.htm 00000015 - Disclosure - Construction Costs Payable Sheet http://kiwabiotech.com/role/ConstructionCostsPayable Construction Costs Payable Notes 15 false false R16.htm 00000016 - Disclosure - Related Party Transactions Sheet http://kiwabiotech.com/role/RelatedPartyTransactions Related Party Transactions Notes 16 false false R17.htm 00000017 - Disclosure - Unsecured Loans Payable Sheet http://kiwabiotech.com/role/UnsecuredLoansPayable Unsecured Loans Payable Notes 17 false false R18.htm 00000018 - Disclosure - Convertible Notes Payable Notes http://kiwabiotech.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 18 false false R19.htm 00000019 - Disclosure - Note Payable Sheet http://kiwabiotech.com/role/NotePayable Note Payable Notes 19 false false R20.htm 00000020 - Disclosure - Other Payable Sheet http://kiwabiotech.com/role/OtherPayable Other Payable Notes 20 false false R21.htm 00000021 - Disclosure - Stockholders' Deficiency Sheet http://kiwabiotech.com/role/StockholdersDeficiency Stockholders' Deficiency Notes 21 false false R22.htm 00000022 - Disclosure - Stock-based Compensation Sheet http://kiwabiotech.com/role/Stock-basedCompensation Stock-based Compensation Notes 22 false false R23.htm 00000023 - Disclosure - Statutory Reserves Sheet http://kiwabiotech.com/role/StatutoryReserves Statutory Reserves Notes 23 false false R24.htm 00000024 - Disclosure - Income Tax Sheet http://kiwabiotech.com/role/IncomeTax Income Tax Notes 24 false false R25.htm 00000025 - Disclosure - Commitments and Contingencies Sheet http://kiwabiotech.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 00000026 - Disclosure - Discontinued Operation Sheet http://kiwabiotech.com/role/DiscontinuedOperation Discontinued Operation Notes 26 false false R27.htm 00000027 - Disclosure - Subsequent Events Sheet http://kiwabiotech.com/role/SubsequentEvents Subsequent Events Notes 27 false false R28.htm 00000028 - Disclosure - Summaries of Significant Accounting Policies (Policies) Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPoliciesPolicies Summaries of Significant Accounting Policies (Policies) Policies http://kiwabiotech.com/role/SummariesOfSignificantAccountingPolicies 28 false false R29.htm 00000029 - Disclosure - Summaries of Significant Accounting Policies (Tables) Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPoliciesTables Summaries of Significant Accounting Policies (Tables) Tables http://kiwabiotech.com/role/SummariesOfSignificantAccountingPolicies 29 false false R30.htm 00000030 - Disclosure - Accounts Receivable, Net (Tables) Sheet http://kiwabiotech.com/role/AccountsReceivableNetTables Accounts Receivable, Net (Tables) Tables http://kiwabiotech.com/role/AccountsReceivableNet 30 false false R31.htm 00000031 - Disclosure - Prepaid Expense (Tables) Sheet http://kiwabiotech.com/role/PrepaidExpenseTables Prepaid Expense (Tables) Tables http://kiwabiotech.com/role/PrepaidExpense 31 false false R32.htm 00000032 - Disclosure - Other Receivable (Tables) Sheet http://kiwabiotech.com/role/OtherReceivableTables Other Receivable (Tables) Tables http://kiwabiotech.com/role/OtherReceivable 32 false false R33.htm 00000033 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://kiwabiotech.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://kiwabiotech.com/role/PropertyPlantAndEquipment 33 false false R34.htm 00000034 - Disclosure - Related Party Transactions (Tables) Sheet http://kiwabiotech.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://kiwabiotech.com/role/RelatedPartyTransactions 34 false false R35.htm 00000035 - Disclosure - Statutory Reserves (Tables) Sheet http://kiwabiotech.com/role/StatutoryReservesTables Statutory Reserves (Tables) Tables http://kiwabiotech.com/role/StatutoryReserves 35 false false R36.htm 00000036 - Disclosure - Income Tax (Tables) Sheet http://kiwabiotech.com/role/IncomeTaxTables Income Tax (Tables) Tables http://kiwabiotech.com/role/IncomeTax 36 false false R37.htm 00000037 - Disclosure - Commitments and Contingencies (Tables) Sheet http://kiwabiotech.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://kiwabiotech.com/role/CommitmentsAndContingencies 37 false false R38.htm 00000038 - Disclosure - Description of Business and Organization (Details Narrative) Sheet http://kiwabiotech.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative Description of Business and Organization (Details Narrative) Details http://kiwabiotech.com/role/DescriptionOfBusinessAndOrganization 38 false false R39.htm 00000039 - Disclosure - Summaries of Significant Accounting Policies (Details Narrative) Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPoliciesDetailsNarrative Summaries of Significant Accounting Policies (Details Narrative) Details http://kiwabiotech.com/role/SummariesOfSignificantAccountingPoliciesTables 39 false false R40.htm 00000040 - Disclosure - Summaries of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPolicies-ScheduleOfEstimatedUsefulLivesOfAssetsDetails Summaries of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details) Details 40 false false R41.htm 00000041 - Disclosure - Summaries of Significant Accounting Policies - Schedule of Foreign Currency Exchange Rate (Details) Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPolicies-ScheduleOfForeignCurrencyExchangeRateDetails Summaries of Significant Accounting Policies - Schedule of Foreign Currency Exchange Rate (Details) Details 41 false false R42.htm 00000042 - Disclosure - Accounts Receivable, Net - Schedule of Accounts Receivable (Details) Sheet http://kiwabiotech.com/role/AccountsReceivableNet-ScheduleOfAccountsReceivableDetails Accounts Receivable, Net - Schedule of Accounts Receivable (Details) Details 42 false false R43.htm 00000043 - Disclosure - Prepaid Expense - Schedule of Prepaid Expense (Details) Sheet http://kiwabiotech.com/role/PrepaidExpense-ScheduleOfPrepaidExpenseDetails Prepaid Expense - Schedule of Prepaid Expense (Details) Details 43 false false R44.htm 00000044 - Disclosure - Other Receivable (Details Narrative) Sheet http://kiwabiotech.com/role/OtherReceivableDetailsNarrative Other Receivable (Details Narrative) Details http://kiwabiotech.com/role/OtherReceivableTables 44 false false R45.htm 00000045 - Disclosure - Other Receivable - Schedule of Other Receivable (Details) Sheet http://kiwabiotech.com/role/OtherReceivable-ScheduleOfOtherReceivableDetails Other Receivable - Schedule of Other Receivable (Details) Details 45 false false R46.htm 00000046 - Disclosure - Advance to Suppliers (Details Narrative) Sheet http://kiwabiotech.com/role/AdvanceToSuppliersDetailsNarrative Advance to Suppliers (Details Narrative) Details http://kiwabiotech.com/role/AdvanceToSuppliers 46 false false R47.htm 00000047 - Disclosure - Property, Plant and Equipment (Details Narrative) Sheet http://kiwabiotech.com/role/PropertyPlantAndEquipmentDetailsNarrative Property, Plant and Equipment (Details Narrative) Details http://kiwabiotech.com/role/PropertyPlantAndEquipmentTables 47 false false R48.htm 00000048 - Disclosure - Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) Sheet http://kiwabiotech.com/role/PropertyPlantAndEquipment-ScheduleOfPropertyPlantAndEquipmentDetails Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) Details 48 false false R49.htm 00000049 - Disclosure - Deposit for Long-Term Investment (Details Narrative) Sheet http://kiwabiotech.com/role/DepositForLong-termInvestmentDetailsNarrative Deposit for Long-Term Investment (Details Narrative) Details http://kiwabiotech.com/role/DepositForLong-termInvestment 49 false false R50.htm 00000050 - Disclosure - Goodwill and Other Intangibles (Details Narrative) Sheet http://kiwabiotech.com/role/GoodwillAndOtherIntangiblesDetailsNarrative Goodwill and Other Intangibles (Details Narrative) Details http://kiwabiotech.com/role/GoodwillAndOtherIntangibles 50 false false R51.htm 00000051 - Disclosure - Construction Costs Payable (Details Narrative) Sheet http://kiwabiotech.com/role/ConstructionCostsPayableDetailsNarrative Construction Costs Payable (Details Narrative) Details http://kiwabiotech.com/role/ConstructionCostsPayable 51 false false R52.htm 00000052 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://kiwabiotech.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://kiwabiotech.com/role/RelatedPartyTransactionsTables 52 false false R53.htm 00000053 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) Sheet http://kiwabiotech.com/role/RelatedPartyTransactions-ScheduleOfRelatedPartyTransactionsDetails Related Party Transactions - Schedule of Related Party Transactions (Details) Details 53 false false R54.htm 00000054 - Disclosure - Unsecured Loans Payable (Details Narrative) Sheet http://kiwabiotech.com/role/UnsecuredLoansPayableDetailsNarrative Unsecured Loans Payable (Details Narrative) Details http://kiwabiotech.com/role/UnsecuredLoansPayable 54 false false R55.htm 00000055 - Disclosure - Convertible Notes Payable (Details Narrative) Notes http://kiwabiotech.com/role/ConvertibleNotesPayableDetailsNarrative Convertible Notes Payable (Details Narrative) Details http://kiwabiotech.com/role/ConvertibleNotesPayable 55 false false R56.htm 00000056 - Disclosure - Note Payable (Details Narrative) Sheet http://kiwabiotech.com/role/NotePayableDetailsNarrative Note Payable (Details Narrative) Details http://kiwabiotech.com/role/NotePayable 56 false false R57.htm 00000057 - Disclosure - Other Payable (Details Narrative) Sheet http://kiwabiotech.com/role/OtherPayableDetailsNarrative Other Payable (Details Narrative) Details http://kiwabiotech.com/role/OtherPayable 57 false false R58.htm 00000058 - Disclosure - Stockholders' Deficiency (Details Narrative) Sheet http://kiwabiotech.com/role/StockholdersDeficiencyDetailsNarrative Stockholders' Deficiency (Details Narrative) Details http://kiwabiotech.com/role/StockholdersDeficiency 58 false false R59.htm 00000059 - Disclosure - Stock-based Compensation (Details Narrative) Sheet http://kiwabiotech.com/role/Stock-basedCompensationDetailsNarrative Stock-based Compensation (Details Narrative) Details http://kiwabiotech.com/role/Stock-basedCompensation 59 false false R60.htm 00000060 - Disclosure - Statutory Reserves (Details Narrative) Sheet http://kiwabiotech.com/role/StatutoryReservesDetailsNarrative Statutory Reserves (Details Narrative) Details http://kiwabiotech.com/role/StatutoryReservesTables 60 false false R61.htm 00000061 - Disclosure - Statutory Reserves - Schedule of Statutory Reserve Activity (Details) Sheet http://kiwabiotech.com/role/StatutoryReserves-ScheduleOfStatutoryReserveActivityDetails Statutory Reserves - Schedule of Statutory Reserve Activity (Details) Details 61 false false R62.htm 00000062 - Disclosure - Income Tax (Details Narrative) Sheet http://kiwabiotech.com/role/IncomeTaxDetailsNarrative Income Tax (Details Narrative) Details http://kiwabiotech.com/role/IncomeTaxTables 62 false false R63.htm 00000063 - Disclosure - Income Tax - Schedule of Reconciliation of U.S. Tax Rate (Details) Sheet http://kiwabiotech.com/role/IncomeTax-ScheduleOfReconciliationOfU.s.TaxRateDetails Income Tax - Schedule of Reconciliation of U.S. Tax Rate (Details) Details 63 false false R64.htm 00000064 - Disclosure - Income Tax - Schedule of Deferred Tax Assets (Details) Sheet http://kiwabiotech.com/role/IncomeTax-ScheduleOfDeferredTaxAssetsDetails Income Tax - Schedule of Deferred Tax Assets (Details) Details 64 false false R65.htm 00000065 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://kiwabiotech.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://kiwabiotech.com/role/CommitmentsAndContingenciesTables 65 false false R66.htm 00000066 - Disclosure - Commitments and Contingencies - Schedule of Future Lease Payments (Details) Sheet http://kiwabiotech.com/role/CommitmentsAndContingencies-ScheduleOfFutureLeasePaymentsDetails Commitments and Contingencies - Schedule of Future Lease Payments (Details) Details 66 false false R67.htm 00000067 - Disclosure - Discontinued Operation (Details Narrative) Sheet http://kiwabiotech.com/role/DiscontinuedOperationDetailsNarrative Discontinued Operation (Details Narrative) Details http://kiwabiotech.com/role/DiscontinuedOperation 67 false false R68.htm 00000068 - Disclosure - Subsequent Events (Details Narrative) Sheet http://kiwabiotech.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://kiwabiotech.com/role/SubsequentEvents 68 false false All Reports Book All Reports kwbt-20170630.xml kwbt-20170630.xsd kwbt-20170630_cal.xml kwbt-20170630_def.xml kwbt-20170630_lab.xml kwbt-20170630_pre.xml true true ZIP 87 0001493152-17-009199-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-17-009199-xbrl.zip M4$L#!!0 ( Q^#DL4PA&PYM@ -2;" 1 :W=B="TR,#$W,#8S,"YX M;6SLO6ESVTBR*/K]1MS_@.?COL^.(&7NBSW=-V3)[E:/%XTE3[^>+Q,@612K M#0(<+)(UO_[E4@440) B92X@A3ZG>R@2J,K*RJVRN&/OC?7)GHK7UJ_"%;X=>OX;ZY^V$^$WWGOI"-\Z\Z8S1X0"?N"97ENM MDWK?MJK5%<;]IW!'GO_URT4\[B0,9Z]?O;J[NSMQO5O[SO._!2=#;[7AKKS( M'XIXK+__\?;:^JEQ;C5J]6ZMTZQ9]=H_K'\TK//WGTZ^CV$QYW8(S^'/\%BM M!_^IMZ[K_=>U^NM&\U\K3AK:813$D]:^U]0__/K?O@]\1[[&_UJP(6[P^GL@ M?WYFK/.N>>+Y-Z\:M5K]U?_W\>_5^O_^* M?M6/SCV)D^LYFJ_PYX$=)",C@$N>GX,$?AV%\0OFP^U7_&/J49G[:(.^&"\$N?,*?M4/RL!K->K=9>OC)_0+ M45"]L>U9_,+8#@;TL/H!@>FF@8%??,\10>X[]$O.2Z[GNM$T'ZY1Z+\*[V?B M%3Q4A:>$+X?Q>P^_E'X!8,"O\Z&C7W*@&T:^#]+B/G]/]*\Y+TKW5@1A_FO\ M&[[43+^$G!J_\DW>V0/IA6(X VC)T<_/WOO>5*^J5@\] M_MRI)O/'KPDWE.%]_&W\O1SA+V,)XI&@%*G]TL@XN_C[LU] 3-3K[7ZCV_[; MJ^S+R72OI5_3W M*0#TEPJEB_%\&GP>PQR=:KV!A'!8N&61&/Z2+"">0OVR420=)@$:2,I0TF:1 MI#BV8W!LYR 1EN+8SF,XMK,[COWW, I";_KOOX.T/K.C+ZQA"/8A_[JWG4F0+6ZFPJ#!^*<1 /-]YLBA#!E6:R3A2;:B ME0WP^HMP +&C2]B4>V-QP=M[\Y?3[S)X]@LJM]>+T/2W5[ES;A8L X[\[7@8 MBI@.,V@[%/G9J]9;!R8.TO(3%[!5^9EC\:S XVP'_OOLTY\E2V^%I<\4BGEB MC?#7@/!=,VW!#4I%QNUJ'0!K$1GSY[8FX[/3TZN+TR]?+F''+D[?G5\ &\DP M"D7P1)720PC9*X6IC5R/PM2.[]( >@B)I2&T89HK#:)M"LGK.R_9D@OW;")= MN]3V0"<+\?(D]'U1I7$-;(IVM='7Y/O5]7G_+MR1O)6CR':>J*!=B(G]R3:] M6=N4;6J.'LJVDC@*3QRFD-%;MY:0R=+4-@X5RVCJ@NXT\(Z!5,('.96 UB=* M5LN045+60J]UO:F]UO"YI2GK=]N-;/_^O1?YH1 N&"#7$R\*;'<$IO.5_(Y? M[IG.-N7GKC?7]G/7#7_8EHYY3V,W4D>/%%JWHI[IBD*)4OX6VV*?.WO)?GNA'Q-1)?DNR[Y M?K2'$^D*_][0#K'$AFS M%N'.K;XDH'4)Z/-X+(>B5/99TLK%2ZGFBTW,F.(8A<+/;-N3(MP%."B):5F MX%)I^*3(YY%R;UN^ZYW$V'6JM:;ANVX:ONN/_@<)*/L8_&%K)\:AD\,R_W7. M\]$L/A_>EPZ$5N M>"0V^H4[]*8"L^D%CO+!&]J94-WU\'&LXB6=$UK2RH'3RE938_/E"N'CPKV> M)!B$Y]#$\\4$47TK/GC!DR&5M=#QM*1*22D'22D[2K=OJ3@N];EOIHN^E=ZU M&$[>"OF7=&_.O _A*)T.Q4>"#\(.Q.F-+\3AGXQ&0K[^(&YLYQW!F\D478B0 MS;I_&*&^CUX@7$-R%B-(%F-]WQ9Y:]VH,TUU6_4+_0"5)[E2)1_)&.J M9*W=LU:^4?H^\ET91OZ1!'*NY!XCNLDL_,@-S,RN$[M,/&=T 3:4=WL$(G%] M EB,@R.G!4H/30X;IT- 42#)YCX.]1@[1V'#/X\-U6'L_N)5[W'WU4K8Y?HZ+&%SZ\A;F Y,,)H@# M9V/J&OIB)"GY%=,5/?\X:.LJ&@1R)&W__LK&NYBKT!M^,^@K%RF;-9&7W0(M M0ON>K>.ZF?&VJG5,Q+9MZ[@DZ)*@5R'HM-5F4N:VK+;#KMC:WHT?O0%[H3F4 M[YPHA1YH]0G9-$L7OE\/.>[/5@W<'PB0?+)!XWL*D"S#Q5<0:.;%X'DDD,K/ MZ"_A_QUP"@STJ_ C>1Q4>^:YF&CMTQ7@%QE\>WO_5KC#R=3V31/D03PP@A.1[<8C'/MO9O.'.]>'$M:R8K4L&CY3TLVE$10-"+8I20H M8^&+&@N_"U&0T0?E7>]3W/7RKK>@=[U[H(4_;SW7%<>3_K)VI.>=JM$7;;TJ-LD+ QU5LV1#JD MADC%4\7YMGW9$;) [>,.L '2'HZC90^O BO\DH07Z?5&M5[3>GWE<*/XKE;: M[M5$GDV$>_.[=&]4FA9F;+F>X]W<'P=Q;S$Z:14P%F?(K8C_?9L<2&-KFQQF M;-4NN@&\EWYP[K7>3>.G_Q;N<6>!^%1EB?IN*;%E'F)*O]R?\"]@*QO1HU-O:\BE%PSX=$DFV MPJR!E_Y16*-=7[BW4(2;&;.)N M)A5&MBV.;A@*OMG/;Y-.$:33YP.=F(H;^C&SW"8='9A&P;PK"C5J;@G!'MVW-E%13(*I) MVS'F]N_>CBE)H5 "I+ 63-.P8)J&!?/6L_W1Y_&Y],7P>%QCR^JYY*]XWX33 M?(SMTMR![;)(]'SY^/8X:"4=:$HD$J]MWU11,'&RH"<%1S1PPN-AT\3B"YF< M1>[7[-AU[-S51+C_A7^/>YOS5GFL^YS(^%9&QA_RW89:3H&DIEEC/IW)=,AX M[CP&SUO-[XGK41PB;E/U&O::J'E$97S6/D[NL73/09I^G\.).)8SXXH%7LPE M'ZMED%_9I]SL?6WV+OJ8$D'5NHE&J,77YW_"9+:\%.[-;[;W2=Q]!+'B2]L) MDB#VG,Y/''5_&?G#R5/HA+,>DAXFIK7<70\F/RS8AGTK.:2X1RBYVI:B1[;% M"K$_J>2-G?/&C[GW2B[<)QPK%"P4]>V6*%42*5"*KEP?2YL M&US8QJ.QKG>*S8$CH*$K;QS>V;ZX /IR;^3 $:=!( ZN#,4'>8NM M4%+K"][>?[3_\OPSQPZ"=!W4E3"S;X)K/X;@VCO(ALC>S)0$=QP$5\PKJF6M M3$J".VB"*YA*S?N)@F&V1 MBZ14+T?/6T_*59**]>\EL?[),>2(:DDUJLI;WMGQJ)7$< M[_DJWW,:MW$Z[!U^M#++K/]8O:8/'S5*0M@K(13<>LX7'MQPR9&N.)M(U_X@ MIQ(P^T0):!DRCE6LY/[X+LZEO)K8OGAK!SC3= 8;1F7(3N]L?X3T ZSV MV3WP$KLEK^Z15]=!R#]A-=C*)Y72N@:![M/F^X'>M=OU'QV>P+F^\TJ!4PJ< MX@JAQIZ,>ZRP2K4@7/K$G%XEEQ;2IU1R:>DI*OGT$!PQQ>/4 M!^(3TWO9;]>:M5Z]>[1<5!#'1@'C$Y^(;ZT@!' P<8EFI;F,UEF0'?=>CD,A M7*6L,N]D_%A'55MSQ0R;'-1M5H4NH?V'=V;/3K0"E1O==1W'U;AKKB]/R6Y[ M9K?==>LI&;O@C&V:6_6.-K=*%7IP/%URVL;LVGIG;;O69-!=EX8H&;1DT*?% MH(4Z>.Z=08^NQDO)L3OGV-V='IZH;%A4:J94WJ4H*)8HV"Z#%JPR3G[!DQWX MM8ZHIDK1>+7T;JW45.TIUKM9G\E+GBX$3Y><=A"<]G"AN9+K2JY[*EQ7\&)_ M^W!Q*Z;XJN7FR'@N_!FD*#QW MZ?LF(=RI1QSB&NU]R?N2A(I&0@630J9[O)0\Q2&;K-,V$2';<]HV:XD(J34T M+5R+X<250]NYBF8SSP^?#BGDKWS? J1MR((U!$BML6T!4A)-<8@FF["9[/ZN M$S9+2BB6^"BL_=&IUIN)4^'/R';_L(_%H_"(XW,: ?N6'_7FMN4'S-%(Y$=) M"H4AA:P P8UZA !)*&C79^!KX;Z;SASO7H@G=(Z97_6^":? FJ:7S(0U_;WXZ"6"W?H37$YIU$X\?QTW;4'5[]O>BJLE.E4 M:UW#!1O7)F3-?1GYPXD=9.^<#YV6EMVV+UWXOLD(=^LQCMBMEKA\-!D=G4;; M(ET=BV(]3@K&DGGAI7U?BLC=Q2-E,5Y2]FXHNY3:!T#JI;HH,E-="1AT5'+5 M/KDJ9P]*MCILML(X*J?DJOWJJNP6E$Q5 *:J]Q.F:L0^P[_+._NM]#!HY&HB MW/_"OV?>AW"T@'?T%ZO,1%MFB ^4)\:L M>5N[?[:J]Q_!5HT=N$Y_A*U*+BIIN[BTW:[6C/R@6CN'MB]];Q0-N4E$FK0_ MC\=R*'@[CN/B8"4"GT?(3NE[,=;W3>5(3&M3.5+=]B5X(Y;@72.4O*3RDLH? M( M;'CNI;79'MK]4BW\L%HHF:]DOL-@OL-59R6?%(]/GI1B6$C2O=5(^KA*=A2= MG(M5'^2QI+S!R+O(E4S'7Z_.YXAO*NP@\L4O,O!:C7KW-3RC!],_I:? T1:, M?S6Q?1$LG$(A@1YZ]!P W^6">8@6P/KW%!960"B8)^*!+9O!QT=OV)>/;Q\DNK-/?ZX^/EZP M\MWJ%W$C@Q#,K_"3/166(OXO8KPL*QVDQ,4?I];;B\_5ZW=GOUF77SZ??SV[ MOK)^_?+YZZ5U]OG+Y=]>+9K#A.'<&T8Z"F#EN>NUZC]X>//UO&$OB;_?,?>O M/+YYN;MP-'.Z4_AUA$^\=^R;E:<9VTX@>(;4 .;(["H/W\M@:#M_"MM?=RW5 M:KU1;=9YFD6CS5/%>^D(_PQ^NO'\^Y4GNYK:#KQG?1%8G$ZZ-Q:6AK'=>Y,8 M4D.;,U_[]@C>N;J?#CQG=4($=<7#I][7 \=W#G8P.75'^#\81W]K.P+KU81G MMN_?PUO_M)THC55UDNTP I]9R#[T VH :R2&$E8;_/P,";+9ZH#9M-9<&P-0 M8V(9@-UZN]W:%X#M%3#8;=3W!5YG!?S5&\U.]P0@52NS[&Q7%]]B?31AZ"WMF.[0P&'3)@O M%-, QA*S$";@Y*#3X="+W+BV=K(",E",)5Q\>O_LE\Y)O]4UZ&=%.#>XO$ST MVJ:7U^TU][J\S.[1DB[T9M3JE")2I]FB+I &D7S?(8_$4/P;, EG] M/9"O7>G\_"ST(T#:JXVLV S?/K.C+Z""S\_@%>&G745H" JC$.H7@J]YH M=$T3:5OXRBSE[/3TZN+TRY=+6,O%Z;MS3+J48337$NDQ2^K46IWZSBA@LYNS M6?K)UE+;*-(? G5!==[3*:FRSV/CNQ6MPA50S?+GWV>?_C3 12]"AD9J]$]" M)&L N^%UPBFAKI.2^'-[U?UZB V*O\+K.R]9U(5[-I&N?(AF#W\/ M5Y J>]C)=";_!2)[68C)Q[>LW8AUFFV>U_8[?E(UFKNZ>8;:Z:HY&!P8N[_;IJ-[@PS8P$J M881%;X- @"2?X4V8A$V"@S(Y$\>>?V?[H^"QY\!FJ]ML-LU3P.IS;AC<5;QZ MS5:[UZ\UM@,N>F7I_'WJ.-X=.IJVA]7YN38$WF:P^ CP/HEUG!$/GM]6'/Z1 M[@4S26!W:DJ^^5%Z-ORG/L@)IY:?'PE!N",AR_?OW7N2C:(8#S_7$BP+;'8&Y#%88?IEW$MC)NG@.57C\OV*T&FTL@$Q9 M[Z;]OF2J'X1JGA:* -4F]GXKZ[CTE=S9J6A8;=;-P?HC F+7L.Y63&QB=1L5 M%HTY:EX^V8^#MK+$V#UH6Q0;VUC,11!$/[C][16 XFE^#*"5-_WQ "UJ0G&](WY^-K7]&^F^MFJS\-G_N0G?X(^O M9O3I?^I-]1_SA3',\MJJP_/6M9R*P/HD[JPOWM1V*_Q%Q;H2OAR_L>*AXX$' M^*%>/['4LBQ:EV4NC.8?; N2-Q9BJ&H[\@;^_ LX0H[OU9?2Q;AD>.BD+5T& MV9[.WOQ/O5/;'2QI5+VHOSRQE#_2&D7""CU+^0JM&=_/[ %?>\7-7P*V AKXLF+])IQ;$ #5U;5&N[D*)S@L[6?WE@#SQ\)OSH$M-JS0+RV]*=G"4 (BZ\G(D?1T';T MT@=>"*HH>1I%'KTQTF^H*?A!>,&Q0<#53]H :N Y6(UU1 MG0AY,Z&%=7^*,8EK-===#4 A\>(7O8:A%X1G?#Y&>CA: O8Z0*5W=>FPC\2& M26U#NA7:,(8^V2%HH!)'2W&$SM$]HPCX$\2!^_.SQK.BHRN6>BDAG1%\>R>V MY)[6$@F$618'1BQU@P*PD&*[!96$@5=U0(>#%<5Y<5ZPQ:B,-O$;3= M@9S6RMW.5X*=6J75J1_OX6]/FB\^<5][H>T>NYKK"P=-?.)B]<5,+'X(0P8,G LL&0LOV1->4; M #R0GPZI-,VE+P(J\%8A<-2W9Q,IQM:[[V(8A?)66-QL)O4B/X*=4-VAM!W] MR(F%H2Q6"-#B?3_^;\6*09G9O?V\7JOA'Q4+$# 30URF M;>,1DP-JUAX6T$(HNQ+Z_3&E\/("2,? M+%F$YZL+B/(#&=Y;+Q#=#'VOT:B].3O]&O]5?_/2LC$M982[\))@NN8KGV%$98 M4AS2@$Z(4>L9>M.I#$,&9@R'".O+Q[=6W9I*Q\$4QQ?V;.9[W^74#H$(@#;@ M9%2KU6 )KAO9#GRE!HX!9@!/@'V\,6+= Z=<*)%]U,TBNCP8"#8)01,A#R!\&A>$1QP\R^IPB3 =<4@05,;>D2 MRQ%FKB: >@_$I-JX>O=- ++"^V8!$TG'.IWY\-]Z0_'=W42X-&YH)(CB*O'/ M,1 1#DI@J(%%:F! I653H@/MN"/M@70D!0(!@L^E[0) \@QSD*S?4"OD M7_#A)2T7MG'F"-C&I\2FUP8! <6@=32R7-@4DF+-3J79:<9T2;!DF2F6LSKX MBH@9M,(2LK/&0)FXT8'\;DUA/1.@-A>GGA?$3&U/5HP.7UJ?#3':)LRT*RG. M#^ U,>+=L; &8"ANY! (VN-$+N"BA+.SF>.8_$GPQ3[ZN>&^B,"+_"'@*R87"VL:>B[\> GRQ266 M-28C]W]:)^!5P,(9W@T]UX.%)..?)W1,T*5'?W=N#GYB(:\ \4ZUX#U-2B Y@KT%,GE MDE++UI\>V:EH_OT1*>LP";WWQ0S%IAO:9.("R1"Y5BQDD4JBK$&)913Y_\N< MHC5XH'0EVP?$Z4A:'\E0J#<585E7$GDQ!S(TT%W/PL6@B9TRU1EJK;T!C.>- M9K/21B.6-R0MCB< ]$" C@;('-"T6+5Y9(W1(L>(V[PHW/M8U-3K;U"1C^@1 M4R7$"D19$T^)27+5+ZK=1K_.&KA7Z79:C]' PI(QR59^5.%N%3T%B:YO@(@W MTM@M#-6T+IDF]Q=87RC7QXF%U0VL#S)ZLEC0" !!.,1:SF!P8<+.Q'-&(GLD MB[D5!>=$.".K72,5QN^0YV%(B94 *N;L!"3$K\0L5.(Y#J0\^DP.,')5+II5 M[[(T2ANY=' @05G?4^9NB:W8D$2TR)#^S7>*SA8^D+RV=)!N><;[@-[=*O5 M7]K@^'IE/6^U&I5&IV^] -.DB5O'%DB$8^1 ?IW*H, ZSF3^" P[-AJK#>T M\!V .$?C1*I2%J!PX3FTW/$Y55O#4F4MK!>@Y5Y:,W*1N=&435%<,8$@*=$E MA@$19'&^KD49930V8)"\9O 9L>#-XL,U#J5P@C#P4-C%P(+3N3(+K-I)OT8 M$.72NA0^<6WKJ.P#IM$<7V&:1D&%"]"88/KXWA#(BRTY>^!%(9BOK6ZEU6@2 M*5GUA);(?HI)%<5%; G$U*%4_-P9VT4B>]ZN )GRB;U7:74;L;:G,TDLA9;K M_L>?L8]+P+\8@)KCKQ^QJ/:O=77 M3):GSJR4$B& \M19:HL>J]*>6ZV3=G+$1EG4K&44F\5.UC446Z.U8<4&IU:" M8=N*K7G27J+7GJP0?%#3(==K;4>P:(U'-,<*KU>O57J-+A-9N]).*;P4,:,< MX1/K*OJ.+ML H&:CIS6=S\J^&$S&*L,W3N1R/ M!=:?%,%;$=X!I7.7#C'B1.53=Q2W[=#UJ^,6.?JA:SQP[B^/_Y7K^5/;V9!S M0ZCJW"0! BL*U&:J0MW*.%%9W,!Y2"K$YU]/KDZL<\PD]H/8GIE%_LP+6+G, M?#%C48._8*8W!CL2M8SC:^,@KI)NW<'&8,8WIW\'ZZ1T;PXE#VNAQZ1LUPN8 MLKV=B+E=)U7^6+#Z*N(X$;=S43X#WWJ5VH]'CS^?/;MZ-%&Y:3:X=R=F"U@-J-6)X_$#M: M6J/;-FPZQ3-LKA:L:Z\;I14V6L)BIL&)??^.#H$'NQO88W(W MN[&"'9KO"UWL3TX\Z%MU@R_VN2]RW._2C5[6V2SK;)9U-@N%H[+.YJ.RC\LZ MFP7?H++.9EEG<]49RCJ;1<-+66?S("J/'1/2CWA;RSJ;99W-55!3&!5W5 @H MZVP6M/)B66>S2!.7=3;+.IO%$_G[Y^/#7T%9%+&LLUF2U*&25%EGLZRS6=;9 M+.ML'G@%H;+.9EEGLZRS67@V+>ML%GM_RCJ;99W-PZ3SK+-9UMDL MZVP>2>V=LLXFSE'6V2SK;)9U-LLZFV6=S2,5\&6=S;+.9EEG$V$HZVP^62'X M].ILKINXNZ38IA@+'UC[VOY^2K<1I^[H0W(7<51E-!-R0)<$K]L*[>_J'H:5 MQ/YJ6Y85AM8J:U?628E%\&;R34L\/X3GS:6-%J2L4V%Y;/4 MD.IAEC$13Z" ML@ZH$M(G$5KJ3AFL-BQW!"\,;=^G>R#/O[/]T9ILN^.2.S^R^N>/7-KN:O8T M*ZUVK]*OK5NUL_AUCY[PCG:;E69SW3R:S15BVDK6Z*X$U@<1!*^M?]I.I,)@ M\!R"KI&=&W(/FUZ[F&,W1/OBL7)H"["LFPM:[O2Z._TH^;33G=Z=45:\D\#& M1MB[:5W<$?:.FF-3VWC.R',G%D*49[+%"F"6K@+F;O3!NBG^1>#>.H[GO.:6XE&1A M^HYUYGNWDJY5QQ['1$G"!@INF'(D\"958MBRNJ(%/ ! R4-\.ZR"5G5X@9G8 M(S2:YU["Y,/R>FF/UTO%< 7L%D%ODS7&-=T*YU[&TU+.]Q[I2)C?5&OD-W@ M_!'V^*IF]^:JCVQXU(.X;ORAV]QR&S:X#8^_Z"VWH>2&8]N&_7%#J:H.!^X2 M&R4V2FP4(^ZFU=M.2,*E+ZKHWF!/QYK*8%NA%X^^TMRE@S1V?:P$\&YU* ML]^I]-OK]J@\B("N89ZKU[I=W?46ZVDB8.@B7:EWVA56IT?Z!E04L71 M446CV:O4:_OKPKB5*((MX.GKR=6)-1:P9[8#1JL_\_AZ*'U=M"8:BW YO:,H MTW6ESA9@^*G] MIRT"=@X%OR\:M4:EV2YYH,![5&]6.IUMGMD.^$A!#16H:N1M >I)' Q%]=N5 M5JWT96W5#5"K;=,-4-P1=G2'4&M7^LUU+^&+@)]#P7"]U:ET:@>@=_9S\/KD MN=61&$5#KH.L^[WLG""?5&6;>J7=:%>Z]0T="0[+7GU:.]VN53JM#4F?/WKMQ:GN$R^FV>U7^MWF'K?S8 FBK.WT!#;Y.+F^W>]7:HU&R?4E MUV_-\[*-BF[KEV++EG5[]Y](AO?<+?J">E)CZZW/=Z[P@XF<8LJ M:%%T+ M?XJ5[#[:+@SQ>7PEPM#A!F(Y9>?:U7J]6FM1V3G^W/[W, J %O^-/:JI734, MAGW0D^;7'ZE;Q[-?%O="EX%JRI2T0Q\(V$CJQ1TW1&]P:Y4VM6NZDXZ#YJ/T M1:IK>IV[IO5.$I2MO?*Y7'7:J]4:U63> ^GIU;L)4>_9+M=VIU1OUIL%&O:+^@I^C, B!>)"J5L(#OS:W/>T:_I- \\!< M&P!M'DG; >VS;M3QP0N",]OW[U6'CN"QA--L92!:/,6/ ;,*'?T ,.=B$*)( M\R.4$!_M,/*!ZLXQO&F>YVL 3+O:Z"'/J\]]+2>_NJI!W07LP*T<1;:C!20_ MW*TVN@F$B^?],0@[B"X%(7^.(<1FC5?R>Z)*#/CZ_.C6X6.I6>]HJ0F?N[&F M2?H[(JBQ&F$P]5.J;:1:1>:=(/TL=M+](*-DG?4>3[^3=;:KM9Y>)WSN;V^= M'WUNH4@=%(W5]AF(QZR69E$=[\\BW\\:#NN(BDZ:.7.&?N3L*\F&;O*#:Q\^;PZ>]R.KW_U\2+5EU< M';B\U2W4VIK&VIK&VC[Z'R3:Y<$?=BRE'EQ?L]Y*T^(F%_@9CM% 3PZ+1>XW MBS8X%@4?Y!V4'F< K'4J6 ?"7,N<5WX>8>MET![2&S%&V%*<.3+,.\YLC_V: MM5X_:^*O ./#IXXO I$DDG<6T",H_*:F1_CA4,R"J@QEIV6)F#*+N(,WLF0]OY"B@+3B,XZ_OROV*4 MKU@?"^O#(J-1JV7LY7RXLM!K GRG.C*O=BC>E7FW3*'U6EV#!#/K>-PR6P5< M9KO5.MQEYAFQ#S@/&KT-KW9WM+N=U?[]C[?7KY,#'CJ_AJ!R1EE86/YNZ/SX MH'JK@>VU'F0[64]L$?_J>]'LPAT>P'K4F;F==W[^Z"^2% O646_O=1V+SL?+ M6:-X:T%CO@G[0#3&GWMZ+2E^R8R8%1X[I\9\K\![>RA.IUZ4?^A=6R;DB++& MO$6?-_T/@+EKU]*RY;::[6:OB,O]\O'MYMWP ?$]?+?R/=PO_P [>.E(\]>H M@;#]X02.4^=PBG.\&;ZVGK6X%!'=1K?1,B\OE\SWP\!U#. ZJUS$M>O=3G]7 MT"TQM/\N[^PS._J"8YU1[>]\&OL>R->N='Y^!G0$2O'5-C"V+DP9%RK\7P$0 M^N#U_;)%-)K-=K^WPU5D3YL/H+C5W!F*.P9PJW!4M]7M=@JP_PN\K7G8;/3K M>Y1/ZP/*U"3B(M44-![SQ?RQDW%8YR;12XVH >JC5H#+$+S*/\H6+:X MI+6U1[/3Z15Y0>M*EFJ]T>KTBKY':\FC7K=;V\)Z4EZH!9?>[-0KVN>NB"4FUO NP% M=^+_M)U(?!)W]$NN[Z.#L=KUEH(8/\=QVY>^O*5 =#>,DOKI\.A+T:2@A7P M;M];Y4A;;Z35X4I0K[-4_AJ,D"OAW\IA_I+7)JUNO]?OK@;U' ;AWX%$GO( MM;%A&!Z.WVNT6[#S&\+@)XPY!*I])O#VU2 M?R ,+,&+?#IX00^C]59ZU6LQG%B@-K"^2V#13:!U9M3-?\$0]AJ-VIMP(@BL M,V\ZL]W[^)?ZFY>8>(.9.*#C(R=$8K2M (.!+/%]R*7+PB1AQK*'6+3?D<%$ MC##IYB/Z4:QZ S-N:BUK(,([(5P:D491,4\X;@IR B<#_8=P=)("F]_XYX4) M;P7@&_(R+$]%O#GXD8@#@(ILB #T["G % MV.&=H&G3&AK$@]<2#K%#ZU> WOHH*0=)X2X%(#\V#UZR"P:(V,A =1@:P1^, MHQ!CP@'&KZ$]24%3;U6L>K_9M$+/ ODW]ORI-65(O$0>PC#XYHEUK1&>;!OO M*,\%0,5EZ%"&^IZ#'QG^BG4GPPFF7TT!F0KB$#@W])8\(MU!Q,X]U48'AX/ MHD$@1]+V84_'! ,/?6)=P2_B/Q$:9("3<'[!!IU6-$#\$^ J,RUL8^$9ZW* M0B?69]P0YY[ :-29QBLTM:8&X@81JAE\D6PR]ZZ@AZ_T+I\+H$F F49FUNE1 MKEH7]D 8@WF1GQV,@,@.^$G>>_,2YCJI+!"1 M^J&47& YM\BS M0*B".,6J$Y?4&T3A[\7 QU!4_6TWS3MT/X;=7YBV57X@I6?"0<3(#27Q= [S MPTHEX!_.X];ON#,OW@H), %V$&VNYW@W][C$M)!6 PJ1P@_*$#T5R&>B&T-C MZ6?K729KRJ(&^&7H",*M5 =C2^-7[X*63LF\E-D*QK+UO'Y2JQ%J3F>^=)3> MU'BY\6Z%[]**0<*"01R0M!_'X9:+C39 MIVNF&]K!D"2)-K!F8("2[>V!YJ$[2((()0L,_TV@7'&]6QN3OBOPE1N-P;2! M\W %!6_HRT%$V81!6!5Q/25\6[BWTO=(C)#9&=AC80U LX1:1&*)*)0PK&)0 M-MDWOAR"L0C#$Q0, 0#I TN!H$+CE35E5N^!_<8.K)&5C"]H63P# Z66A&", MT7'J@*GN&W++R!^;._3/.34 V7(,BW##4SB-1)@#?W/I@3Z'B>,R#3MW%;QR MP7X&Q&[08]! HWY"38(^F/8;;.82TNB2Q]L$PEZ MDFP]H"8L*+<)%\+1X SXF0,O%&J D\? Z( U&)[.I^2I5G;TT(E&@NWCG(?T M:5O+![*3X.O\$YY$0/6AL&+]AK;3W_$_;VVTR?D\]AN88\;QNT)P\$NVM+W$ M9DYL06WCZL$SS\V;U*M9U)4%1CI;TE=@E?X7_C5&39E57LZ!K:#Y>(!P;YYS 7IBP=@1TX!8;!S!(KG&KN)Q]BG2-7SDD E MW%F4;%_O09;8Q'8K9,K#/4W$B>['LX!98?T6D%_D N MS_Q^D7*%T!DNUQG"/U&1$H'G2# =;"M)HO1YWQ)WE!50 J=Z*YB![8/O$ 3> M= IST:T#/Y#81B,UK5YO@STOG1, %!G&%<,TH&IBGHZPDN=#):O.-O(S.3W2 MND/3"#&$EI$')S8P\K'B/OW+)TW8*>1O7](YKU[+_LPJRUC1S/:IB00#\KP& MA\DZ29FYD?'5N.Y+]FV+WV29XPM'W++ 00<@;Q9E)TL^RKH1WO8%\?D8H/;H MXB*(#58PU90OSAQD8@/6Z:3JB]#W:*-@(\"8M$=(@XP8 -*A'30Q;FPSF:< MYXPNCM D!77EKGGJW0C#J"\E;"F.6SMI2S>'AV4.6^]1OLS)P:\!L<$[> 9= MN#]Z1CL:48CG&B NX!);7\LML8-08B"IH\>*),;7*^O7T]-+H&$Z#@5X9+-O MV'\%9#ZUOX&BUC@GIK6#()HR)P'UVZ%EDZQ2G ""DSHC4\(#<1\\CV)5@ M<*0]@'-42%84' F'CA=$?NSA!^[%J9.7+.,%;+B,TVB9B)\?M K-(H)'0N M!$+D7S=2R]-U?:T17?P:+^)?S,X@@N!,:SOJK@+O=R-GI)K%66,XM<%K7F!@ M[B1U"++3AZ $OZ:AFK3=01&&R6Z, TGWSX [+2:Q&K&!+U6B(:]MSY,TJ5"] M@V&.6,3KB1C9%87M>!<4PM2>#\'T![)FVKLG0N9=P^N2H9"W6"DF)JVQ+7WM M+6!E!2\X8(E7'8FN9MZ?BB(4T*K,-'C/= \D!S:S:SL$!M#S2!)W&0 JOG$^@/9JJJ0 M+K0K&Q]:R!VV"R80^H8&=L#7N*$^!*J5*@8 VZDM#6?[^[@A&.!I22" &RH MHJK@ FC9,SN8$!+I UYMP 81"DM]J\2)QM 0/P@#0ZB)9!#J^U^D:'HF/@3C M6Q-Y,P$*=H"1)5[&Z#*H :MC.[EZ!V"X=AEK.KR/ 9,ZG-!AV@%*/K'>"F8\ MI0H#,.;#^#4^5(\5CQ@S\4EI:/NDW[0>-*['\7<09R332)B=6%\$^FY)8-&: M0)J([Z2K1LS=PT5H>9(Z9YZQ3K7R^!(KC]*$5=.?SBM6_*R.3!8'=*IKQ!PE M'+!S/[9RZ.R%%:7#<>0D6AM(-M8;%(LS0.>3LJ^&JLA< $0+L$\D!HS2A<,0 M#H@4@#).;%@\$Z(M9PR.DAV^(E5/3&[!^?C;B?75588$*=Y<$P*,7YX$WKT! M2R5@(_>!]1 @I-=L.@[;@>?2>*"N00R0^E53\W"*ST=@0"1'7/%]8M.9%EWV MPTDR*5H?8/*X8%W<:9N%%6L2:L#&L H0 !$SG8'$T%61$XR4$H EP /[60J# MN6@9T$BW0$?(>&EV(%#F61S4#L"@XABTW8BA=2D>9$9(W0BFO&+ZQ93$,"6" M&DS%-N&!T9?D J3C,1XG)2! GT^U9($#:12HL(A1KBC0=GK,S/?S)GL>Q"DS M6<_[D#BD*N0<9D:H0(_!- 3#_:PF%S7OQF+Q'%9"E6C+ WM MQ1=\G#A1H1OUD%T/.GFBE 4\_5(DD>(D-X]RZ(045D"F,1)K-(W8$3)"2V(H ME2\$6=3XT5!:#O!:HO=.K%]1%Y.Q33^@%!C) #C2=O@"2_F 2><3"#?D9^ 7 MM)+$G@#(D_I5ECL$*=X_3%'&J5M(XG$\D"NG@B/'Q,ZS!]&@O/?HR><(.74[ MFGQ-,Z)W[SYV,F&!$@S-@*TRP:B88[OH4_N.H0T!^]W! "SR;]'^PS/!QPE M@;=^+HD,FH;WPX][=Y)1!-.B* 1+X]S<$)0QB=O.\+1%/N"+_%U:#X D#[1[ M!H"W,;2MBLTYK"DUE; P$"TM^PD2."*A $-/3'S5JQUF@0J8#%X?D*RBAB+6 M4#A.,+.'@!),8J&_9_9HI/].@UV?A7"H=^3 EQ7K-^'<"NRY!K#:;E!5 -_) M43C!)=9^>F.I?BVH[>Q9(%Y;^E/2?XU@>:"-V[)N;?,!89OHR_<#(\ 2 :/N MS\\:SQX!H_,#/6F^,HU^ )8G^ K3%_C0]V^]+HU;W.$7%RXWB-EF-\Q';/ C M&S_G2K0MH.UM)"F29O?]G[=#W3NBMF;-JEI;[>*^(5)[L*7GK@CMHSVY>FVX_;8)8 MC,&V0XUJ@D9GO1E^!+7K-CQ_)$*/32I^'H\E'.M*\,73/1B.N-,QSD%%.^=!&.@ MES@G3"P)_-+SQ4'+\;05AVFAA?"&(UL84AC2-YKON,A?_10^L-H MBATTA_3%B(/>T1_JBI!"0NZ3F!!R%KM>J*]^:1I'L(/Y]VATPUYK7]S8/L/J MA:J:H^%51S=P?(OFP+-QJ%E%!\QEXK?B.A&VHTM(D&M9P8MOZ@A.S#,&Z/V MHN$1>T'L(98I3M!XM#(X-),&,-@U2,6W)FM+WRB.HSCGD.)=QNA!9N 1'+U" MSI+$QL'HI([C!., 057 9*;3()EPGB(_S@NR7SUO1'>45%N(L'H1\U@IQ]3T M%US:QA\1AU (69)AB3DK[@A;PA(P7V<4-_WB].KK2^N3=X)7M*UJK5$Q8[X3 M076C-X!NS53PI2J+$M>:B'R8\3^1[:/)!A0]]8#=QS[7.\'\V[$Q.$$Q$(X4 MMXGX\3A'P^!6\1UDK8I',1ZB2-.*-8A8IJ!@,UY$*+E("[SVHOF2 ML*(F466&,.F#A! M9'!/T0 W>-7H^>F X)"^D&H7@"$8/""#"ES.E^ @' G M/I 4)4"H=N0WS$P)88V$D3A,("UH;.-B#H9-A*+C3$VC(H\:Q?>A$"-=T,O\:2[, M)4%'B@B4G<9#^7T\ :+Q 0"ZA!8H4QM [FJ4)'^R]>73)CG,F7 M)A0>"Y@HYD5]TQ]SQ0 -0#E<_+:Q+HUSLD?G $^B_R@>:>C=<)4RFV*Q$IP0 M"!CNL"2<*I7($L^?%(TR$FTXS!E),9#?=;@S)R.F0X[,(F&NEP>0* TI-J3> MXZ;^4]/ ^SC4(NE04UI3.;&'*BP$TT_M&]^>3:Q>HUVMUZKM&OS7"*ZWWI]> MO6J)&7-Y,!]8N4/CV2LE!=P1E YX2^I7"6?XW49(J1E#H/'L&$5<8;A M@69&JX[U\^[0SC3GBEQO$ B?0H/5MB Z&/YD;;PJROO-6]-( &-RGN&"+<+3 MU(@*^P[P.0&@[#P8[J@"WT)OML+%S?(C+EA;Z\[Q(YL>JO-1\K!Z1B9_O6E@Y1V"-Y.4B<>MK,1Y?+R4)LK'5_]P!9 M;8F2BCKLD:'N*?!=XS5Q&K*%TNSL+2(']UK#DDMP'0[;861!$W17H5!DM;Z?>" X)E5POL,J>T25007(&<@J&D&^>M2AO"I.K;'4J M\ER1NFZA&8S+4Y; 0!OH032/,D_S_'W@1\X+?9] S)X]>*?K:MKYM9O&MO)M M ]1T0T1J'\F(3K#&$=0>>%@\6%>NPQB%&RQ3QPX ,RO76 8/PA3'=U%!BCY5 M5G"^7R.Y+]&>J[U3:4FO);T>$KWNBTIS[A>7I94N+68%E!'_[6"T3*P?XD]]TL)H=J&*#T%),/:%J&K+5\ ",'T-H=$1=2K$Y8NN<6.KZ#>Z MMT@52E;E8E,+JW!8S0AF"B8HI7!(O,.]3Z(LS%?N4T,2('="V9=8ISU4PDG@ M!7I"Z"R"D-YH5&P48TN'A'@^IE* 1RZ%,10VONH MC5H$8N::'[B%$] ,&+LY\Q&)0RYE$IOT\:U()H!F=,OAG%2&RVQ\E=SAC[AH M((N;-&6XU+?@22)^_JK\"Q<"Q1I=&/!0EMO/OQJG&"=A7HUW:G0U?M7O5^N/ MO!I715AUL DW,C-GC:-0@OA9.@E+73.'ZUS04/@YM@GIIMCV72P]80ZHC]>! M,7?>(%8R@!47W%(+3+IM@2T(C"IM.H?#B?JU]4*^Q+BD( (%6WWE8+6MPU7S#_D+>OLR60DU7*,(3O_]$1;=)38!X M.AIQA)XJ*(PRF=4<89Q:&-I#7>R1@@'5%L6:7KTY$&S1Q)%7T0SKSPC,$Z > M@W$GG!/K,B8R:S&!\?$(^\5-/30?N48PT"O:3T (;^)SEDD=&4)*J(7 0M7 MS"B;0//#+()3(@89T!VJ'M(7K.(8%5RK6L_CBP&%W&K/% 4K@D4'IAKZ_/%H M>%OJ)U5";D0^\X ;BP1EX%8>(W(MQ8"DM)T@C$\#5 0)B%J=R=)UB2BNPL,N M"&;Y<@/G_+HNU@C#!,)!X[X25U^F<]\(&YX2BQ%+JJG0Y"8@GK=[E5:]SRYS M,*C'6J O#WGDA@G8Z (_D0'_O-]LSPV3*A6;,U"L$WFP)/_$V7UAY+TE\"46 M7R"HGRDBY)P;FI$Z+MG+F#Z%I9&!)68(HX(IFQ@+^.L\"?1=F=;]Y5,S&W0; ME6ZC18\\K[?KE6ZGSREB*>(VYW^(2=:%H-FIM)I-AJ#;JG2[.^2LO>:F+N"K M*[15R2L'&/D-_N.4.BLS_57L^< ;5:H63@1%#6L8>[&HGF@,&G8?%?B-K4?N M8I.$2"C-I!GQQ$KM2#P>3YE6'>GP>SZW+.$0Y@#00'O6)8=3^_."LG*L:_M[ MF:> M(+UBQ+:K"**X^XWA?:"BG0MZK!@7!GRKH!@(N6V8) C3:^AFH'S((5>?5)G9 MY%--CNXF[X:KM+4A-P ,[PN8R0TX&>C\87A5Y=+X7*E!SX?8LD/NV4J.$'4: MY*X>]/- A'>"PQ'P50(";[LRG7_R[O/(%9EI%Z3S2G/6BV5#5UH<.]KYKLRL M&"I9L*-6334"19. +RHTY'X7VR_2PW,Y2!/7VP @VV\!/F14Z^H*'4 M(U_==@>4O9D(2309 KQPB&T5\YI:2P^1B)GY&5+C94<@>D#O-;G;AFP\L>;PV:HEM>5O(LG9\\2!!BP5Q'D0Q&[J"C4[2Y!G80?4 M$7O2IC/'NQU*;#8^VF<,-U(W!L@8 MB<%)VW.WZ0G$@SBH9I2.T;F!E\(JE-$.1V(H=KRQ0W(DGSI%-ZT M7R2N5)[$$ZC['-UBL(A:\1#IT_7BQM^!-<(D4-4?TTR?_WIEG=-/IEDFJ=,#S_MFML,DT4?E!<"R5,75AHI@*M89 M5KX.,/#%!3$QD*D" 5\^OC5AK*B[:78:S T6:TG5AU3Y#V^E[[FZXAWK;H0F MKO469SR@;Q./QA>NOE1++S54Q*VNVA<#U\EY7$8;+?C[1&S+?F M5IN]<^/;YF4N2H[L,)R3>=Q0;JNA:C+,K5,48IYE?TKB%P4I;$@U5CG)S4W< M+8DNB(11E.IA1S)M[AX;(1U5[8>R:I?;CT>.G(V.R M\VR[U/@Q;YJUQ5V;:S2YQ9USUDEA/X@2^V]3]BR<<:;8\^\[AG*2/A%I4_*0 MN"('DSZ.LQ4\=DZZO6;C -%S. CNM[K;1' N;^>,O2IZRN?6?2YG!PZCIT1I MC6[;L.D4S["Y6A"U6BSSXS"WNX!V;'DFV"@N2RM]'81=H%VN76T/>=8.B4IW M;$+VNNUM-L4J[@B[0G"[V=IYB[N#L&V/Y;F#M=%W? __SO9=K/2!^;AX2P:6 MHG4UT2T,RQOV-Y]$J&^O9GRMA2BB.!X,!AERZT>^2YI%F-/,14@"P=UU&AVJ M6MUJKU?M_@2C_^206IRM,#U6+1S)6SG2P;7&>X-[FO>.1!?>:JJ;6C;8?BX22K=!"70P8N]'^I]0S3HJ]Q=_#8-DREMQHFT<+Y]](EW- MBO.>+@UM<:6T!0-:;=3FZF%Q@! %,[RV[)?8G4DZDJ[ATS$N<$1\B:D2JB @ M)BOS['\NYO= M)"#B'14OS;YAV?T>OU0UR36=4(APTE0K";B[I\IN6&(+2T(R85)]%\_AMJNV M:]9S='3 ^-CAQ#H8C*XO25M"S<(=IPZHXBTYU";@NS$T6+ZS8LFNT M5EH?&WB9->8M@$A+ITEB\4W:5MS\.!-'N@]A@4LXYFW&10K8I4CV.#X4I:0M(>S(QZ([U4R+A(%*G5JL+"IFPX%TOD!B4]%E MN(I"1]U'U?4J<2 UCZ K9$O32^=AJV#,!P6YZG,53]U:U(C;36NV5'I*+/\$ M=C9U[3 )MN.@+CN6\&2H*:M7#8V'JJIE6>SU)HS*%9-"/)S0_UPE, MTLXX4!!Y\47P4A$Q-44<@=(\L6Q5'G=F:K?T5B3-1=,X\)2X=;VD#(]O82RQ M:U3F44%K7(&76F&S L96EKH6E7YDQ*ZLZ01$'RFCZC#\MRTVKFIU<:SR"/. M3<0)&.YOIADC5P_-/3BQSE2^L%&7&*U4JBN9X9U82#RL0M@Y9B1WT:"<*4#9 M=)SGH"I#Z-5CDVY^6G40!Q.(SD !J0@J'L"H,(PK58%"U<=@=XE'Y;&I$"Y] MD:Y-8.O6V22S$[=)NJ!W+-3MI#6W=+$JH6&6JX:^9/L)?RA9??\5C6Y("F Z M"K^.V*3*5#YR&P4=]B.;W%(U)2 M35R!'1/^!(A1=&>%.;GZZ@9.Q=)4C22TYAC8W>&$>#*,R4K)W!*Y)* MW'I^"IWX:%(P/@\=L1ELBM"LU+EGF8.R1 T1V\UD2F&.A@+!XE;59*28U7>5 M/<)KK"385H;Z$\U]_3 O=XT>2;Z8>CIO)M6M"O*I-TD)1H" M(0*QB+AP3H#^DS#DTL @?-D)DO Z%28-S/I!"_B/G3XQV^E:(A6E3TA\&WF8 MY+M2R8E/TR&18_XB0MZ30?=%IUZ65F].@8:1-U-'-E49OM%4=[;51NN1EP8) M-29YKTEM'J$ZM5!1@%G<*?U>F:]4[(%.J.A7$'':*;%_ /I'G3BU;[*2.+M) M/2B^09L-"QLF%W ;.ZHY4+=@?/)OPF?%4QRN3QSV$Z/U6GPJ.",KG88,VT]X@Q:H[ MG\GW16]-A$-XR8 E=2D[71D0"XXEMQ+(L*K$%B\ZQ4#HTMG4H2<6$=K)E"\FV/>J<^JEF]E;ST^(*%VASPQ^ M2?BZ!WR-O V,73?YFH!X. JF +JIZ/$ =*&*A2]#ZQUY(4H=O]BSQ9:QJIVG M>#*Y>Z=^,.W:>OHGODQ.WY$$R;:P-C4_3)4L3 M"?#6@_^Q7N#3AN5+FLTT=Q7QYPJ1KS-BZD_>"4V-W/E"L2K^\;)BZ=9>9'*> MI?KP,)_J2NHGEO&BDBWZ-M:\=:MR#3-W!"_Z]U4L?(Z,GM?'*A&3',FB3:Q? M3T\O58FFF6,/52Q R#$GM@YG0;\4.1"H>R2>+L9&JR;N$I33.FMN%>H66(VEH<*D255) M*A'^;%YQ4\38^591;LP*6J/:T#.+WY+_F3$2VWG*1O6YCPL'8>J>1G%7)O-. MVH@6(2CT38"*)U'&+"PR_8/-Y:C,^MH<\!F$22<,NLT8T&4-GC C9XR8L U< MO371;W)"[,]Y]WW&^O'A9@#%(_#B*5"/8S7Z5!^AK1R22$"W?!SY/7+N MU4\+6.,/I,*8+:P77*6P4^N\?*U*<2M7K-*#[\CPQXRDXW^63OU-D M'^&.;]G:M8;Q/@;RMN(Z#P@F9N-55 5/VW>4LT&?6F?(#2%WLJ2N9'S-X4;I M,FHK3M0Q24'7\IT?1G4'1HY2Y_FYLEPZ>)"('=WENHYZ7/]7WYT%2II90E+P M@2]"WTOZ*2"IT&%(%=&"+ZOJK)54:V*&F;LGUYABNTG_A;_,;5*8NJI1@5?W MV%W47NIDS#-8>&.,SI_48RX)-7F21@=HR/=BX$<80L*4%AN1VT DN8A\-D)W-66)5;UR- E6V M/8YZ0N'D8WL/CT_4#DYD7GB0"XR\[4F-SU"'?5"\:ZK:*+^OC[\535CI6 ZJ M=0UL0P_K"O+89Y8B-AP/1+"*Y:HW5%YV)7M7F3Y)?".??_8XC^.3+#""P/+Q M%GOMM&;/YF=F?>EXI8=C.WK)J DJH).29# MU:TM63M/Q0$37/Z1/,"4$TU*$R.^4%U45,"STB&IJ"_03!+C4LG 4AW@M%239T- 71ZF=UVDS:24[AAV"M[F!Q4*U=W%%:J^7 MI_;FE!T&$)K#@I9C?K6BNG3^QX0XVJYEZ$\<&=O8=:SZCKX'E- M131^X&JHP(>WWVU7:Z9NCF:Z^DJ0X*_56CU5"ONMBG3%71G@:8D$H-9$M398 MC6?4PN)>>YK/XXL3EI-ZA!.S6"X9++"+(\-/*I.F#?%M[S ]]B@SMH[#I:A- M$(O H7%>![E3S/.4NB="]PPRP0WW2D5UF&YJD[FOF JA?/&+9FND>'%T7?ARJ0;%92O7HE!N^;";%CJK5PN(' ME$@1AS///:A"B_ 591]FEY/X W9PW?.*\N?Q+Y_E/S)6K5$(JZX(RA,^/+M MV^1./3%SO&_ J4/<-QKT$QK>_>MZ(CD?(4USQ5HF- M9KL&8N,*=L4Q>/L:]2O25OSB!6R;]#E0;TY@J,LB0VA0VXK$IS.)[19N&.$E MYIG620[:'6D^O-&3P_/*Y$V^DS% JC$F ?'B*A0SBVQR;J.#5T,5$C/9YY7C MZ3]X?#4BMP;W*C;%-DZC$8B:=+P5&+*$+?46UO83(_(K,U_&"ZEPJR9//9() M$HN7DYB@ZJR:GAS6XZK,," \CE5A0:A8$JU!X:/9'9NON#(9LGUD1'V1R9\9 M'E^/.QA@H!2._!_TR.L!#/2%E!04)''Z&8J HP6&\*@ '=7*GCPFZ'"+S4IT MNR^MJR&<JA9BY;!ZDI=RY.X-]_4!#S5<"OIG[+0OT7P M&P'I T&!&&EN5MY"96\H"?& P4(ZB]M4+K%6TB-75O>TJ2O$E8XY5I&..$4P M5'+B,BT5DZE"='34O?*W#@7GL*IT!XP&CD^IFE) 74>PJ;Y6/9H9*()77>PX M<2"V/7M]E=QC)-Q^J7)OKP%S;T&U?_OE?_\OK 3T M-_W6N1B$B6\G?HQN*."/+V+\\[/WOC=5!T'X_]#CSYUJL_;LE]3>QELU"Y]M M^:XT'G^ '^K-$[S/H/)O>*#YY&$X^:5]3\6+$(I!>7>;\(N)*I=0-6-4<6@" M6AG/E;U2JS0XMJ/S$Q<[P%R1N=>5N@/I]E[ZP37F[EN_TI'SPAV>(/53_4R^ MI*IUK(KUO-YJ5^J-+@Y=;_\T-Z8:4LP1<]/771_PMZ#9^P0)X ^7.I,OUGD@UE'H0? '>@P!Q9ZWJS5*K5: M'-E%@$IN!,L!$D-L%?SB>;W6QN> J?LU]4%]E>H3_Y*-MO3R"! :V4Z"S8A9 ML=4LEVE0M,=^^:32$SMNDK)-U%X5(ZSHA@OLN2!4/>X2I9H4&+F**[>HJ$KT MY,,T2>.EP'9B/YQ1F4DG>#!4@9'U#BMCQ2.9)N)(V07 W%%<-_HSE:!+K%1X M[O,P],@ ;;+0?)(RZ3.*9:!-"V\L OPWXR&X<@W4C,)%3.)^@*[I>&&YK 4 MNCN1TO'GY_5.C\CUQ?-VOU(G"@;-UX)O2*_PEVEBKO"MU1Q3L5_#O'PC7JHS M+Y%#"/Y.=2.I<'HD'Q9400*S4IFB*[X Y7,&UD>A9( ,-I+3G6)C8Y@YH:.5 M?DIM Q#/E=I/FI_Q8&9;KYP&R??\;K]5:3>[<;ST\W:C6:FWZI44^IXD,<\K MV#PK):C&EDZI8V,ID#7X,GG0?'.K ACF"/WTQA=*Y%+ G4OY.;=RI,[J@=:D M1EVI,?7A:FH-3M./\G=(\X>#WO-5L5YJ]&FLU4ED#H?L/)NP1DBDZ$^QU MF'*3-?1,3%6"J;&V#M_-GEAO!29+T!+I,?2/<#O"6!$K]3CAX.+$_:K(B:]" ML9X&+H:C*W2-*4,F) OF:RZ=X:N@3R?[9U)]S.^G7 M" GT_&(IF+HXCEO3ZG4DT)) @E_B8\0+W*VZWJV7J5MH)@NUMN?M2JO54.>% M2JO;2%8;MVQ65X_SYQSM.F7]0FDD"QH%Z#650F]5HOA4Y%KFG X6>-P%5VQ![VM-!8J^= M[,Q8+V9>$%8QS<(/5,[=S)$A M,GFOWWAI^&,>DIA(2^T'> M_ABY=EK:M=@!17:>^IPG^5SS(&QT6EXBUN(NRWP^?MYH5-JU6G+@Y;]7G^TA M,6K,]^2M25:@ Q4#E41GK@VJX[: MS0B9I-P2QA7>N+K &!ACG8HGS!1:( M('OXS?7N2(Q0,7V")8&5@ICL;S#'S./2;^S491EGI>0/N_UBZ27FI%>J$(F* M$27A/'3L*- >98(@@_64O;30$,K>X%(\"!-Z\(YJ>N-;AWBGN_P0R695Y\0R M%VSLLL6+W[.ML__;*/*7FV(Q;6E9Z(TE0<+*/+]QAKHB_2!)Q'T,0 ;8JACE M" QX=GW8#HH K0*O^![,9T0F@MMO5:O]%O= MS+$+P/M=3J?WUK\F7D0U@3&]\^S=9XIDBFZ0J14"/ 68Z>V>R"G!B$[^?K?% M5L0IBUG=?".%$YYU3#FPIMA"7*@: @-U\2 4!I7_BS6)>66'Y]FG&:9SGK15 MP5A)9>O,*W,5QSM/"Y5.FU7@_+YPL9?0>EX[Z24G[GE*Q,![*B6M-LBHG .$ M\;P.1V2^P]1'>+X@?=YM]V'V?OJ #K\Y(NL=:8.:;K;JQNU3,B>_J2O!S:V< M#^_QB\R@>2_C&8,4N7.?0).0?O,)1S' 8?.3=YO-\36I*;ZE5S:1:G?@ VXI MB7;,E\ Y(M&F>$0P]"2?*_F2G8BLWN S1B)/L;;'7#,BW;.' J75=26!H>_: MD_<-<(TQPE3A6NUD1T=3S7"PXP]<6CN#BT8]G9^%Q68YJ3AFNLS@)/0PA#+M M3(L7H@H=J"RVI,1V$@Z:V(]Q;+=* 5-%3O10(X^ P$@\S+#)3;"!R7"?\(Y< M]5ZYU]>4D9E!26$$5"7R<,P'#4N3&54%*1AE M#?1Q6R4?/DDV_'%9WT479ZTWK_G'.F-'E=M**EPD3LG$YT/5*E(=(-2Y6YJ# ML*CE^A:Q1%5!QOHD$C 1?X0'&9OR'\A G436@Q7H]/%>I M=# * M%\P2(I,#-0C()L7&L-R-[LM1##Q^#R1'&ICK$0<44"HU8%6RL8DT*9 MX'20 2/-#^5_D[1.W0% )2/'J^949%.,<&(YNEV:L+,]]+L$YA;I-[4K9#5' MB^%2:;##:I0/6I.R,ZVRLCQIX_VS_)+?QL%(](F+5?R)W5 &I&1;?.75:U/@5(YPL[8O MV)BB'A!NUG+!%L><-1-&OU;IYIG%5LHDUIM>FL7& MSN5'3YD[UZWTVCD[%P)FXZZUV2--O[WBD::/KHGNHW,9IQA)*)[*;)=. M/BJ49TA@"905]GN1ITRBYY*:G+)Q6:/5)+<\ %QXA_!EIN ?7Q#EODRJN\=( MTG[*G%<092\K1C1NK5%I=)L$:,8HMX,D$")I'*R;">LR.^KJU(%S:^QG9;?= M-+Y%PN+,EQ=G3Y+^D[KESGW>L:3?>^AF+R9YD#\M=2P'U/=Z&??S_$MS2N<$ M;\:1,'PL$LK>9N 3.-0D8!(H7&*=.2IQDQKE^?(3FE>]V)[+:8X?^3PVZR2H M)O!G6**5[O*I^.JE*I%W7/?D775/K@HPF&@H\Z$79YFE#H!I'J%'&GG2J&&)@8=ZHY9LM:"7 MA*X3Q3TE4(GH$AD$BRZ(C6=);P!#$7$&KTM4+LJB>5%_J:+05!-%;&HWDCM[6!3*5H3$FZ+N@SY_]![T MR+L46A+>)^9SQB__)\AVV W<%>LWVR.P/BJ>"*QK])MXCG=S#\.?6!_"43J M])0K0J:BU74V/P>^XW$GOEVE I*!<8^.F@N)!6,/T2[+&/GX#-5\>MXX:<2I M0"_2]V^4.4\P+%RH39F+;-[TX'8F>F;.53$F5QO#A&_0%NJKLDS=4S:=C MAT+,(=LDNMW1UR*-UG@)9Q9,8;F10UAS7%T]D02ZR@DKM%);K1$+U];]04SJ MYC0&=84&^B, #L0.XXI>:O3?PW0T[&2Z!:4G2IWIMGG[Y M^ADDV]30I:Q\ +ESOEI=R M+>PI7R@-!.J(N/9E3#$J5H)NI-3U49)[+77= Q,RQ2))4!B'FVP-Z"=J!/Q M?28Y3SH)Y.RK*A%'H0O6.O(T7UKGNOE=6C;%W;W^;KLW(1#_K\*/I/56>E6T MI NE+8J 7- ,2873KE8-?Y=W=HPS D2SO*KF=^;Y,T\Q>%8=9*QT$JOICAI) MY\+'*I:<+7[Q5LB_@)->)IL-!Z;*_(F)'I\3^N2"IAK\6)H60.5158L<3A]1 M!'>1)Y&G=_?;(P6B8_G%>NW MR/R;0/K_I/N7M)48.8U"5%->%"CUEZX%8,((*E.0PQ,',709EH$&=9/.NT/# M&8]1:!PG$I)N!O=PTZ(? M$RQ%H).',&0=RYR#SO>_S9,*[N=51)63*5>+T,?UOI0VOD7\WV,+= YE.-.I MYYDVI:ZF?M6Q&N]>E.]998L"J-3UG%(FWL #=Y@77J'(-,>Q!UHVZ'3:&_4W MIAE@@J5E=#]4G7&HNO@*ZM/6S77H@425XCV5X*"J.8F&*68@%&>A5J^8"L)" MSI8V>T=BJ9$($BT_U.&///T&!?%^<+EVCOPF+$ZP4T;J*,?9_#?LFZ#$ \,K M$5C<[]WA*AU8P23NP!>7DUXF-)ZD R+'*&B]Y&9H<:^K4L?S].@A_ISI#YFB M_[2JGZ?_DUA_8Z6=\1@=@WSAFW%E@F2JQB%9)]9'C#L"<91J_<;<$$EGQ,[_ MN&+W6 @=0,#G S#WN]U*K].=+SWT]>H<+/YZI5EK/DGR1Q?)A2ZF'%\=SIMM M+ZXFPOTO_)ML9H6=OH#$^*"(46K1() CB5'F&]QK%O !G]SJG!@WMY<@QWD[ M.Y5^NX6=149*/HI;B49,=GKEC:4+43!U,')@2*8;VQ;:0^?0K:T,8M\WQ8YX MKGB:%--\::GHYG8NO22G>H1GWLQ?D2SJS3C[:8D,T(%"M/&=7NUI;DF+MH2* M ]6WN2= \P^+Y=26U"NUWM,,++R.;=%,QU(,#=2A&@0*7S+XF$H^A8$YY!<. M4'=%Q5O(E?WA&!O,;#24?WY6>T9_SS :2_V=!K$^"ZTSF&W@2SAX"N=6H+ % MN&PWJ"K@[N0HG.!R:C^]L088I^Q7Z1@P"\1K2W]ZE@"$L/AZ(BHU!_);KVG@ MA2#3DZ&.DW3 P,B07>6!A<79T(/*LC)-V?\G 2CG8W*BP;L.S^_*P1 MHU2AAA<("X4CT#>K?M(&%%/3N?3>/@ #S();-$]1RTF)7M8'SL\D,V@1^'YL M'^\23T\/^]HD*]&_%_1_O3HM,;\7S%]3>NAND4X?_;54#^@PP! V2G5'J,<\ M_[7U/V=G[]Z]?[],*RDMV&C]M#.$4F[\>OC4NOJG3=#NPX/]R.J>/W)IGI5>MU/L'2BWS5*XU:FO;8EM#;\['6$W" :VK[1: MK>/!\/'Q0+_2;ZRK:\L-VB4/M?N51F_=TTHQS]J[TYK]HI#T\1%DM2BH+3=G M4V?A7F_(B:?46! M5*FOMA[KGBWCLU[=G6S5G@MWZ$W%M?W]2&OT8 M97J,%BR18!ON JJCYX!?Y M&5>J%:45VM\MQ[[3'%7ZBD!0"< C58KQ/G>N.+=,8LK:"'O' MI:=:MZMC4<,XMSJ]D1029W]4<*]M)_#TAG-$O;GI&(R\WK:_7VDS*KB;!]:M%-LA.4V;' ;.N4V%&$;2FXHQ#;LCQM*574X<)?8*+%18J,828&MWG:2-BY]447W M!GLZUE0&VTI.>5AG%N!B,G9]K 3P;JXQV]BPKM)OUPJRD255%($J,.VIWSW* M-+:2)AXM*?J-5J7563\JX75#-M2#X:?;J !RTL#EM8$XU%"/C:#9DU-Y2']R,P_%3N3KD[Y>Z4N_.$=F=W7HLM+.LB4:[8 MQ"@*.<(C5Q7G!).5)+OH=%CI-5N5?F?=LAA%P-"AX+CS_[?WKB?P65 MZU39592"!\''[KVIDF7+J\1>Z5AR4GN^I$!B*"(+ EP\)&M__>WNF0$&)$@" M)$B1,DXE)[($8+I[^C7=/=U Y/XKN@IY= 0V.[K1[5C'TZ+D%=)XH'>&]@G< M_G^) ^%76:J(9>T)FXGBP--BQ.IL=&+RT9*F)* M:*IN&&FW7R\UYD0X\2Y^U3IV%]*]-Y /CI^RF-:#EX\PEMJ M+4>MXJBAW>G6;O%Z#/0Y%0H/<$CR/L, Q_N% ^40=+LSM%Y1)\RCH[#1[75Z M^@G8G9/T:!F+MT9Q6&X0L\.?MK8NXVETC4.=V#JV:7?Z1D-'@M/R M5W^LG;;U3J_;D/9I]_EX][EC&SC>I:&V[NU.'^U.FUVC8UH-Y7?WL\\G?!#& MET?XP\>L+P<6=13Z80K.TWYO#)D1(>C M%]S.DV6(NJ7GQ[/[I]@4LY7Z!I&QA\..+KI.'8#X%D0S&1ZDT\>N9?5YB^?61Q6**%VDUN4RT'3+5'YXF"YE418A9]&N$VPG$ M')]KUPG.**(U?>]WY"!:&@&!'_@\I!)C#9@$^ S@E":>[_W)7,$8](9@F1$; M.RD.S<)!R]H3,*$F7HI!"KP)."X H'A8WM'-<<5+O+"WX+B,I]H#"Y#(" 7\ M:9GJM",1 XJRCF"/G NSD6H.K 90E%R0DD/C2I!M9Z@UH:EPMJ*&6BI":4P# MW!-@@C\%J4>POQ/< +[=3R0R$^!+!5/D2OAXQ!X/@(*4NR_XQ60>\ETRY# CE\#U!%>4_ MR@E+H#-#^#)0@8'*@P_/&>B;Q(,/@\1R=DY"%3,@&3P= P4?4:) 87JS>1C# MRF%0(+&;1OAV/MV00%@U;G(I-]>A7\,>%6<-9K#B7W-@/904-H-/!_"A.':B M9U2/B^S!:P3*EFN%2@H531(4^X[[B0K['C;^PL69A''"VY-EE+P,?5]8KL_. M$Y-JBI$CP+1XSL:H(<9>-$YG\ %0SD!04@N<"""S*,IC']X"U0 :&WQ0E\8R MTDA9$%- *IM%$ #Z]X$H"R!@0TY_)7/ _7"LWL&)O V"O%*7:Q]BL)T3K!< M*NT*J7X#71H<= DF"QPX-% @?1$J9J J'TSZ%)Z1TXA3+L^U+V@98$W^K-0" M29@X/GSKV]T'[8W1T0?].NKY-6S!4.Z!:E$EB<$&AH+^,S"MVEV"\G>;1N,I M4O&B2'$P@$_,T_YWRH*'.!B$F0>?G!-GNP M9K.M-9O]&VRV]F\'6S\&8C>+D\3EM^KLJ;9B/PF$=D\W[ZFP?U;9IJ)&>Z8" M;I9ITS?=0;_3,_O:VZ]?WL-K5@\;G>CO)(4Q? 5*-08W=QQY(R9T),4W1XY/ M.PY*>*>3\0E3?-&",!Z4$R:$?0>A8!27FQ @:F2&T7&!*"L.$,)02K+&4X9) M1AK;/@7O^8&+E?@% P,L) N,)I[JB/=!BOA9C^07C]K3@E3)H#-8X1 C1SQ2 M"H_0%^"-4?C(.C*HQ.B4JL(HH ;5KIQ$B_&N"!Y%GA'A)3[%/M+<[)A8"+*6 MH% #?PU O!\@6_S4S+\EL>@Q"=Y M.)J_Y'A.F)^NW[YGWG_AR7?PZ'E'^YRX\N,+S\DL3OZ@]I;OP< T]9\+F9[L M]\;/[U8=YPFBM^CFH;^G?!6Q7Q$!>/L+&S$O?Q:.;.!A%X/5"=TUXH04>G!9 MV:"7SS!P%3C2C(&*&:N,7JHIUBD J2S^^>_W]S]AXBR*V=W<]Y+7K"@$GAHA MVNJ&W#%V@A1S 2**L) %FGB^X#I'N\3*)>1>'H&]P,2J#$FC$ECX.\9,\^!7 MYBG?)>+O'YCO/#F1<*(C1DV Q7E),\[@1'5FPF$WXOO&70HZ!\>X@_(M##Z3 M-T$0J$=W>B!//;EB68FO.1#.&T:A@=$#$:+/ !4+\^4ZF6,N*",5A]'_&80T M3:9A1,FEL3/W\&3_E*>>$3IP)@V3O$WEP-^AR'WDQ:C_#'WQS]RB*1C-'7$D MX-ZL?J[K!BFAI2_CJ[>13(PNO*WQ-[E*RK+.7C!!KB(:J(DM?G*)\Z,+>"QS MTDU9@B./1Z@?R=-?$4NBD#8*-@)3@R[R("<, .G+/&%&<66;*;8!<,KC%^5GOO&,QH9/C7[V"G,X9"J7#@6#+CDL*3 MUTI&'. ((SJ"4,R-I$O4:<"KO#[$<#(Y4?EY I]$=@7IQ*7SES3E!4W6 M@0B=1ZFN30X@3R>KT'$!SR&,>(T-7TXVYY%9[/Q%BGZ0N(**&2>I@UH&HV*Q MJ*OA'=]EV4@8*Y0[U^X4'\D9CW%Q^"#/C&?T5?W4O#0$510; S@BX8W'PDYI M,0ROJN&YQI+2DH.GNH]!0-!\@U^.5 S3*-^2CJ!VM@N"8&+/18B%\]XS,3+? MM5@-GTC6HK 6 /,[G/:SZ)8/COB93\%HOC^=O "+"PU&R)XI"8W%7B)&%[AT MWE8!%.R4!MX?/#6.F'B!"VA&SYS!>5F2K^$XEW#FC;7\0[*X:A[&,?7%E#4G MR*%B;F=^QH8Q"O0CW^%/\JKJYRB4 "8JD047C[7_HUB M=29C+60+^0YQZ1G0(&I$ "L8Q#66,13,):=U8>4'BR* MIG/1L%Z%$0/.NDPC=.:>[Y6CS$7@TC]%)=MK/FL(*FB2#)J">*;@;RCN@^YD MQ(#L,3JIO,Z@-=G+ <<43\\[X$7T4Y .+G*E0*5D1-XN0K75]/H*C" 8QLX;+7YUZ<-*)\#(0 MP1!QA7^AZ&-N(O"K68UMHJB28C2N<"0MC=XY(E+-*VMCA"V=I1P>"D/+[)=" M-%$YWA;_B8A)PM.\RR0B34&80BD]G"<0@HCDG$7*MQ MDQ-G7"#M Q*>GSMSCWG#28QO[@LVZOJ!FW)MZ++4]HJBTK.E*V>C2/M;83^V M_OYRJZ\3N;]X])NF[7'7RAN''4V[L /T#]B%>N\+_BQ-E^V@.6)S'@!G15?R ME*2B]IW\7>C8.^\/FFK2_FJ;'NQ&X&%WKU/.2V6[Y-M5R=,^5_>YDATXC2O? MK3>Z;\>F=WR.S5UV=[)XSCXN]^,TM_L(_=CV3- H+5^'E_X2K5>OT4>78;=- M4;::5#[^]I^':[C9.Q_T:P]X/GX"GNQNV%:W[MC2YGJ?+OJAY;'0U3GA/(F] M=9IZ,=]]/9L[7H2R?Q-]\.)Y&#O^S>1S&#Q\QGJ&"\J%O>94=TX U'V(^!EA MKEWD/>+:5+::RBZDZ99*7V1M"UT8I-0!)F23YPX%@>9$:*JZ#Q(G>* J%?YB M\8:GK!?A*5DO>&0\>80FJZ3<)B^@D>MEQ9W9LAT*16'Z$).AHMP'"T8P^:W< ME>%)%#*.A8X06(?#BX-E/R#J9$5I77Y?=>8\RW9#V3(^.R=0_I&Z#S(G^N#P M]AOS,,$K6[!!7LZ%F./,ZEY\>#8KV>G(PJ.%.I@LX^U0F2E5L&(T3L"+;\K4 M#RQ*>=*8LN%(O3A+8'L%29!TU!9H6*P1^)W%A3K!'#=*V(LJ&U=MDI.EJ07P ME(\4&%(ID;S^M.)JJ"B91M_$66R6I#2\V$*O+>I&T9+K:WXUZC4K0MF 3$&W M57[+=3Q4YH%%'4[D/$3.?*KU=/O,T,_NAL,S0]9B(*->7=R]UR[R^K8[4",N M];R[#%U^ST"V/!*%J>HMO*(ZS+H_Q=FS5.KF4;U?Q!QJB*;1I_#GK&\>2:\3 M!:*!G-(E#S2TBW7Q^=IE']'R#_ 51?T>R29E=Q&U<>11ERU27C,&&_#6>X>Z M*$X=/$6(NDM8D-^OI-O^481ZEO0-W;V$+7GKP6N4?.;WD.@^))7@QU-O/N? M*7>)XT*1/C;S$2EOS%+#!H8S+&N"KWKOLC(F4 14DX-7VSVL,_G./ROU#F+- MJW'>>H_O%LM#.;7C,. ]PF(L:79_R');E9N \+#+W%9G1=98\<.+.(CBJ"LC M9RPZ-]&C1E&O,FKP92.9^D MK0432/VML&X:^!4>\JDKAC@5&RKF%P''&F-YRQ'JB8H+WVJ (B?RD M;.;$2<'K]^4Z$1M1[1>6QZ.:Z" C/H9^.J/:&'0.'EFI?=MHFQ:-V:VPY[>^ M$R1P1O@H37I)1ZBCMVO%UD[]<^TV\S()/Z)]AB$!4K?+TTMG _8JNSFYYAFY M%!\OX#XFNO#RRN:"QF]'[QT^K](&@MLI>\=!YY.9LM= 0'X/=+SAS?-8P3X= M;71X%TR/?R#6L-L.-VOW\DC'FNV!1E=I!,<%C,6=D%$\:(F8H7?,WC[K+X[W M"XX)ROL/M4EZ M9]!O:"C@:S/I]]2)=VU(YW04R"$]U&-A[H'5L?9J$=M=/H9=UCOZ8'C\*NRE M_!ZYW;Q9O'8<[)$]&G)QH$&YG:!JWH->2^[ '+XN<@GLT6FWK&,'V&@ M\4LX/UQO%$N7EFO23L;].4'7_-7,:&WWY\=R.=:>F+0SS((?A^)HAP>OAKP+ M9R?C%&],MSM=$W)[V.GW!X=59J=Q<7BOI4(?E&.8[)E*S:'?&/U.?]#/V@&^ MT:R.WK?4+E*E-UL7.DCQ4LLW Q#C@1@?7?@,'R=9Y4,$15X=[C^WS:'$'EZO M=X^S^4R!YR_0'8E;>2-;VI<-6\WZG2I78,&RI4R;)H]Q8'9+K89QK+N['J3&%[OL^!ABNN( M@;F\H1<"4C)A>DSUWBD?C3 .XR3.D.%&K-.S[8[5M7[(&OZ;0+MBHXC/SS#6 M3)<4=TED3U"Z8(H-GQ>F2G[P')PGZ&F7.(I4^P>6\>=C;W#"3 GOH=G'"M3 M: @K/\A8H7>M[%Z(2XF+)S2G 1/D+(H5MN'&'_T\@-]+Q,45.4J\@ZKTB>&, MR)@^A"B&(R"((^96!T7FE+7_.5S$?'Q:[3F.H\3Q;?,(#*9A"KIELJ#,OR$F M0P'P6>G(A_4:=FDHEA-/07_C_^!&/#H^RN!KOI2&J-).T@\*TKP77'LW+:<0 MW:MD"H7R2[A<>H'MZ9EL5!,-G .1P>','KSH*O=LQ94<'/4,4N7AU=*9D^!H M M&.6?'*03! \X,F?L]X?WAI Z9AE&2O*?<(8J:NU!&3S*,HOTH;XSV[*/Q. MUT?Q[UZD7 4]U[YF8V8Y3AY.>!>]9*G3\'@56!CQ7 MCV/>1H._^9H%\RO#0G/U>F.1 OD1^H5E]%@]K.M ^^(\H^7H<@&XRAKI7A2G MAN3W1M^'\#_:6WQ:L9UXS[1@-<4\R=*KI]_F-%/E5["_N/29/M3>7MQ]D_]X MU]'D/6 2H\O"I3T"YU)>V@//*W^1CX;.!KVI-O!,F&(^Q.(,SXAX^[7LTJOV M %J(KM2E>)E3=)).^.0:WGD>CDYC,912.!T.7M<3,Q3YQ7G2'>!&DLV6]SKY ME<*2>[9+6,B9F&+N!3I"'EW6$_<1Y6<(BL(@X_RBNO ;T(-^"''N$T"275IU M<*8& T4Z'M-X#]E5F4A=!,CQX[ (%=Y9$I?]%Z9T.J,PY?WE ]2Y>(MUQF\5 M)K@M#T1!E%":D\(5N:1(IBK%S7PQU(OK4GD!,KO"J39<4&8"$A3_S1H=T#?S M9@K%/XC0@W+)DZ]%+CI\/8W$7=YPQ*>Z1#@2=X*4#Y^ MG_/!0Q\B9Y)( 1 R$DHOSN1CM&T>CB(&>N1]R6GP,O_3"M'X-W)A)A;:V_MP M#NS=TWOO?M(^T/ >T2!?V,6/V4RW#W3[4]UONBKZI(Q]X]?#B[WY\88LZ!=B M:< )=B8[^2"8W(OGX^.OLW]D5C(['":#W:DK@I+%F[!4!:M7.], M-S,KA_\ *T=UUIFL#KKFNTSOTN/9F#2'?%O&^*P_/G"(9SG.PLD934-"39:% MP5$Y11@)Q1XMP-\^+I0-$GE&>^%(3")0&-'V.Y@G=1@BMRWX?=(% M^=7ZN)QN0LISR[[8:HZ"HOFH%I0]#;_M2Y31$G3 )OEC41 6A]D\*_ICD4(> M'>S#,9\%\DCX.S#%N8-.1 4>5:2=)<*3$",)$!M(R?#E QN MR6PI;_^3AUKE%!-:G'0'VAI/#(/;;+%766F^]X B;#"V%V%N43'R\$2N3#,G MB5I:"&@FXBS'&!\$(:>!*FV&)$_'O&L'GVI#C0M$K(C/E"!SP44VLR&J$43+ M!,03#E9$:EH8@WQ&IK9V\#BQN* -O(,[,L;!:*"678\[&CAWAWHPJ3O/O<=X MP>T] MSHP"&<-=&>%IB12@M$2Z#5[CI0^B/7F6?;3 B?2$&B4]*;]PKLX (X=%CC06 M2@D82YZHN''"@5C%;[L+WQY)Z%"&8PH@LF!.0$#SPQBIH M#@OS0!5E26#,&/YAW>I<"E)NQH5^%(,("0A,+X"U%X941G27FX5)&,9"OWD4 M%L/0193-& )*9:8'&\C@#&@GZTM'WJ3V0*/>,?P,>AD(6/*@B&/A*\(_7$0G M.]RJNH= J*Y_?,7-Q*#O(3:L&P=U,8=[(JOR/8]VE?DK>S% MO!+@?%EAB 2&HC1PYY68SC3S6^38X,P]DS;)1[^C*( HDY?+P]BYA=%X.D//+[F#A1.6^7I14)RF2'2(8E 1(S'>D$=,,."6N948ABI35WY M81@3W6<\O"R.H9KSA&$OH8-E3E[H$_370$:?Q?%/ *[,5P8@,SQ7QK<(?@ZH M",31:,BB-(MHH? WA(;8X+"0S<*7UWHKQ2]WJD?:>&JBVC%'.Z8CSC$X*E^< MP!&=.-V0Q:*'L8]5.-SG1J+2V5W$6]&!]I^S"?4C8.[LE"HY!&6REZ-&,JP@!UHT;ENDR^4+5'(5*O&V/81J??&R[4[:KK5Z^]K@:!U>MT M+2N'H-_M]/NK"X?5;J<;96M1'"]]#I&D-Z5JW$KW61@@O:T+*7/K-)F#.Q7%O,G\OD!@&KW'_X-0OF MYJ8LK9!NN(>)(6MRZD1ZE5L42E*M;! MPDA_0$_3%?,B9*9NXO/#A[@E\R#*4? %F:#"V 5J!?DJ5QHR2ZFT\A)!;" % M$QW'?6_"BH-25I%!)..P6"8[A<:%7PM-A'-(>'@8:8?5[VG$?>D,C,5Q+!/O M>T*NL4875G"&!P9%<.Z[QUN98^T_ $WG65HFRR@(3>8N^#'JAO MW32E>H/ M.60> SC\U.QJ:3:2!)4EI=KQ'A\.%IB&>7(W'R]"D*0QFZ2^YE,C^H7P_\M- MHF_[5I_$@,@#=5#^QGGT,XC\82^ROO;].YH>V6^O Q[(WF=#G"TV^-@'R*>> MCRKM\*U:]L/=!^(V2]?.-*ON0,-C[(MX*$;[@K<+ YPB\[(-$D^:[6S@.N/( M1E3OUNJ_;QQP]NY%"O"&(P^3^_5HN*]V\?OA1K& N=@!?H^<6;<_R)$W@#\4 M1^XXD>('5X,546*)';FD$K\VD:,N?[=4[\LCG=00@E,O MRU],)065.9%4JYC=T,.@I8B/TA4#D:Z1@'Z%!$LUIB\T[+D;3YF;^NQF\E'&1GG("8<>QS>3"XJ'WI]6&Y^*O8VQ-R&F$^&X4XNQ+QU_*MRH?)KB)BMK;7MX,@3V3945%6**!>/;<'IJ8UN M'3ZZU49"5B@I?'F$/Q0O,B RHTS$3F0LS$G0>:G!^D%H??"C6L]<[:R_H ^\ MKZ/9$8P9DM LGN/V-TYHV*T[->K Y&_W\OCV\E"'\CW0Z"J- @^O^)R242PY M\^R/BPR]8_;V&7(\WB\<: )VQ]SKF//#^0E[&63KQ#371+VF=W!F_)$&H_;- MCM%O:'3VRX^.?*V;I'<&_8:&9[\VDWY//0DVWS$_"05R2 _U6)A[8'6LO5K$ M=I>/89?UCCX8'K\*>RF_)XY_6MG)X01EXS!,];8+7-5KR'O9!9!]%J&=^!:9 M>L8!3\.Q6&> MF\@U;IB.?':\/O4"F(?A[BZ=2T>&T:L$1#0&@A[[=??@+'*3&WLSQ8RQS^;L]Z!K#TNZ-8I'MP.@I8/3* MP?@>>S\%G@]N=Y2ROVA_VQK?;AU\AY:]%VR[.V*[DA]DH=JDZG;_1WSR/_)F MRQ>JSO57_ZNG^L]4;6^$SB5A>E3A/V* M5> OXIL)4= PSRQCK3:=<\ M/+B\Z@JP T*X.YSJM@*L#2K,(,'=@AD,W>SI M+P;IMMQ@&OWNMD!?Y*E(M;\,_.PS_ $^<#'#WC)_TN]7?GQ;56OJEJ&P:&\!:8R^^ -;%M:WV,IM;>TIFZ# />^1^) MY3QC-.N2S]R"!7\- S& :VLFM6W;4AR"BLLM0OF!C1)X]9%%,;S(?P(.N*:/ M(44N:."*L<()'"A.X$ Q(O_P9K/G_YV&:05=8>M#55=4A:AA3"P%$TO!Y$OT MV0,*?HG_[<@HR5IL+*-KZ+J^.S[7 <[]NW>^?_SNS,20ZEL6.#X.<0:(KFG6 M>YSL%J'C M!K3I%BO4I"KI:U6#\7E&7(V=SJW?XE4]0S_75)QX/TE-8$5@C/8,4-/W>?=Z M,[I *][I<"U:/!&+B:E3Q]5&C 4T5UH,2_ZG]^1H M=]A#$IR PM#*41C^+L8X^RQX2*98PB+FM%]0?\&EZY8=NITMP20PBJ ^.;'V M!HQS!ZSS#SG*]";0KM@HXA.=Q4CG3F%<,UV3E=.D @V=K^19NX^<()X J2\> M(L8'B.)@6NV#!\_<33WM<@I[I/T#6T:^?<^\_$/[[1[-IX&H1\^/,/GS[6W MD*; M=[#CY!/#679\I!V-G1X!01P^0]A;8#TY;SB'BW@/%*/VQCC705L Z2[FD>=K MABGHEO$Y@>QPV4 6 S.#?CG668DI5B/'I\E0^->(S>"LYA::FE;3L17Z_GYE MCRQ(]V58ZRW80(2U-H:[1EEK8[AKPO,".T<@;UR%T8#=N.OH."\ M1]ZFH3%'8?L%MR8I"/!['-1=F"J^+PZMNE@#W)DYE$ W.,1Y/C^5PX'.9=A7 MV0-"-EBC<&;8QF#0[^?'EQH - Q[!>H583>[AFF9QP!ZW5()(+MI]PW]&&"O MH' 68==[W<$^0;\$"_K KH,/#,QF1(R^ IA(C(JD6@8&+Y(JY MF"B]2YPD3<+H.7_?21J15'BL:QF;67@[" ^.?ET!'NA#>_.&GPCRM:5Z8'6' MOO"M7U,OLRJ-XZSS1>'([>7Q?3BRK8YD""#3\/9;8+ U;OO1"C:B+$ M=AE^3EQ1O2<>XK465!F0Q>JJ%#(8ENJ%+0!Z6#PP%SI^_L_EK[_50NKKE_>+ MA0[]0:_?)%(D,L8P%Q]3+T'J;LJ"/^&_);L#,!9_<3%WH@27)>0JX&3 B4[- M8!X!4AMP*&&V'CC]#:-@ X])%.!GNP2%6S[MZE,4IO-&A*8W:'XCS&PCX#_F M(; P]$%U(;ESL'WP71*.?[^-8+5;%E'(;46\T#PSLF0]3R7( /M:"&_IF_&2 M@L9(O#(!; 4LBS#G4#>)%, 82GJN2XVR@>+'7V:+Q-"B$2B5,(#? 7".":H MDZF3J*E#%6(.AH1:SH);SV[:DX>#"RD"0J2(>+XL"#>^"8 L#10D$)92Q*6C M!)M4$(6JB:^,2O9NP3YZ+#ZU>9QU5(G 5!.HMJIC676( 8A:#&P3SKVQ-K#U M,T-7^\A?7=R]UP0_82H=3A6!ZT1N#!]Q/;#N3C;+$1_WL$@D_S5$!+;,.?; M0.+O>O'8#V.\F['PQ+.:N8[/"1(X&,4I7OL'G77'=8H %/Q"6G5Q#3$J]"?- M>:001X38@7/(*:((\#<_+PAL=5*>.%!S'> MXN O/86ICP4D #\+6)N1W-&6'#"=:M0@'+=B>-%VJ/CIX#UG/Z0!JX867F% M?_L7_>V&_PT'J.;OWRFZ=&#:F6(S?H;M4OYA=Y!*HTQS E$0L]$SAXAC(.9E MBE]R?&F:*A(#Z#)^![N0JJ-31SP.A)"PV=P/GQDP'0$3IT R4(D8+D)8<7O! M(L'#9U@F00,[^;=(.:-?!GSK/#!:'SZ?TX">@P]/O3DNQ!_#??A9<]_!1V%7 MO3G(0/@4X$Q83E4"(MM1]DYY;6F_)^^T$)5HQB=4,,)W72TXF3G/X.;!2MX$ MK!H3C(FZ,0K]&($>@ZV-0;2(TX/$?R8PO& "&X@V ;^F A)I6$#L$)7GJ'.] MG!TY2+!K\$V06A\XB\Z>\0_W#<#=0'.EE#=BHF(N3( (O(QP:N,14=N,KAK5.^4E5HX480> M'"W5D3.C=,_Z%V)MYOA/!=K*9M ' )2Y 'J$>@.TF;AGA0&(6@Y?\ M2_@$?!%U%BR;"EZN_YCO46DT'V5-58D19QBIX>'5C31#'S@(D\ST\&^%,5.> MX>Z[2LH"D<$^GM/Z $R:"0 O8T,R(]@@CV_C=V@D0O^1N6 TS\%[A^/&./+F MJG4K;@5?@6M_E0:A4+?H0?,C!HI?$")!?/DK@H#F;CNXS CM*EHBYHRG=1S#)O,Z.M(6 M9)]PE+DK)I23(:5 [+)Z0QQ#OJ<;-Q#L+*>^BU=$HYP>1;[A6GU7[+.R/P5R M-'7\;"/Y4 [2GN#Q#@X7'FR_T.B$)HM 'DCQ$3.G<8&%QXQ(Q&'CEL4]S]!R MP;6A5T/2PTMN849,5YS/"%]1I2@4!&-)$:4.FFB4 MK2)P_%>@Z?9#@;*0<9 M00'U!?:%RC=9DOA$I.6"Q[7'H^4K.[.9QSU%.)]=AN0A@\EYY0H?R3^AZOXC!Z) M!H>_$9P 49X5&\ ?)^_5"S"PHWCQ9.IB[BJR:.QQ:__?U'T@I:%=!^)UI+XO M+\9FY,]T&P#JLP>@(1R(QHRTH^(&@!="^M)Y@)V*BW$K(@>>C7 =O/ZEC7W' MFXFWBU0G=)05%HKG'ZE,AYQZLAL8-X+OS8"384MHDNN'C\1F?N".0;A/^20O),IZF1$A@F M=@J*P6*"(7\E"X. 4HK2W"4"U;B/ MG-$(=5%Y[+B#G*F2$Q\%6N#K*\B1>$X=G)J"[^^<&_CQY&9S\MZ%WG+<_&N$-UH$;8-=2T\ M@241L-^XGQGA0,'Z+"9%]BR/.-I#"D>Q -1>(P1IFOLQ#R0D/^U;".T+WE0 MQ T9<1\!,4(E^ A4(CQG!+DF#8BXPH MCYGDLNY@,[Q8>O?R"+(J"Y*+'; >N0<=84](?8M0#IUE,-053[4)^B^EB8KJ M/G"U>Q%7831AU.OB5?O0E"+6"'M-1;]UGY?=YRRGAHXNW;T[(RD2MRG50,\3 MN>-]8]#1E(N A6LZ2G!=XYM6V*[\ MIB /AW-M(6(RPEPI(..U3U(.A8@! 95#/,*#N(/Q&C=/K9+N0M<_,[I8Y_-S;$X$F>+Z#1W\XHDS(Q\8'B-7G(OPG3%HL5)C';ZX_ M31F>Z.71Z!FHPF8B "Q3A9T\]TS'+^&78DP$JYR]+,.7E3BY#)X1 2T9(L:# MX4,8B8-6&HM0!YX9 M2TEN:YO( M+7+5I?&\@"4Y\1?HI))CA!M/+ &_QY=$X)^^Q#%D&!E U;OFD_QD5/@L-0&@ MW2NF"=YB$06<.5RZ .;X],NY$R<*@.NX D^_OL]C ^)M&0'BIQ$>ZJO\L;R1$0Y.EX61\ MP!*)V V($@/AS?^#A3 M9&QHGVEQGJ*''W(2<0SD*GY>PRC+*/)S\2C$D$U6HH+OE:H)G@K%,RPEXH,% M+@JCG(EDQHH\6IZ\%]5%F5SS.AN0;91O$&YCHVP75&E)(XU-)GSI=(SE/W^D M /!'BH'SQU^SW<\QUCC*K=%?G4KBH2B/'Q@\GC_):^-LM$FV7H]ILV*O8@U# MG&\+S\84U2*%HV22052$+;P 'XTPQI]G=Y]D"+4TS429?^ZZGVMJ\=_%W3>L MF-7/]&%]6UM,BW"__N[C)8#@LR@[9\14P[.BWH*.TA+V9[(Z3_ 2Z"\@61)Y MHU0<>L )B1;JXR0-L!B1:_\9JN>/'SY=?"T_,511 (M:XQ.<3'!'>!6[Q06X 58#"?P*\8S!R8B\SMY,PC6#%/U('? VJP^")WH@S.987JC6? M:M0\E@F@D)=]*C,$*:-]KMVE5 *3/33&T'R'@<8-&5$,^WQCMTXLWH.!]GN_CF1)XF9HX M.E'T3#X8Y1'5BB_)#)3)4]@%W4=TT8737@\R>9XM@4[; %D1!+RIACYN\A2> MP9ETCJ3$NF=.RXR1%1X#!D]H0Y2-H#>%#5IX5,L*") /1 ET:7#+F<]!)U/6 M9P$I$LX",O0BKX=7S:],*I;%S[PD7OAN+,X>F%J>C41[U@P-.C 1PZ('(*K' MU8,+P!N%<.06G?A<408<_0['+?FW#H<]3<#._9G10/3O0I@]IO;,0W_ R5*^ M"UM7RHUPTF',C95*1?7/A5QS3HX"$X#CCP<,3K(83S5N83_7\D#)"P3&JI=6 M<0,\YF/#R1*NH$,=Y3!78I:M1L1624? *-\#025[T4V6R*$ MI#ERT#+@E+ &9NP48Z?9<3)0:8(Y[C6WRAYE4QF$(5L_[U[HIAD%P:-B/#<> M>]]!CP3)-,9#*#Q5N'DEN 2/AB(Z$"X"Q,ISF]6]J4*XEJZ[WH,>/O!E>CZ" MJ A"=<#V<^=Z9YCV=8GZ[[>&]65':NWG8C1 MIYDU]D%I370+3ORMQF^Q0\L MGB'>"P_G,C<1=Z#L+L8\)0C_Y/DEV:;Z.J _ 1+Y6)RRN]=P*#6421'*]U9? MO"[MB5&\+)O%QCT$^:1 \2PJ66[AF$*YBU^?-4!.!_F\'EQ<$F#G3TQ M\WE-88$/9)=N*:3(.P7P8VCMWNVKV@ST["+E-Z_=#+34,2$GDPFV*Q]U ';V MB7G_BXV6EWAY%2*Z_F*(8%XLMR5F9DNN9$ 9]/5_,>U1&9FA-7@I5"P]9]W< M^%!_:[R ?Y?.T7NLC(EMJ*T=#X@)BD".B6'EW/4;',Q*IVBLP&'8&[X08RU- M-%!38!!^?9*3%8JW 8[$?$Z8+TEHJUI,N,95921?FJ MC8"YAM+K-6I9GYQJRK1Y#+:0VI)VG$.]?U3T7RNO98UB]8'>/R+XUTAJ&?6[ M._(.R2]_8V/GI5*!7-5423\?+)1.E2VS$SRU?)GJ_9_V!:L%_ZDF8ZL!-\2]XG0,#*-C +HW&TTV-^QI"60R; MR=9&Z&6#@:^RZ+?ZP)%BRTU[V+.'V4";M6N4W?"6CQ,.ZDM;SV:V>[K5-8IW M:%:OLCM,?1J\:*WGC?7QET&_9_:/#.*E#J9KNY1:5J_H*]?#X:,38:5;+#GW M-9=32%PU0%;C9-((Z;:2@B__:UY?.B_1*$H.[H5N!1T##WSP?"+RFLW@U:SE&Z+5V@RY"_FVT*4;JE:6 M5Z']Y\(N\5?R=D+*:TL;R*O')]BOCO]6?A/ !2RI4IU:@M&-5]Z-@>K)BTR" M%7+B*CHO=LOO0\L.3]ECU DT[\LDKQ&%\^SBZ1/].2E/S6Y0QTL6""\PW$S^ MS3]Y$WU%2O]*Y+V9W&4-_2Z!BLQ]__S1&4^+SZXP]<:9D9UVP+%Y=!)V,YDP M).]"D6_9J=#]JS5%'Q;?X,O M?['AIPI.OHA;:):S 1]Q'YM1 M5^R\Y0?=FN$W>4+9I5IIB,(;E5%_!;JDRKY/'6Q+ZHHB4[5KH"Q[4MK 8GEM MU@"%^W_"PA8+!3V5(ILZ0&\P;OD0\5>L'CB2&F#9JH6-E]#EW3),^)WE%N0VH+30Y$R9_4%*X8%(?+4\&RN.ZE].'*>AK2 M)3;9#DI^D/F^&5 M][OEK7 )>CG$FI/PRR#<%P[%I1IT$>C/(Y8\,7$!!E[EE>Y.S#%=!0"OMO6B M[+9>IJ^\U5=ISK6*R/$V2O(:?'Y!D04.[]2%1,,+ 6KO+BQ??B;\G.^$JF [ M 1 -1L\[Z/#>I 8@(]M5'.":=+@4R\<-??"P0&XA9BX8!$%>MY_;H@#6_T ]\J7HK*NFTTK6 MJ$K=.T>$6S L@!5=J#*"'&4?CA?VD50M=F[HYY:.]]8C?FV=B)K%5S+]DP+[ M4:=$ZAM1T)L+G(%=(+""< Y>"RM6F9>V2J1;ZXRWKXVIBCU7DEBY'./\^*R0 M7H@>L9/4'BQ7,\LK%+ZW^ 7B=^1RV=X)_O$["TIZ[]'O);L[BFX\UY;HV=7S M>_C9U4.20 66O%> O'67-?,FDH#4^*(38Q[M\B0(V,UJ)IO;JLV4^=U^:IKC M\4C8OX63%H1Y%ZQL-PO(5KQE/FIC@ MZ(KLPA2F?,Q\/YX[F-'&E +]>^ZXKOQW$41CGFB7L-HH M\CK:+\Q_9 D(!< %3'PF@'ORW&2*Z.A__5D;X=DA.L,SB3./V4^:_.DO.4 ( M2R07 E. G_0E3J,P@7-@_C1R)[WARC=4"HQ)G_T,1BA@9U.*/2(D_;^6T21Q M#_=50!NH'/R_OY@9205I.(* J.^ I!CG-I"8/+[BWFZ 5;!+5KFJ/6L1"^+ MBQD:K]\G)/#]3.8.2:[BY;R+T+Y^Q! ML&% H8<('#L7[5@8_:3]G\O+CQ^OKM99)6$%S>Y?#T90NAA8CY[25O^U"=[= M_+%=L'NS)6J]A0V($*B]0-@;= ;]WG'O0+N=E2$T=*/3-\UV/U_-?G9ZNMUN MYVO9SH'1,77K,/O9D-_P-/42MLYK.)RG,*A)N-T9]@BX]#"V-[H M>] O'(; (/:=;K?[>BC\^F1@V!F:=6UMNT&'E"%[V#$'=4\KQWG6/IS5'!X+ M2[\^ACP[%M*VF]/46;C=HE9^VLTYC/R\LA/J/4Y.=";85?58^/KU<66K,MK- M:3>GW9QV M0W+;"__=OFG9AG+C?]-"30!6I:^B8=J#H=D=; _9Q7B(^.5D]B!\5>6W$SN>9W\-A0\LP9#HY>#67/9/4!=B;R#GFTT!O17AK6M MS)5W7Y7/?6 3;^RMNJ6ZF;K&L#O =E#J]:--BS4#7A4RGAE=JVOU].XNX"VV M>Q#='D;,?9\FWP(^W:/0 B*_@;4]7OFH/JRMY&XR+,[OK:JQTJ^N^7259"N MN[1B;2_%!=MMN5VW3' SNJ667'Q[N]6K;?; !@O2J[,ZF< F"6 ,[8&50[#B M^SN 48428/'[P_I0R.[DX+FB:MR9%EVSUS/4*RQEG]\>B$H\89C=GC6H"@2U M0;BE^T'/S5"A.S M5+NKO[S=VI44@6D97;W*VI(Z=+.Y&<2'QM"TE M,WE#M)5UA=6R4@7Z"@_?U=M<$O<' LJV"WUWR^>V!J':R@J-5;U@7 MB&]!C"UD]4[#ALY=6 ;5K&\6.A'L'U3[3A__9LE/W #RD X.K=F!=P0Q#6[?T@='? U.0 MX?N0LOOP*Z-C^:T3H?_S:QC<1XZ[NX>C]X<#85\W+], 5)6@/=C6X4S[ZH5=H-E2X3%A^/[\%)T;MJZE:QA M#M0S3\F7MUQ\2]2$E]/\;@V6?LA(@U*>E(4_' M,@8#W2S 4?+Y[8&H-(VI-^SW>]W:0/#N+$WE4/CGJB^R73YDW2J@S\<[;JX:4WR.B[<1^PK^_'[ MG 7QSN$S..YT51$M^?;6 %2*H/7Z:N2H$@"2;#FY&F ?>7BHLLBN %4AS+!K MVI8]W Z@I7[_?!Y%->*L:$0\Z)N#X6#=* >^R ZP+--E]61%[3+QMNB&_QZ2"M-'ET%M:%;EJ4K)Y": MD.P!D>+ O8J(V#T3T+"/"8\^SN&NOR%6KSB^[N41Z2F(5-X0R[;UGIJZW0\> M2^_Q619-RO'9C85>S9BA5W &P].Z\%3'6EFP=L/8^N MIYB]9XJM8;SU%-L=L"UUZUJPU'A1Z7I; [4+=^T-J!TX2ZWY;9Q26W-5OR90 M)=7)I?7053EK,2YG#CJ!MY*^E47&F:1P$LHU,MD@T0^\-!OT# M$6T]JRT2S3",?G&$0,Q _5,M'F*5*7J:W^<-BW]KQ'FWBYV3U:Q+_>'ID]W1AT^WO>HY5# MQ!W?FX1@()P[[#9_%3G!>.K%^-TJA2[JB;@6W'CU!:&[#+$K? KV2=S="H/X M/0.(6/8Y%G_\GD1.&('3[43/UPF;4?(*WHQ"WX=79:UI$SK$Z!JZ82XQZ%[@ M?6'2U+64IC4P5'?U]5*FKE+#$M3!D@B_1LK4=12,@3'LOPS/P%.AO _*/R<4 M4Q-JXLPPNV97L:PK5]L)K+HB>C;LVNJ!9#]0U16/LSYX(7N'JBYKGG7[MEK\ M41DJR7#BSY2X;(*G!E;7*MC3Y66V!:4N']F];M?:#RBU3T&FU>WMC2JU. :. ML*9=#13U*DC3?-+5!T:W>-MD5Q!J'YJQQ+E9$.KRA:G;?;MQ*M0S;D,3/<5- M($A^^>R-*:U)W]#UH<+SZ@);X+=IAQO KZ8- )4[ MJ(C?3=$ZH!/3R(D#[^WT%.^Q9)TM0:F]W5:_WU5KJ9L#I:YX#^V>K5XL:Y0H M]7C$-"R[9VX'BM 'S3 *7C)38^!+JVP%1FW=OXI'=H*B+G^ []93!;_5Z75VM&CH(#>LY']:@/]A^E^\8'9X;Y+NAWE4%LKA _>4;"+57PK'> M8:1K6F:C..X:JOX4@?FYC<*&4BAF?V@6XO/*]VLNW< &;D:NUNX9?<,PADTA MM^O.H8]Y,\';$?%=Z&]7(K*HM72K6\CW+*RQ!0@-[&(U1.MED89]?6C8#2.Z MZXY^Q1 $1T;'7AAG%H566;@I8&OG M%KK#KMXTJ(NWQQK*\?7TP5I0%Y=M!M"Z%#7 JAJ&L0V@I+E*MF#Q*F,C]+0' MMIT%S"LLV@20S51L+:QH&>M MU:@+JS8"9EV6ZP\VV*=M@53*;YITX"U3-]?;J97K-PQZ[8CU<#@P]P1X2?.E MLJO36XN[WC,*^<4Z$#0-?6W7QK9TR]H7[.05[4O+]GJ#?G>C3[:-KJT!=FTC MUL/X;P-0X]5\)Y[2H=AE[OOG;S%*1Y8@NQ@GWF-SU#:-(5@U!?#JZS<+>>T0 M@M$=#%5+LSW@\,J8,9,8X3C-A!KW8\7KUZH7WK1$D_==\43LN8O=%+>M@3? ^2B&!!=6V0Z.!A!6 MK?=EWCZ[*2]\:-M#==[#FN5VA.PH:)'[I$JS^.SV:O[)SZ$37#Q$C"2I4DOY M?E>]YKD_,C:+U+K+Q66UH/1_+XSF4O?\!O9OL_L]Q,5C:MQ/ M[=Q+VFQ^\.*Q'\9IE _*K*JE_EYQCN>*P9_YZ-*_!6$$Z*Z?8/JSEJV0?7^$ M/]CG&K_1DV-%:X\. D5Q&.H>5^(X1H54?.S%V)$HG&CP1VT2^G[X!.>,GUX> MZX2#R'P_GCMX'D)6IG_/'=>5_RY"8\P3#?L1C"*OH_W"_$>&L]D!!.#A,P'' MD^" @.^ O!KG-I N#GW/_5E#R3W;_QSZ3/Q !S+-TCL::H8%P3N1 M.= G0602R#60Q2F@8NR&48_:?_G\O+CQZNK M=9(F)+MG_G4O=/R0@H($6Z:-Q2",LW\ZP4/B!!I%.[6W[YGW7]!+[[3W7GAV MS\93[3(\[VB?$_>\)GVECEJ-2 VVWLO'>G\M\N_^1HX;''4T/-D- ML4VST[7LPVQ(0_KC:>HE; L[O0NE1'F9EH0:F\W]\)FQ^)2LFOC"@=A*MSM& MOZZ4'P-]3H7"8/;[NOXJ3/T>J$.GHU8\5Y''''1T?7B"Y#D5 O<[QK!W_,+Y M$G;T,XOCG[0+C$V0/9V$D>:&Z2B9I+[F8@KDX'RY^71WB#4.PYEG)RCU[?X< ME=9X09.N!#P[6L"2XU 5YKF)?():S&=[X8HW-1&M N:A#IC=OM$QAZ=X%F@W MNWXTH8F)' *H4J,5(*ZG$V*!:%W3&YE'H\B'(^-<)F@7?^Q/'(KII MA.]29[P>#7^JD-O M8)=X)WC6PE$"4#%7\7<>@/,4T/,/D>.FCN\_8UZ5%T0A-*,TQL]C35HH M"_.T)R^9>Y9O;*<>89K MFS9OT^;'ER;M_IRH.W,8%Z;-))Q$<'E; M;^=H54^[V#]?UG[0UFLT$M8;Y)S7@@$/AO_DF>FY*W_,3G@S#11HP%V@38'G-*,BF44[D(W!)9/C&Y;+,#;7:@S0X<+9W;[$";'6ACR6UV MX ?>T38[T&8'?OCH<[L_Q[T_AW-GVNS B]O XPD8M]F!'VBSCR0[4![W61VW M4B:%;A],*_2PS+^S4,E\?X(!N+:E51M]:Z-O/RZ=V_#;3G1L6UJ]4%"F;6EU M9!O2MK1J6UJU+:U.CL)M2ZNVI=76Y&E;6K4MK=IL4YO-.!&9;??GJ+1&V]*J MS3[4.&"V+:U^H,T^BI96]5--=?)#I7+HP(OX9D+?-\PSR]@P1=,T M"Q.>2[^^-0B5Y@=V3=NRASN#\"D*XWB/=*#O[P!&0[0H!>-#RNY#9<(U3ODE M&4I ;GX-@S'_QQJPY BXWQ[#(&#_=N0 N?4S[ZS^4!EF71&*!H$76[L5\(:N M-P(]&R7700S"BNI(&7_'?XQ!6]U&WI@9*XAOG!G]QF9*WMY-G8C%*J;7OU[] MY>_Z^5 Q295!;AI7^TP?-CJ#<16^UKE]#/BJ>ZN\C956*R8P7GF3A+'@ED7C MXHI4G55\ML M)\L'S=/E2[3$6Y6YI@'BT#!EG+#,W _4KI8/H>9K\M^#FP/G MNT=XN\( \D7CM0)XHV_H UW19_7@:!X+V&?K3#>ECP4_6_D._98Z0:F>7H%= MOSAQ] AP6S6"5;B 3HG"6H';8- ;N1^9L)SSZ+9"KC-,Z,KX8:?[06X8;U% MC?OW6^,WX?D6%JB]M'UF9DO#SW8NW*+8]#8*_\O&2=S\PI:>[Y5NRH6Q!"G M^.Q=.I^'4>,(]\[,H5P7R?T?L0?_;9H2"Q -JD&TH"4V0>,R[Z[7 SDZ9OA^.\=Q#1N:]$S,7 M S0LB"G:\O$[_E@AGK&9G2W+&*C&KMK*S<&[QG"O<4I*\#!UTSY*-+9B>-/J M'R4R6TB!U=7-77&AAT>+#U]$$3 '"=#[Y_R16]ZKY^+)B5SXGL<'-W"G;:5? MG*M92U&S[T/XQLWD@Q?!QH61X@?IORD.8E/0+061^=0).%7B3(KX*DW2B'WQ M F^6SL1WE$#4Y<:8TGK#-C!,W5+"PMLLOF\,LHWAA>LWDPGXW!68$(QVOW3 ./9-\T2P^W9W40.Q7B&3=7B\KH/[IQ!=S:TCR*8]- =;LUZ^ M_@'PV%:XNK9I;,U^+X)A;1$#S=CM=D\*QSJ"-AR:6\O9,G)X6/L8)%[R#/9P M%@840.'ADILTB1,GP,N0*U 8@"FN$%S3NR!7\F2X>;$2T "+R/&O Y=]_R=[ MKGP>U77=,&#MOEU8N_BUPC'DXQ\I/'&-M^58G%#2=,*B#RP>1]Z<9DJM//OI MRMDO2ZKP[\GOK(C/?O"1A[27P1QPRO-E=((FWP*FUC MJ :'RS^_"QA5M+ME#?7^KF"L,9XK2+$I)5WY^Y5P'%IX^E[[[44 E H"X&;F'Y#5-/N4ENY*E&K M%?DJDO0)L78-,VW ME8?N2L$^(II7E)%Z-%\A)A\\/Y51H::MP:"FR*JP[ 6972Q"]]B0.:15.,3. M;&T9]H?,1E'>H_1TC:TUU0$1?#$+L4?IZ.HG0OF#V8EK&@N J90PHA![DD3> M**6+$?&(:AKY2#IB!].7K4O6)@6@.CGKH[+7K4 MO6)@ZU;/J&683XL>=:\8& -CV#\X?Y2JLD^.%^#"-P'\>1[&CH_IO)('F[R2 MU+6-KM%38R:-@'8XA!NX%;'7W:@EG; ;EM6S3GHW-HG?QCLJV?VFLB3W78G=;.6"M7&@GB)JXI5.3 HLLEA7(88X?/*+H+IPD3^#9@#IR@@B!Y]HL56Y G+]73Y+-P;KR+*X:C-P-D @F4B\#R_&?Z3> M$A\V0A]#5X.;&Y=L!,;]T$;.$&N&+%V[VQVN)4RVWJZP-2)+1:J#K=T"!4B^LI@YT7AZ$;@?V"/SPSD^(FH*Q43%K2^D]O1N3Q8A M5UFH$<@J51A9EHWW)K>##*_TE0&PM47J]3Y8]*U^OLVH#2@-$X]*)I[=1 M^.BYS'W__"UF[G7 .0=KKW$8(DTZ; ;M;K\_4!1)]>6;!;QVMXC^H*\>U;>' MN\23".FZ'K4+$)O=#+%->V :UEJWIV3IY@#>@3V)^X7[*:3RQ'KRX[>H W?W M7!.(: (36GIT4" 6VN<<9'&)->-8Q^U4@G8JP3%TRV]F*D'U)EI[:4CZ:G:C MG5VP$QVED@VIAEG#(L.:9&L'33;<3-G\D08:O.[M-,R.K;=#0ZLJH8<0X PH MH#'Q, #$Z0/*="8+NCMY,1-LDM''A^=QY:>7V='=-/ MA;;]$Y'5%[.PS]RRAI$V3Z/QU(E18B=I%'AX\_#@G/DC=>*W.P#O"1C&Z_4Z_=XI3E!J9QK4G96^33S@. 8:K$BFR82;1YG+ MG_**@=-)MQ4W'\O_O,ES,<@\.-=$=02Y3WX8/)QA@83F9?@2@/O.BU4 ]<"9 MNM40W00:94H&/%'2H8P=5D4ZP;-&B0'F$B1.H#'JX)R^9:K\Y M0>)XVBT#?_47)R2POCCP!<_Q8RUOMH!C=6FJ;@>=[/%4BZBM=2S[+3A82@6; MB.6"Y3 6B*"880E&K.YSS#! MZ07PPACT%HTU(R(H+_$]'IA&_V>>%979=&WN S5A05C;\[T$H*/W %97/.&R M&+8*T8+51EZ 9P#XQ\P;1^$(Z,GI ;P-U.>%KT[@:LCL7@!\,4%?Q??^9)'\ M:'S^,@R_,2.[U^5OTRA.@2TE:\G3%1(J1H)*-N(L+OFY* 4SQ^7[,_&B.,F^ M 6^_,;K]3M>T2AD-C[GXWW>X>%79(#BD?&BA$$Z9QCQ7]?UJ7;Y8VR&+X2X" M=[%F#LOO_3"&@^6KL@3#0+L2(#<"MVA?8+SS1QY$E7>^W]=:V^ETF\A#G>MK[QU0M &&Z"TD6@6]L4@'<%.C$N+)B8N&Y!].D-(" MF!T_UV"+%FVA"_J"-!/@A:\'@":H)P<%64-_QW-&:$ZX$I&6K,,MPS2E%R:. M%VF/V'J5/N'(!I1$,_H0/IU]Z5S+*FHUGSV096'TB)H$8LA]"&T2(F&$@B0H MT"X75.,;J]LQ#%-[*R@#MA @6_MM_EF \0V]^HX@CQC:762P&)[GHBX->H9B M."$@$#3YC.;!]QB5)X'G %0#Q LZEB L7)XMTJPQ-RJ(HV(]!X1T@/;X$7< MF'#;DJW@$"NO4MP_CI:Y5VRHM+-$1&)\O'5#<,3BZ@T*P1?G6?JAW#4\T;'VGO14&ZMWBB4RULWG+ MNX)1?T(%6#P9<04K'B>##QH0U)\'7@-%: !+_&Y4&:F%T0]\S80#"WS--[* M[GOOP>^>%'=F;L!2C5D< MB],6:91\R)L&"@S.B"Q0##?\]@+LB*\9IM3T!,04S8SR:M'<(RW89,*P?)R5 M?$-356=NZ7#\K?8 ;H>V;%:['=L \]@S-)?&>[G\!MDXLE"&\92O;RK M9BU4H-_!$3K%( #>%XG@./6J%+ Q.-3KRO;'VQ/P) M>D'X)9)*E*&(X6I.V0=(WKAXP;%J HKU+'&^DXKPJ,.$ZKF6!*H>6 #R@6<< M^ N;DUKBX_P0>L B&'MSO/(A9/+VZZ7V%G]0=#'^[M/%Q:VJB[D"O%"I)3WD ME>2 +T2D1=),2O8-7'O!& [+#V)E[>,@!TS*C W3A01XAQ5.3 A$!DP<'IP!S MG//:9^>I:./S,YD@@4 XHT(>*5U-4&GZYQV/74XZIW3Q8\N<<@EQ]I(>>^_X)&@9XQL_R^B%IE;W M'T&6])#YR[;\H6KEE)"9OO'74HG>"]TN0,BE+5K696!!MF#;?17A'Z*<1RQG M]BJM=Z@Z_'YG,#BM0OPCTLLYGF4:NOP&UA'HZ*.K4-V.#8]1T1Z'Y4!LW1]VNKU]BOWK4ZFEKNZIHZ(]#N7:AC2.XB#7AC3:D$8;TGB- M(8V:L8I"H$/T:K\/[]+YW/=8%+]P8*-R-*"XE;US3:!"1D@BL["U>P5AQ^JL M!L(@=Q[B+R8'^\5+>6[(L!8_T:;.(Z^R@352O-#'ZQ;%];KGCN8E5+Q)D HW@HXJM>=8G)*;B)\$EB_?9P$D1-:?B*F5^ MP1#0N%B^ID! ED7+TO$T6T7EQ:PTW[3MCFD,Z -OC,Y MSMZM]N1T;4Y+W7U MG\^71'V3M*Z(82Y<=#ZMR"5]OVV68<6V<6X-)=0VSJU+N;9Q;MLXMVV<>SKLU#;.;1OGMHUSJYXE7T]3 MUK9Q[O'OT0F46;6-<]O&N<>^SVWCW.-NG.OO8ZZBOYS\7,I4K\M(+^DJYW M7 //YA>JLJTV*!J5GNO66!2O&VP+^)6-F?=(,W)Q:# O5]A:M.V>85F*O*U> M8C=@*@X?-\QA(\!\BL(XW@S.?\9I#);L/Q]2ALG[2_H7B_[I! ^)$WQB4>I] MH9S8>K@M:V 8:^!6H=D5- M_LM0>BMX+:./ZO,%R$NO5P$1#*X^?!&*5@:Q;PQ[VT%X@64MN&V@83^ @YI, M4G_Q_?HJ=)7E:&C5FH8Q!\^0O9=+Z\;JEW MIO?SNB5]('>*]Q3'EN*_."&XM%D_\;RQXV7X.7'Y7LJW>,M(8=A8UC"R"D^: MNJZK@E,'MZ.GR]R MX7(Y56R%*C8:!O&A_UR*KLWR_86&R)41-V+N^S3Y%GAQG"YL MH/]'&CPQ[W^QE6]5#(9F$Q@()PLW:H*%"SBOI!QB>#>*"LCO<"7+-+$/BV)Q;-!OM1G5 M\.$1 I^Y&$6YF7 9JB"Z?$@+1CJQ_:?SV9MY"7.K2K&E#X:F#$\L+%Z$C&M4 MH4X_L%%2HN/15^J=F0/4\?SG',X[[_LMGY;A/+ [-D[!GBC$_C5,6)'&\,)U M$"=>DE*C6I\C&LH#A'SL5T#WDG=._7PK_B3-"N'Q'KO9HH%A04P]8R_ $+C8 MRWL\93Z!::&2,5_'I22 M:BV-KKPHOH_@9^I^?AV,JZ#2&^Q[U\WA"^QZ!=U^*OO7N$:TA\:KQ+Z:FK/U M[NO$OJ+RJK;[TND14KJ$._=GCE7 3>Z,YKZ;@L8BAE^S.Y-P7LYA/3Y-O>". MKH&[>.UY/$YG*4[2Q%%%?,Y*O;C'5M .N[;5EW(M RZ@"[#[AM V M+:-K+$,H(%B:V01TO:99G4ASV&CVJ@GU)5IYNJY&+GLQ#/"C MD6NMT T,?;"]T)6W]?S ,%0WI\O\56^XO_ UM&K_"GQ&3 M5U:U1%5H5R#R-2%Q[WS/WKCC),D-?%5:Y^QP"R[(4A!'/S>D-U9AT27W3#YY MDPB7]8;?7RUIZK%IJ!XAZ"D1U^+8B M1'+#N&Q^#N.8*GA"&B:'\=9LFMQ[-@DQ^25D&"R%%X01*!_I\M*L4/4K/!'X MA273T,W'=<=-T-T>FMUN3Q'/ \)_9*0K,DB%FE8+C+3=4HX8K5N+Z:QA;ZCJ MS1^7=#V%=%68SA@8P_YQ,)TL(;C(1XS'LE@!/-(QN^"#Z.#WOS$GNIDH#_[* MDH\TO_0FX&O7+-%IL BI431.AD8UC[9+!4E[H9H::KR9+$&^#_PQ()2()6L4 M(&V ]*@0VC**<;PHWJ&#Z^Z.XU$C>>4%CK\#CMV:*&9UN-QP! ^?X?3.XJL4 M[RR R?!FZ4P67.4%K]^.V' 8Z:I5 )O#<%!<)';(,:@WU!CJ'+5 ML:FV=Z_PW4U9\"?\=QV KV$?OMU=[+('!!*X0'@7S?'++C:I FT.I4##?\P\ MZ9:.8O9'"I_X^%C1D.@#);I7"L1R*" <_WY-!78?J#\ICP+R,AXXC29@=A/F MTF.4[Z,2^A6H]$5J2OP\7(_*#A6$/,.FADBVP>((:?$_J4/RA7*V6%V6%4EN M]E!7%5X.#D>U?SE^REZ>@4INB%B5>&<]_,='A(8XI^1L,^P>C%Z<]7YE3_2G M?1-HL\!TA]4%)H-ZG[@.JN'Z&^#Z;Z>Z/K6:P%->=GO/ C;QDAA,3WG=2".A M7=WL=Y5+&Y47;Q3J"M&]3:["E>-%)#LW$_3.@[&'=2@R)Q??AKXWKEJ0<(Q3 M[W !3_Z0X@^(L48H8V8M0UI3L"9(TPQF[^6@W]B">J_+WRO=U\75Z M\=@/XQ0+QIU1F";:!'?G4>X."(0VR7;(RW>(>JJKH.AG! + 8]EG5E^K!\M; M.?C#U'^^+7Q5?C![P/CY'36?!^\6P.8MR1=A)E!*X3[7RC^O@>6"//^;"7*)'\[OSNG-'*'",*^PU8!;@I9"90ET@KH.4@_ M)&>'F*J/$B2M9@/QGP@ 8T?B)P1C4D@<+Q@%?'HA8A1[91*]D[%?<$\36@6 [XCRA?P^IWW!YKP-!:#$01O M*E_W BIS +=+>VN]TT91Z+B:SQZ9#RQY7^3A')('[Q%'/TSQ=P\ <4*0",B> M<:D_TA QGV-T--;>IH'C(IF9^XX7/N" ]R/WQE*,O"RYV(=PQ@VT<'[<3$6 M+?@>)S;.F> 3(9@&N@9K]=2UTB <87J26MOP;4%R)&V#:B $H[;337080).&\0K?S[F#^O=ZEA&N MA6C-$8//@27/M#<$B@5*CP6HP,#9SSW^6+CQ61UV2IVOI;Z=A2X<$CIT9,/8 M %51QU-M LX^G)^P2@A;FJ 7 YHS]F;@"$7J60OW5Y:#\^!'@)-O'P(**@#' MT0H(?3KCU>FD@8$WL+Y;/!-0:$E#H9EU&4GH#DH MB@-0ST)Z"\P^LA&=8)4CJ#,*'QG-0B08QJ!+'@#$/WD -AIA,%B+0Q4-/A' M.,>1QH+G5/X4UQ[*XQK2)<@C5R_.I2V_MOQZ2OSZ4EPZ=J+H&4V<0U3%*7;[M0DL>6?\/@D=*#&(SO#"&FJ"2<38 MF?1\F8.W>#@T,^>9O&3VW8N3<^TK0Z"P7HA_A^"S..;2%"W@"9L"6T" Q.DH3D#?88,E]X=DYFM2_33!&BS# M(TV9ILMA_$9DYM)G69%B^DU,9 9[%84S@#,<_SX-?3@U<#8!'0A>?\J$/8$W MBYP1H')AA8G,M5+EA>I:M?0%S?\MBRBY7Z$"$X%:[OWWJXJI3C/ZF-7K;Y; M)2/8F(CQ2Z_--83= P@O5M):"[HJ!:TO"%[].M3_^[?OH\CW?L+_#__\_U!+ M P04 " ,?@Y+-HO'-D M[3UK<^.VM9][9_H?>#USI^E,95GV[F;MKMNQ+7NCK%^QY&RR7SHP"4FH*4 ! M2=G.K^\!^"9 D-)Z2^92F4DBXSQP'G@<'#SXX9_/"]=:8>X11H]W!KM[.Q:F M-G,(G1WOW(][)^.ST6C'^N<__OP_%OSSX7][/>N"8-GSZ?3JS_VQ]:^WN# M[_?>'>Q9@[V?K)_VK>'%]>[S%)09(A_P!!C0]M[#?P9O)H/#H[W!T?[!EYJ5 M^L@/O*32O>>]Z)]ZY%?$LQ/BPW=72^_[YSORRPS3]\$0T2?O,_IT^^[A]O#W MMU_>$_PX7WT^??\P??STR\N>.]D_>.^.?YM\^76Y\.S9#V&5'SQ[CA?( O]3 M[W@G8]*G@UW&9_W]O;U!_Y>KR['$VPD1CYY=0A]UZ(/#P\.^A,:H"N;S W=C MU@=] 7Y 'DXX Y08\ GU?$3M'+[C)P19Y+?]$)A#)5K4=R$JB5$=7,#SL+T[ M8ZL^ !_\*:W-^@=#&+TP.O-$%HF)%/D/4C6$4"0?*^0<.9B3TLC(1HBRB@- M%GKK.#[O^R]+W >D'F!A3NR$KIHH3P RB&*]=!*BD4[TH83@D3RA!\)\;,^A M3R[Z<;^"@<7%"TS]"\870SQ%@0O>^RU +ID2[.Q8/N(S[(L&[RV1C:L9QAT' M4"@C]]$"WM2%AV O);X@<,)J7L!;P/'3 0LIY0YYSZ MQ'\1O9$O9"4[%G&.=XP8HEH00E;LX"FA1$H7]?F!U;-B\NQ/1!TKY&5EF'WH M%]EDF <>=F[H/^3O)<<>L)%$EU 0$48H)40VU/-/6HG%IE:N&BNLQ_KNGJ+ (8"]]9=P!?+F%RY[\C1>2D!FW[S= MR#? W)+!S/V#9\A2G[/3N=U,,W^>B?F<@C4 M7>8%'(L_4I["-3%7.<]G^7;5.^-@L4"<8.@38S*C$ ;:" (JVV8!1$%T=@MM MW 9PU(7J8IN]]'W12PE?X:,,9RME;<6\N^JIR!3>';8Q6:$'%U]C/W2+'F3V MP?NB#V(F5LKE;Q;PZ:J];SE>(N** ,#R$' MRV=6PJ.K5K[E;(FY_W+KHC#Y\%M EB+\BT>),K#9YOOJ@!$R^ILE687)B9A9 M5XT_Q$OF$9'!NF1TUO,Q7XSH"GM^Z@ SBMD)!VH$*9E94\8MR6X"[*R47U?] M\)$QYXFXK@C0Q>@[ M7HC,#@&XTY)@2S#]X4?1"S"L-V.=9GN'75 V()ZO/ M%O6<,4]DA5[2&;44:K;]VZ+MLWPLR\I@(6?0 M7(G1HOLER\R.FW3L,_MQSEP'5H!#J-$FF-HO<8Y="S.;65EK9KG\Q4KY=-KB M/7%0PQ'[/A@B@31K7@8TVUQ9:V;86%D^W;4Y\@.?\9<[4(NO<&83*5]LMK.R MG$P86#&'KEHXW+2B'<9[DX52LXTU>Y QO14RZ*YYZVWR;K8U7&^+>%]9*:ZS M16Q]%__J[*F+NNZ8H#1ANR:-V8'*:G0]!X9U=-9]VAW]K*],"$;''"B+VK*- M_\X[(;_;G[6^%F(VN[+(+9P&Z+RU"R< LN;6@\SV5A:XQ2,"G3=XZ39UOJ6; MDNN[J"8KJ:JS'JV[EM9[=6-JLV>_ZZ MWNV)B]M.X.*;Z;GGDX6(M>X]/ W<2S ?4)]X'O9C-Z[G^S5Y&UO&&R4IL%;+ M /1(%H&=2&.%XEA2'@$))4H:TK;YU'?Q!>,84,\"SL5.^/FS/4J\%SSV)S2%5(9AD=>B=H'51-9?:8DOQ1/);O5:4.[:P;U4ML^IY5 \_L*B6!I+O\ MMNU@-;82] ZJCV[VDY)EJMA>V#JLTF&YR,'LI0I?KL/)[&8E(65V8+FENO55_: MU+NL-K;97TJ&IOQ2Y]97U?OQ>E_5QC;[2DFEF/;HM[ZJ\E4F#*EPD-F+:_ Q M^U=)KAC\FP]E:C2$SKI?>P%8WT_KH9J=J*1?2NX.;WMHY7WBTHFO%K+93;K' M#/3WC;>.TMY!UCO'A&!VB))9R=Y1WOI ?V_9D#_>S M*WB1WKWGKAJJ[SB6' M-NKAFEVCWGLIN0N]]5+E_6B#FVH@F_VD'J4IN3^]]9/A2&V9AZK0C+YYIQYF MT1RSW7JEU"N9I4X1=@+KC17Q7W)+IJ]A8/:DYF4(Q9/Y-9*"8,4U;M=(R2EJ M?;MM]U,L7XNDV S:A.72(%OIO>[WBY@**>Z-J0U^TU)1&3\ M5DP\9*L2)?>[XUV)N#V55>9;"-4PY]B!4LTIS[4HS'XT/(A1\&-<@01M#V-6 MWH@H2TW4)S![;KW'-;:#:2VG94^V!C[8]1)#4 YK6XF=ZX1?S<7L7B79879O MX2"LK-62U5IQO=O>JGU.I62CNA:JV85*ID3_$LNV:Y:_SE)VPZ4"R^P7S?,@ MA==;_G^[1/Q'Y!KN\-22'_P[\@%^O.,1\97'G:ALSO'T>.?QZ<'OQ1]L^Q>H MMON\<&,4P=KPP3_IT:(UHHIC%HC;"A?E@X3 1)[#@8&N'PL?,_")+\AO,]58 MHAX8I?NOH;*+'M95&4BP^PUUO13\7U5):'WK*EEHL-](U;.TEE=5&+K.N@KG M>]LWTG>85))5-_HD8C_])F+T=_&[B1] <<9]BRK?8#1]CC/\D.@ELR4K XGX MJQ?3]411;[#?.QCL/GM.*NDZ0J1F6$^(F&X#(?3?&:U9?4P@ZGV[5HUEGR$M MJ5A+(W[T4N*Z]1N_:6JJ7TO8QZ[OQ26]E-4FTHCNZKV2.)+7!O+4^!1KG<:1 MI;P."44C.12-<_#N*X793)"-I<@U/CNZ3%?;35K"Y*\-/)3C2N1Q3L'S8!UA M,F31[U[*HB!(])E;&6J*+^/^ZQ9S6P07,Y&3#D]J%(\8C#PO$-_ %=)#-+(& M 7%=L7%ZO./S0$P'XBO*1S!-$.9,Y&SF!/&3D.'L!GX5<%'!R,<+@00V@! 6 MYI! ('[D+%@>[X2<"*"8=,MLQT_PLW_J,OLQ5J,$MK[$\N/'1W[,XQ7$OL/B MF^=XO'2)+V^#OBC2FU':H(3V,)&B1R56&U2I=Y]\HE5P0]HVJ)WMZ*47%7[ MKG/BG3%7G,#CR)VP<$S0C1:;,&EX!!DMEHAP479#749GPFM.Z#/#MZY"U3>D MK=0X#%+]&/00?I[X>,>&;D3\V XA<,$H+/;YRRN8HNS$M=+DZR"VH7UG3JO& MSZ_J!EHS4AL42;[9>X=%E!$_9J J4P>Q#0K)W*ZXX!(+GBU86\ 0(RY]C4$A MN763E5$I;5[0CPRB!"K*+K!XP"H45"E=0]#"D./@AV\ZXBR FSP_)+*8\5-+ MX M!GC"\J/Y-:,3CIRB9K4P_T!JUM3Q#Z*@[D.NH4Y:R,9J?-NA+>H]T<,@\I1Q MH6,50&T=HR&271$/J"X8SP\)B3XFC,W5^L;-;$2A B3>A0G_/Z)*\THG_CJH M[=74\P)1TAMB9['Z"EP1 MVT-TEUV290M;ZYJ3&<>X&%D7"YL/K"]@8?\S<@/9"V+3)F+&2%RBGFF>=.8Q7K(&[H+L_G8*[7"(ER[S(4/XL=Q4-FG)9&$>(D M-^+V_(0Z0[S"+I,YI"AR*$S#-7';&O:)_'!!HWQ1>P.DW!KV3W*!*Y!P'?.D& M7KH7GTE=U4!M> _^Q''DJ5&(50J&3X,9 T9KFUHT5$&P$LX26$D@&#':NN#) MI 5O.;$Q-"4Y;6BVZXKP=6>5J)U)\E>0_!-Y0FOLI+7@IM7.ZQ2)J+EI<76"UN7-)X#[#4R":$QJ7_ MP@)8'-$9]!7J,#J3NS(P&N15J,1J7(^SDY/QZ.3N[A8ZX>CD?#BB(1_LY36I M@=>X+I,GEHHUHF=S0E&AWYHP&I?_GG(?!-"X]*'"5YQV4*: M]9(L@,+)*U"!T[@.XA#SF#RGT5IQ1"H#-R[YCV2Q>/DR9T%>8K6X<4G%K']* MV 3;K.,9KAA\S2N,:Q+/554")39;(3;-D M^FG-A-@:;<;R&3,L6A!E+IN]G 8(ZQ7+UZY\\V7HIL7KC9&7^9*:_,VE2-ZRFE'-')'(M%LP1Z\E#' MDF-H6AY9X4OF%=1PQI?GMY/D15X%(T;C\HL&XO\4( ZK_9LIQ.,3"$X\F!;'6+RF@#%5 M&U1-_.9UB_.MS! ,-S-UJ*S)B-"Z_W([P9(ZRI!<8,9J7 M?PD-6A1),Q!FQ<:HC!9$9?Y"/$NI[Q8A\LA3QA%Q@?L2@:1*J3&M1@&^(*S MQ1D$7&R!^2?HD#ZB'S$/2%Z3.HB-:Y.$[.1#+A1QBMHU5$FE H M],O:Z(UK=L4_8G'INI Y48L;E[3P?$;)X%Z)U;@>%V0J%CA1NKGX*$AQG50+ MMW&=[JY.\X)G"QJ7#M:7R1[++1@.0D7DQL%+P>(U<1O7Z8K_&- G3+[(C&VA M[^I C4NLN=RA=-U2A,:EO^*_!HCJTK-*>>.RGC+$G9OID'!LJRV\%-JXW)DT MW1C:[N_PKSF9I\=J7(]HN@]3=@7C:T%MD3A)4FB%5J&-RQTW )VI2V"-R_P9 MDRD,%T/L!H\%D?6@UD@,U3]>B #$);]CKNF:=1 ;UT:SCF[9BEE>H"V,VH6R MQF7\%5$?D5N(,'Y [!H_78DWJ2!4\M)%CJ:!K$W5N)YALD@Y6:K+*)4C-:Z% M=HW7YA6>N+58O<+38S6N1VEDWLJX/-G<+=GS;8^DR3DS7.,LFAZG<1UR!\WT M#X,6PI@U"-J@77P2$TA+%]G5:(UK<@T(9VA)?.1>WA;."VI!C4N<:RCUFU1K MV](%=%]J$WFN[M^P5%528V7@QB67P0RQD2MN#3->&%A+H2V0FY;LT6@ACNGPO"UT!L7!MY?B>Z=Z4YV5.$ M-"[O6'R!SM$*K '-GI\TZU<%'T*]:I\9O<T0&WTUBFJ_[9% M]@4S$\9_61W'/YJ_B#<;@@=YE7YMQ2X)E82>4;D,5NO\I7G6P]PTUR#XPRA; M5\<6JY9Y=C-Z35U\Q/9&/L]2]IF'-6G^N^^'?>B'7X&"G_\!4$L#!!0 ( M Q^#DL6-8P,P10 +@, 0 5 :W=B="TR,#$W,#8S,%]C86PN>&UL[3W9 M;N0XDN\+S#]P/5AL#S#IL[JZR],U@_)5,-9;]OCH6>Q+0Y:8-K>4HEN'[9RO M7U)'6A*O8*8DTL#4@\O.9 3C(!D'@^0O?WM=Q.@9IQFAR>>MO>W=+823D$8D M>?B\=7P\F=._H&_! A^BKSC!:9#3]"_HUR N^"?TC,0X1<=T\13C'+,OJHX/T8?M MO4\!FLT >'_%2433N^OS%=['/'\ZW-EY>7G93NAS\$+3[]EV2&'H;FB1AGB% MZ[_^<72+_F/_!.WO[OVT^_%@%^WM_AW]?1^=G'W;?ITS9DZ"G+7C7[-FNS^S M'WL?;O<^'>[N'>X?_"^PTSS(BVS5Z>[K;OVO O\E)LGW0_[C/L@P8BI*LL/7 MC'S>:K'Z=_=W=O9W_^>^+F_ 1+X(92;BJ0KS50'$L,KB]3Y\^[93? M-DV%EJ_W:=ST<;#3D+/"S+XEFO8M2C)RF)7D7= PR,N19NP&*5OPOV9-LQG_ M:+:W/SO8VW[-HJU&^*4$4QKC:SQ'_'\V8%:]?B*]_A,#FRR3+" MQ_X6VEF?T*,@YG*]><0XSTR421N/0\I5D#(1/.*0[N8_P-YR9JM4"#D7:5XJ> 1*>O3VQ:&&>3 MO/5@Q%RR521]X]=$C:+Y<&J+GODJ=TMOBJ>GF#!OQZ@S)<2 "J-/.,V75W%0 M6:S?"_+$UPZS[@R RXT3S0C^1E-+VCR,,MQNCA/GG&60\@$ 0]&ZE=*HQ<2 MQWP)XZ/I/&%>SP-AH\FH:P#H8&0>4^:.I47(E]=CFG&;NX3,$!/<8 1>XYB9 ML(BY OGR-@V2+"C[- K1!#<8@7=LO0J+%$<7E/4"%)\6:$CELA NYR/G&_O* M0K73SP[! D8=$ #1@CW&?Z]8&(X M?>:R,$<"\O:3ARQ#ARZCA3!0 FX#B.^T'K9QXS$8Y0#0D6(S&'TZF+'B-!AE M6J#QPR.H^$#@H_O-,&IAT.-9;^!DUX,-;\EA9"F:3V'5802"$4R:(3S!>4#B M[%N0,\O%D ^]T7$^H19+X M/9#]C1&/Y$6U2.A^ >1K/6QC>5ZVZQ40?"QR6^*24V))/QC?B%L"MBJ 8QC? M)[:EW1K1^"QT9J">NK6Y6Z./:?92['VQ-9!-L==BR\@:J$;?B['EP1;/Z#&G M+0.V>$9GH#5/#;2MRYI]#^-N8-FJS K)V!M<:TP8&S1C;(#9D@P '66#;"V_ M<"I"Y5MAUJ&W%9:Q-]C6HAZ.9KP4GCWA0 3CD=Q:A/O??6%K\#/)E\!E?@#4 MPVQ(X9#&D2DI@$58;O;CO;9BTL$B6;81V5.;:NX)192_:I55YL M'5Q3Y)WM+:XUJBG8:*?,BIRY,Q>8+:3,?)6M@3H:"O^XV^O6$9X-DM&VW^W3 MZ#!X'<%A$(=%7/)[P?[N0.#7'"<1CAH\G.C-CQ.PCSF:^NS''IJA!JK]:Y!$ MJ$*!.CC&I%Y^;*!#[CZC<55VSGYG$R#BB0ID'F3WY5&0(IL]!,'3#A\&.SC.L^:3 MLJ6F/#RD9@0(WF>P-8Z^I"&B*7.//V_M-?T$:=@9/>+QG+K%3L:W+SB:&6%C MI(&?IW2ADWI)R^F >A&=87Z&^3?U0:*6E'E+64.8?#^ZD:^*:$]'?,7+ M-YJ$,->SW=*I(53L4[;.$,KLH0[*#U]35(5@&S?,NLL-9+BI(?SP+HUZ M,K$\_B+;W0Z7GS3L+;=Z$#\<1[7DS1QX.CW>]O=K%G%^GH1QP2\Z:6H!U%,% M!NV']VB<-C:B\$Z/%F\='.GVV[N>$&H5*.);.#:V:S.R6'A=93A?R0*OQ+&6-74]Q ML&8TK'JGEG9M''3JZ&!<.V9@)9D9]U%7LK(LB+ZT<*[],1N= 03@G=[82IT6 M.+H)XO*8"L0T2=N[SN;9F"8-P][IYS9XA4\F:6/7>4"P9C2L>J<6%G_AE,7+ M4,VHVL.4\Y-[Y>@9]DX_Y:Z*3<2@!(!IZ&?W&C*P/$$BK<"WM%40ST\HIT&D MF1QE)LH$!5/ )X<* +'A4 LLN%]/$0(@, #=]4\9"AF,KX\KG 1QOC0:"MY8 MT18H=9=QOX9Z3RV$592R06BRYT'0_PX#$AO;K0$!ZLB#F-_(MW>:6ATC.\'W MYNH=>6N@?CR([W7+K*W3]-YB09.2*%/)LM#2]:Z%6NQ""D_.I'<#Z2JM MCQ%!%")M['J_ JP3#:O>J>6:'UA)<'0:I E)'C)FTHM%448AU=E4C7F$P+K> MOP K#2X([W38(K5,J$A>B[B@&:^WN)RW;H&5.J5VB%SO=("UNZ:(_%-U%!$N MEB"^"DATGAP'3R0/-!5$2@#7FQ]PU>E9]DY%+8M\\QBDF!\1#%-RCZ.C(K]+ M2);QK9SJP_)RP4Q\"$+KHJR!U?5^RCKNS-K"DXR(F3=E0"P(L'&IS9"N/54H M;SU%;YHS<%BL8L.FIJ&6S5]V^EQ>L+^G.G@K?Q>KO#S"^WG C.D<=[*A"CWZX2X*"F2X<_.O*7-KKE(ZUSGRG49. M@Y%GG!184\CVUL+UNB<1K!!1=+GQT%/)F+O+2Z^S&[9$Z9R/7D/7J[%9^ K> M_/,-ZKLNDH5%[XDUR6IC G0]M94J MZ8TQH 2\F_?:A+1N[=6"N5X3H%H#<>^=SFYP'+_QILG!]]JYSK]!M2+GSSLU MK-AYRQD!UNMV8V\6-Y&#?G&64G4P(^IL 3!R)G,??!MIWVA"NPP9Y[X&9(3J MH!IWF4[5UP9U6[J> $;!2NJ#9+SZYTHV]:X&S=3-Y:U=3V*P=K1<^*NA9F4Z M8XQ75_<5C-/5A7?9$9[3%*^N8<39Z2OS*IG821*DRW,FNO+<(X-D4HU+(54" MT"EZQ$Y=S^8))"H4IIE&J&^FY(*$Y55+_*IV7:JYW0HV/'QA[2? M Y7Q4AN0(YQ@;9Y>">#_:CWX4%&*S3^OK[KHQ)@NZ#5S/?VE5%O/VHWT[MN$ ME=Y1_34@"9? 9<*^?J)9$%_.I0W-]5=#X7>]'$"&SK"R]&ZH2#: M#P <]2,EZ3#P35.Z>L#>NY:MUY*^)%'Y5ZV Z/^*ZB(RLY+'ZL_UI+: M>5N[V6K_9<$#A'\:U*0!<9V4VUAG1G%,D3J-5:MF2.>7EHVG5'/IF'=Z[=V3OXX_9'N#D\=)&[!\O,N^B90W MM^O75L3*$Q)AG5^3-H)N51)Z!\H5[^JSG+D"M//KU\:9O HIO1\5-]?$KZ'? M-U"@UC>FD==M^-WB670@.N[;?! M3\N\I' MF:7V#E1?9ETV,]I*%$"EO[\LU23F6Y&KNJ!!HM\L[;0 EACXFGN2=W83JDM*$_KV#;2IR"4=Z!*Y6O !+ M,_*U4)Z:*$LU"S?&FP7EG=?5)OH\RPJ>$2]OVFQN\(6I6 'JJ>D:3L]:D7FM M[-:SL?"9+ !Y:K2&4[!"3)Z=2SK!J[NT+^='1482G/$:RB=8TH? MT0SQPYDQS8H4\S_>4/$320TR%"01ZJ(;]=I?KGZ>W[^V M/(@X+2 M*T"44]0"'5?A)K>]0_&^J/L*_L^HQ%"N')(X9YQU\(EFA!^]N:#)PRS'Z>(M MUI23?R N@"4.-*-1%,";9JY1Y?+VK!(JY@40D\C9Q;SE3[95 YR8+Y:T&C$GP:HGE76D(% MX\^6IH@[- M@N5K02/Y :RQ+B4H6,2XY)=BI\\*0[$O&+H5''H#')/.51&'G#[!D-5/<'3N MQ1AG55HL2)6-9E:WBA,?V%!3A1?[$KNUPE!:W1Z.43T>V<4Z"7M3]W\O\=4B4!7 .&&C@?PD]M&+HO6#";,!3]T/PV]@L[0%YO M Z43NB^80#M.*]0C\RF-O#5,'0BF4Q5_3\1 -Q#742X8TUXX/A'!O;A<1[%@ M2OO1^60R5L2^.N(%RZJ-@"?B1!73Z!@13+ ZLIF("\&WT9$OV&71PYF([)6K MHR-7L,=O#L]$9&H\'QWA@G76^C\3\0))@9_PYX'C[%N05F_\R-D3S#8T)8Y^ MJ#M JQX\L=TPQC>TXKXR/[L)'W%4Q/AR?IKE9,%7M+L,SXOX@A')H*NBHII\ MJ6@^"+Z E6A8\YH$WGI%!*JH0"49_)N*D)4D_9-?[T*_T]?P,6#S_)IQHQ6? M&-VO+[Z:!M00@1HJ$"=C*N%)O$Y=1[7+K>#&KCAUN:?>YM9XL$/1W&E1 .#$_CKG\T?;]->*7-C+AYR[ M'_P&MK+3K_09ITEY%QR)M>^^57>5Z8%L2 M%UNYJ_B=2.#+^N[#JR)E9CGCMT45:4)RMK[+ZB-7A.OA7%]#:*<$B P\JR#J MY6I <,'(5\@9FVF#@IZ?+3<$CF'D'F15 M)M,K3YE]@W$EY"4,>3AOV.LXSWH1R#D74A9ZSOM>==56*R2W+K9")JW2.6G= MJ@;*;16NG+#R1=,U&*KAW+OE9C6)E;8 47A71\VB[F)1E*GQ]AW=[/<8E^). MHO;5SVL<'!JN!_=A@_6H&%J\4]QQN&#N8"+@6 M*O=1"ES-ZW,)TJ>#ZGM-U2G,=1%2[Z8JU.F]%TUE*HC''X4ZFG5ZUE2[P3#6A.RT;E_8%]9:3K6!>SG30FY:PW37H09(9V292"N# M8;H68GI%I;"3Z2FK'H:Q):LUEU<33\]8J\(8QHP0OKQRD]1N>R(+;&:&<:76 V@J&YVP5>O*@C$T4=Q$U]2'^2F5N"*]H[#$=(D M)'$5N%[.[[:S;=;"5"?Q4? Y6HSU?8QV#_R3N^V;[;+AE&40,N;9BH=3YB^P M3\V5-1\U9?\]EAN\Y5="J8S+!YMZ_&K3DO+63M^;ZA&TNG&,OPAXS&;1D@6A M+T$::7*35DA<)RIU"A->F;(6CG?92H&'7X.XJ*0=Q_2%[_M8*%8&[#K'N(E" MU<+P+T!D8(EO1<]XH-R\Y0 MV1MJNIO*N$K/=L%4+018\K->+HIVN^>_8.Q(3E+USH.I.:GG*?_!8Q?VR?\# M4$L#!!0 ( Q^#DM$W@$L22D GI @ 5 :W=B="TR,#$W,#8S,%]D M968N>&UL[7UI<^,XLN#WC=C_P*T7&V]>Q'/Y*-?YIO>%?-5ZQM?8KN[M^>*@ M*4A"%T6H>?B87[\ J8,4F0!(@42JBA,Q,RX1F>2!A1 M%OSR9O_MWAN'!!X;TF#\RYMO=SN#N^/S\S=.%+O!T/590'YY$[ W__U__N?_ M\[^WC^Y%A]?O>6A>/=@[V]_=W_=WEQYTW( MU-VA@5"51]XLH 26*KC]SY\_[Z9/%T-+(U\>0W_QCG>["W*6F/G38;P$R ]^ MOYL]S ^E$M0YHB/Z)4HYN6">&Z>34DF1 XX0_]I9#-L1/^WL'^R\VW_[$@W? M+/24"CMD/KDE(T?\/Y];R[=^I\_N(V4Q\29\2DUWQ?-=KLYD2H)X$ Q/@YC& MKT*WX32EE_.0(IR$9/3+F^_/C_'.8BJ)M_Z;#FS\.N/?643%9_+&V6U.Z)'K M"[G>30B)(Q5EE8/;(>7&#;D()B2FGNO7HJL2TAB1XKLD0CO1]4BL4B&9D""B M3^2AVX0 MN>D[E4)4P1DC\!M?K[PD),,+QM^B*3XID$GE\M->+&;.%7]40[2: M)%4,-;LW:-)1-=:@A<>\[Q/F#_GJ?D)&PF((O%>UB2>#,DODHB$3QHF&P1@C*3L''#OOJA(*0TTN !,IS3=WX0IS;]K M88SRZ:%ATFJ FMO6:>2E+TC(\'HF'$DZ!P89D,$3PF-$_DRX&$Z?A"S4)X'J M\9T?64P?75H[PN@2<._JV$[-L+5['M.C7 .TI;.9'GTRF+;.:7J428':/Q[I MBD\+O'6[68]:/>CV=F_-CUT.9GXGUR,+&-[%KJY'H#:"3CV$)R1VJ1]=N:'8 MRY^4MO@F.#O?O>HRMRG>SAG<$3&I8>*3Z]%I%-.I6#Z^1624^!><+ X]B"(2 M+^@UQ7ZSM]H4SAD+"1]ZG(2A.*>=OG@3EW]\MYSR]F2C_])V+:$<2>7GFNQO MC+@E*RI'0O&!)E_-L+5E>=5=KS3!VR(W)ZYJ2FK2KXVOQ9! 717H8VC?)JY+ M>VU$[;-0^ +EU#7FKL$[NHFEU+?%&B#K(M92EY$&J%J/Q=3EH2Z>UL^<=1FH MBZ=U!G+?J8*VIJS5?T.[ :RZ*JN%I.T 5X,/I@Z:-@)@=4G6 &TE0-;(+NR* MT.I06.VC=RTL;0?8&E&OCZ8]%UY]PC41M$=R;A%>?S;@:_ 3C5\UEWD#J,U[ M+^MJ1 EHGL3"-NBQP*,^=3,/W[>WT5L^HH:C9#.LK3+'UQ42\MV2_UK++]8$ M5Q=^Y_H[;FU47;"1=YDE,3=G+@A?2/GVE8[6U)$I_.V&UVN?\.H@:2W\7M^- MK@)I)G_3 ,JEKL+_L\"W>0E)L&0 M#!>4"X2;9Q/QGP6:>9;8OK/C+*#R?[K!T,E0. 4<+1)?G314H/: D[A,.N%_ M\^UO*,(60_%7Q'PZ%+X-9X[)6:#JBNCJC*("!^^:<.#\I8#Y/UKE2#?SJ,#6 MH1Y;*]P.&SD%[$Z&WOG+M\!-AI2/[I#-4NY2@;GWC9CC.)T4:6/J[SM$0G.,HA=%88G17* M%OF29T@5F/BTSL0"UED!_Z>3@K=(,) ^5:#T\SJE 3LR<'&BKVE8E7!4(/B@K/H/_3R?%D)D2*QRM M+H Z.5@%ZM^55[X4A\-M'B?%7 ML$X*W(F454E?!8I+FUX.VDG!.Z&Y*BNL0&=IRQ,0G9!6F2B6I^T V.RZ($Z1 M,E8@L[3;Y8'_W1(,],*5)>/=3E8)P?< MZB$.2%DK4%IQ6%N .0LX!"=-Z8GSH+1OU3EQ.G]9_-6RWZ-9"EN!T=+&5X_1 M#'6[;.KDN^5Y>E?:,*&3=C?T2_/A"H27MM"U@W/:9 M5V#4%Q4(65@9@DQ#AR,W>DSCATFT,W;=V:ZX9[!+_#A:_)+>/-C9VY^7'/RW M^<\/RZ@#ERXYYW\NM>F[C\1/W_TP'UPU=AY?B3[Q[ <-R[B)3'BC7 [C:>FVI\)EVQP%W]DC_O79MZ1CSXMSB/&AG_2U?,Q>-!!Z$4VGNWQF1<# .24H5 MJ$D!)(5I06G%&\W0;MGP8V-U^ (M>KLF?4;X)8DG;+BZ4G+]') PFM#9#=^? M^+_=L>0PK(WBH6H&=J!?[4-Q/4X@C5HVK-TLYXYYWV]"ZA%.=&K%28QC *] MNJ2$:YR@_[I;X0ZT'^?2\Q9N&/&J\!ABB/$UK&^5E\QA*6Y62S)\^)P$,7I) MA)-1X:1DB"<9(4M!]@[7WN'ZPSIZWQ= M3$$^SA7UTO4F?*\/7_/M# M'PZW34G5+$"J.;2KFNL1/Y$1[:^IFLB K!(T\ MIEA7UI@/-37T@?F('[0W -6LD4HA!E;.(F\>@YC0X M"R*;Z1 N \\&OQB\XL")*NB$@HP M.\SMF3[O>_(V9U!?_6I?XXO>'@>_/:12W):&]:C&\ MW4N!\B)QW>@6C.S
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�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end